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2A bstract
Data from 5 epidemiological studies, spanning an age range from childhood to late adult life, are used 
to  investigate  associations  between  components  of height,  used  as  markers  of  growth  at  different 
phases, and arterial stiffness, subclinical atherosclerosis and cardiovascular risk.  The roles of prenatal 
growth and life course socioeconomic position are considered.
In the  1946 Birth Cohort, shorter leg, but not trunk length, was associated with greater pulse pressure, 
a measure of arterial stiffness, in adult men and women.  Longitudinal analyses suggested that these 
effects  were due to  a steeper rise of blood pressure with  age, independent of potential confounders 
and  mediators  considered.  In  the  Whitehall  II  Study,  shorter  leg  and  trunk  length  were  both 
associated with adverse levels of several cardiovascular risk factors and also lower distensibility and 
greater stiffness of the carotid arteries in men.  In a cross-sectional examination of Filipino-American 
women,  coronary  disease  was  most  strongly  associated  with  leg  length,  while  diabetes  prevalence 
was  not  associated  with  measures  of  growth,  but  highest  in  women  who  were  socioeconomically 
disadvantaged in childhood and adulthood.  Higher blood pressure levels were observed in children 
with shorter leg length, relative to total body height, of a contemporary US birth cohort at age 3 years. 
The  contribution  of prenatal  growth  was  considered in  all  studies  where  birthweight was  available 
and found to be limited.  Finally,  results from the  first Whitehall  Study  suggested that associations 
between stature and cardiovascular mortality may differ by socioeconomic position.
These  findings  lend  some  support  to the  hypothesis  that  factors  limiting  leg  growth  are  associated 
with  arterial  stiffness,  subclinical  atherosclerosis  and  cardiovascular  risk;  these  associations  may 
originate in childhood and be amplified with age.  The specificity of leg length as a marker of early 
influences on growth that alter cardiovascular risk is questioned.
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11Chapter 1: Intro ductio n
Atherosclerotic changes of the arterial wall are part of the pathophysiological basis of coronary heart 
disease  (CHD)  and  stroke.  Currently,  preventive  strategies  focus  on  lowering  the  incidence  of 
symptomatic disease, which rises with increasing age.
Early origins of atherosclerosis and cardiovascular disease
However,  atherosclerotic changes leading to the thickening and hardening of the arterial walls have 
been  observed  as  early  as  the prenatal  period,  and can be found in  apparently healthy children  and 
adolescents. (1;2)  Aetiological studies investigating influences on the development of atherosclerosis 
may therefore provide important insights into the origins of cardiovascular disease.
Poor growth and cardiovascular disease
Recent evidence has  suggested the importance of poor growth at different phases for cardiovascular 
morbidity and mortality, and this has led to speculations about growth limiting factors contributing to 
early  atherogenesis  and cardiovascular risk.  The timing  and nature of such factors remain unclear. 
To date, investigations have largely been restricted to white populations  from Western Europe  and 
North  America  and  it  remains  unclear  whether  associations  may  differ  in  ethnic  groups  whose 
childhood conditions and determinants of their, on average, shorter height may differ from those bom 
in industrialized and highly developed countries.
Phases of growth and subclinical vascular disease
12Few studies have compared associations between markers of growth at different phases and specific 
measures  of subclinical  atherosclerosis, including  vascular wall thickness,  arterial distensibility and 
stiffness,  or endothelial  function.  This  may help to  identify whether a  specific  phase  of growth is 
particularly important and provide insights into aetiological mechanisms involved in the development 
of atherosclerosis before the onset of symptomatic coronary disease.
Tracking of cardiovascular risk
Factors  that promote the  early development  of atherosclerosis  persist  over time  and cluster both in 
childhood and adulthood, influencing subsequent subclinical and clinical cardiovascular disease. (3-6) 
This suggests that an early acquired risk tracks into adulthood, but the mechanisms involved remain 
unknown.  Poor  growth  may  contribute  to  the  tracking  of  arterial  stiffness,  but  few  studies  have 
repeated  measures  data,  which  are needed to  assess influences  on longitudinal  change over the life 
course.  To date, little is known regarding consequences of poor growth for the developing vascular 
system in childhood.
Social influences on growth and cardiovascular risk
Growth and cardiovascular disease are both socially patterned, and a study of the influence of growth 
on  atherosclerosis  and  cardiovascular  disease  is  complicated  by  accumulating  and  interacting 
biological,  social  and  psychosocial  processes,  which  have  to  be  taken  into  account.  (7)  Adult 
measures  of poor  growth,  such  as  short  height,  may,  in  addition  to  reflecting  early  influences  on 
growth, be regarded as markers of socioeconomic disadvantage at different ages.
13Ch apter 2: A im s and o bjectives
A im s
Components  of  height  will  be  used  as  markers  of  growth  at  different  phases  to  investigate 
associations with arterial stiffness and its age related rise,  atherosclerotic changes of the vasculature 
and cardiovascular disease risk.  The role of prenatal growth and socioeconomic circumstances over 
the life course will be considered to gain insight into aetiological mechanisms potentially underlying 
these  associations.  Data  from  5  prospective  cohort  studies,  4  of  which  collected  information  on 
components of height, will be used to address the following objectives:
O bjectives
1st  To  identify  which  period  of growth  may  be  particularly  important  for the  development  of 
arterial  stiffness  in  adult life,  I will  compare different markers  of growth  in their associations  with 
arterial stiffness, as indicated by high peripheral pulse pressure in the National Survey of Health and 
Development (NSHD).
2nd  To investigate whether poor growth contributes to the age related rise of pulse pressure, I will
investigate associations between markers of growth and changes in arterial stiffness over time, using 
repeated measures of pulse pressure in the same cohort.
3rd  To  explore  different  pathways  through  which  growth  may  influence  the  development  of
atherosclerosis  and  test  whether  associations  are  specific  to  pulse  pressure,  i.e.  arterial  stiffness, 
cross-sectional  associations  between  markers  of growth  and  a  range  of cardiovascular risk  factors
14available  in  the  Whitehall  II  Study  will  be  investigated;  this  will  also  allow  to  test  associations 
between components of height and pulse pressure in another cohort.
4th  To  advance  the  understanding  of the  aetiological  mechanisms  involved,  I  will  investigate
associations between markers of growth, socioeconomic indicators and specific measures of vascular 
wall thickness (intima media thickness), arterial distensibility (distensibility coefficient) and stiffness 
(beta stiffness index).
5th  To extend the  investigation to  metabolic  and cardiovascular disease  outcomes  and  advance
our understanding of the influence of poor growth in a comparatively short and high risk population, 
with  potentially  different determinants  of growth  and  disease,  associations between  components  of 
height,  diabetes  and  cardiovascular  disease  will  be  investigated  in  a  study  of  Filipino-American 
women.
6th  To  investigate  whether  the  detrimental  effects  of  poor  growth  on  the  vasculature  may
originate  early  in  life,  I  will  investigate  associations  between  markers  of poor  growth  and  pulse 
pressure and blood pressure in 3  year old girls and boys participating in Project Viva,  a prospective 
cohort of pregnant women and their offspring.
7th  Finally, mortality data from the first Whitehall study will help to answer questions that remain
regarding  the  well  documented  association  between  short  height  and  cardiovascular  death;  these 
include differences in associations according to prevalent CHD at baseline, differences by duration of 
follow-up  and  the  exploration  of  any  direct,  mediated  or  interactive  effects  of  growth  and 
socioeconomic position.
15Chapter 3: L iterature review
Str u c tu r e o f th e literatu re review
Outcomes
This  chapter  will  first  review  epidemiological  trends  of cardiovascular  disease  and  introduce  non- 
invasive  measures  of vascular  wall  thickness,  arterial  distensibility  and  stiffness,  which  assess  the 
degree of atherosclerosis in asymptomatic individuals.
Exposures
Secondly, I will discuss the literature regarding the importance of markers of poor growth at different 
phases for measures of subclinical  vascular disease and also cardiovascular morbidity and mortality 
outcomes.
Mediators
Thirdly, I will discuss potential explanations by which these exposures and outcomes may be linked.
Co ntin ued im po r tanc e o f c a rdio v asc ular disea se
Coronary  heart  disease  and  stroke  are  among  the  leading  causes  of death  worldwide.  (8)  This  is 
despite  a  decline  in  cardiovascular  mortality  trends  in  most  industrialized  countries,  with  the 
exception of Eastern Europe, over the past decades. (9)  While reductions in major risk factors,  such 
as  smoking, have contributed to these trends  more recently,  (10) improved early life circumstances 
may  also  be  important.  (11; 12)  The  rate  of  decline  has  been  faster  in  those  living  in  higher
16socioeconomic  circumstances,  and  this  has  contributed  to  a  widening  of  social  inequalities  in 
cardiovascular disease. (13; 14)
A th er o sc ler o sis, ar teria l str ucture an d functio n
Atherosclerosis is a systemic process present throughout the vascular tree, and coronary heart disease 
and  stroke  are  two  of its  clinical  manifestations.  Atherosclerosis  particularly  affects  large  elastic 
arteries,  such  as the  aorta,  carotid  and iliac  arteries,  and large and  medium-sized muscular arteries, 
such as the coronary and popliteal arteries. (15)  Asymptomatic vessel disease could previously only 
be identified through  invasive methods,  such  as cardiac  catheterization,  or after death through  post 
mortem  examination.  (16)  In  order  to  understand  aetiological  processes  that  influence  the 
development of atherosclerosis before the clinical  manifestation of symptoms, measures of vascular 
structure and function that estimate the degree of systemic atherosclerosis are required.  These, until 
recently,  had  to rely on  invasive  techniques  that  were neither feasible nor ethical  in the context of 
long term prospective cohort studies.
Over  the  last  decade,  non-invasive  detection  of  early  changes  in  vascular  pathophysiology  has 
become  established,  using  high  resolution  ultrasound,  and  this  offers  several  potential  advantages. 
First, it is a measurement, which carries no risk for the research participant and is therefore suitable 
for population studies.  Second, it helps to identify and understand factors that precipitate the onset of 
atherosclerosis  or  interact  with  vascular  pathology  on  the  development  of  clinical  cardiovascular 
disease;  also,  repeated  measures  allow  the  investigation  of the  progression  of  preclinical  disease. 
Third, objective measures of atherosclerosis have the potential to avoid some of the biases associated 
with  clinical  cardiovascular  disease  outcomes  as  assessed  in  prospective  cohort  studies.  Outcome 
definition  here  often  relies  on  symptom  or  medication  reporting,  physician  diagnosis  and  referral, 
accuracy of death certificates or hospitalization records, which are prone to selection bias, and all ofwhich may  lead to misclassification  and biased estimates for the association between  poor growth, 
socioeconomic disadvantage and atherosclerotic disease.
Further,  ultrasound  techniques  used  for  vascular  wall  imaging  are  able  to  distinguish  different 
pathophysiological  aspects  of  disease:  thickness  of  the  arterial  wall,  arterial  distensibility  and 
stiffness.
The arterial wall consists of three concentric layers: the intima, media, and adventitia.
F igure 1 L ay er s of the arterial w all
Intima:
endothelial cell layer 
and
basement membrane 
(collagens IV and XVIII 
laminin. nidogen)
*
Media:
smooth muscle cells, 
elastic connective matrix 
(collagens I and III. 
vitronectin, laminin, 
elastin fibrils)
Adventitia
fibroblasts, nerve cells, 
collagens and elastin fibrils
Schematic view of an arterial wall in cross-section
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The media is separated from the intima and adventitia by an internal and external elastic lamina, and 
is  made  of muscle cells  and elastic  fibres  in  the elastic  arteries.  (15)  The intima is  the innermost 
layer, adjacent to the blood vessel lumen, consisting of a single layer of endothelial cells.
The endothelium is  an important regulating organ,  influencing vasomotor tone,  platelet activity and 
blood  flow  through  the  secretion  of vasodilatory,  anticoagulant  and  fibrinolytic  factors.  (17)  The
18main  dilating  factor  produced  by  endothelial  cells  is  nitric  oxide  (NO),  which  is  created  from  the 
amino  acid  1-arginine  by  the  action  of endothelial  nitric  oxide  synthase  (eNOS),  a  product  of the 
NOS3  gene.  (18)  NO is responsible for the homeostasis between the endothelium and  surrounding 
tissues,  and  agonists  acting  on  endothelial  cells  as  well  as  mechanical  factors,  such  as  shear stress, 
can  modify  eNOS  activity.  (19)  NO  is  a  vasodilator  and  regulates  vascular tone;  it  has  also  been 
found to  mediate many  of the  protective  functions  of the  endothelium,  (20)  including  regulation  of 
vascular  permeability,  inhibition  of  platelet  adhesion  and  aggregation  and  leukocyte-vessel  wall 
interaction, and prevention of smooth muscle proliferation. (21 ;22)
Loss  of endothelial  function triggers compensatory inflammatory responses that represent the initial 
stage of the atherogenic process and can progress into atherosclerotic lesions and artery remodelling. 
(1)  Early  endothelial  changes  include  increased  endothelial  permeability  through  up-regulation  of 
leukocyte and endothelial adhesion molecules, which facilitate the migration of leukocytes, including 
monocytes  and  T-lymphocytes,  into  the  arterial  wall.  After  entering  the  intima,  monocytes 
differentiate  into  macrophages,  ingesting  oxidized  low  density  lipoprotein  (LDL)  cholesterol  and 
forming foam cells.  In addition to increased adhesiveness and permeability, functional impairment of 
the  endothelium  contributes  to  procoagulant  effects,  vasoconstriction,  foam  cell  formation,  T-cell 
activation,  and  proliferation  and  migration  of  vascular  smooth  muscle  to  the  intima  from  the 
underlying media.
Over  time,  this  contributes  to  the  thickening  of  the  intima  and  media  and  eventually  to  the 
development  of  plaque  in  large  elastic  arteries,  and  large  and  medium  sized  muscular  arteries. 
Continuing  endothelial  dysfunction  can  lead  to  instability  of the endothelial  surface,  erosion  of the 
fibrous cap overlying plaque, subclinical plaque rupture, and vessel thrombosis. (1)
19The  following  section  briefly  introduces  the  different  non-invasive  measures  of  vascular  wall 
thickness,  arterial distensibility and stiffness that are available,  and discusses their properties for the 
prediction of symptomatic, clinically manifest cardiovascular disease.
20M easures of vascular str ucture and functio n
Arterial stiffness and compliance
Pulse pressure
Central pulse pressure is determined by large artery stiffness and is an estimate of arterial compliance. 
It represents  the  variation  of blood  pressure  between  systole  and diastole  and  assesses  the pulsatile 
component  of blood  pressure,  which  depends  on the elasticity of the  aorta.  (23)  After middle  age, 
systolic blood pressure continues to rise, while diastolic pressure begins to decrease and consequently 
central pulse pressure increases.  (24-26)  Determinants of this age related increase of pulse pressure 
and systolic blood pressure are poorly understood; however, the absence of an age related increase of 
blood pressure and associated hypertension that has been observed in some rural populations has been 
interpreted  as  evidence  for  the  importance  of  environmental  influences.  (27)  Peripheral  pulse 
pressure is the difference between  systolic  and diastolic blood pressure,  as  measured in the brachial 
artery, and is an estimate of central blood pressure variation.
Peripheral pulse pressure and central aortic pressure
Pulse  pressure  changes  from  central  to  peripheral  arteries  on  account  of the  amplification  of  the 
pressure wave  along the arterial tree  with  decreasing  vessel  diameter,  and peripheral  values tend to 
overestimate  those  in  the  aorta,  particularly  at  younger  ages.  (28)  In  most  studies  investigating 
peripheral pulse pressure, no information is available to assess the degree to which higher peripheral 
pulse pressure corresponds to an increment in central aortic pressure and stiffness.
However, differences between central and peripheral pulse pressure may be important for the study of 
cardiovascular risk. (29)  First, atherosclerosis does not occur in the brachial artery, where peripheral 
blood  pressure is measured.  Instead,  it particularly affects  large elastic arteries,  and  aortic  pressure
21and  stiffness  are  therefore  likely  to  be  better  indicators  of  systemic  atherosclerosis,  including  the 
coronary  arteries,  compared  to  brachial  measures.  Secondly,  high  central  pressure  and  stiffness 
represent  atherosclerosis  and modifications in the pressure waveform of the  ascending  aorta,  which 
directly increase the pulsatile work of heart, leading to hypertrophy through left ventricular stress, and 
compromised  perfusion  of  coronary  and  carotid  arteries  during  diastole.  (30-32)  Thus 
pathophysiologically,  measurements  of  aortic  pressure  and  stiffness  may  be  better  predictors  of 
cardiovascular  outcomes,  compared  to  brachial  pressure.  (33)  As  stated  above,  peripheral  systolic 
and pulse pressure can overestimate central  aortic values, particularly at younger ages.  This may be 
less  the  case  in  the  elderly,  with  loss  of aortal  elasticity  and  increased central  pressure.  (34)  Thus 
with  advancing age, central and peripheral  pressure may more become more equal  in their ability to 
accurately  reflect  aortic  stiffness  and  predict  the  onset  of  cardiovascular  events.  Differences  in 
pressure  between  central  and  peripheral  arteries  may  also  explain  the  importance  of mean  arterial 
pressure, (35) which does not vary across the arterial system and may therefore be more accurately be 
determined in the brachial artery.
Assessment  of  aortic  haemodynamic  parameters  can  be  obtained  non-invasively  from  peripheral 
recordings of the radial  artery pressure waveform by using applanation tonometry.  (28)  Good inter- 
and  intra-operator  reproducibility  of  the  measurement  has  been  reported,  (36;37)  and  recently 
guidelines  have  been  published  to  help  standardize  the  technique.  (38)  However,  longitudinal 
variation  has  been  shown  in  earlier  studies,  (39)  and  a recent review  has  highlighted  a number of 
restrictions, including limited evidence for its prediction of future events. (29)
Despite evidence favouring the hypothesis that arterial stiffness develops as a consequence of chronic 
atherosclerosis, the nature and direction of associations  still remains unclear; this is particularly true 
for the degree to which the observed relationship between arterial stiffness and atherosclerotic burden 
may be due to shared underlying risk factors. (40)  Population based studies have shown that arterial
22stiffness,  as  measured  by  pulse  wave  velocity  and  distensibility,  is  strongly  associated  with 
atherosclerosis at various sites in the vascular tree, (41) and that their relation is independent of major 
risk factors, (42) but others have yielded conflicting results. (43;44)  Some of these discrepant results 
may  originate  from  the  differing  assessment  of  atherosclerosis  in  these  studies,  (45)  or  the 
investigation  of populations with  varying degrees of existent vascular disease,  which may influence 
the strength of the association. (46;47)
Peripheral pulse pressure and cardiovascular events
Whilst  systolic  and  diastolic  pressure  are  established  predictors  of  cardiovascular  morbidity  and 
mortality,  the  importance  of  peripheral  pulse  pressure  has  only  more  recently  been  highlighted, 
particularly  in  middle  aged  or  older,  (48;49)  or  hypertensive  persons.  (50)  There  is  an  ongoing 
debate,  whether it has  predictive  value beyond the  information  provided by  systolic  blood  pressure 
and  how  its  association  with  coronary  heart  disease  mortality changes  with  age.  While  one  study 
suggested  that  in  middle  aged  and  older  subjects  wider  pulse  pressure  is  the  blood  pressure 
component most  strongly  associated  with coronary heart disease risk,  (25)  another study found that 
the risk associated with pulse pressure was entirely explained by higher systolic blood pressure. (51) 
The prospective studies collaboration found that pulse pressure is less informative than the average of 
systolic and diastolic blood pressure or either alone for predicting cardiovascular mortality. (35)
23Central pulse pressure and cardiovascular events
Studies obtaining pulse pressure directly at cardiac catheterisation, (52-55) or from carotid pressure, 
(56-58) have supported the view that that central  pulse pressure and its principal determinant,  large 
artery stiffness, may be better predictors of cardiovascular risk and mortality than peripheral brachial 
pulse  pressure.  However,  clinical  studies  of  selected  patient  groups  or  of  those  undergoing 
catheterisation  with  a  small  number  of  events  and  composite  end  points  encounter  several 
methodological limitations and their generalizability is questionable.
The few longitudinal  studies assessing the relationship between central arterial  stiffness obtained by 
applanation  tonometry  and  future  cardiovascular  events  have  mainly  used  measures  of pulse  wave 
augmentation and velocity.  These were largely performed in different groups of patients, rather than 
the general population, and will be reviewed in the following section.
While  the  first  part  of  this  thesis  is  concerned  with  influences  on  peripheral  pulse  pressure, 
encountering limitations as outlined above,  more specific measures of arterial  stiffness and systemic 
atherosclerosis, such as arterial distensibility and compliance, will also be used to validate findings.
Arterial distensibility and compliance as measures of arterial stiffness
Arterial  compliance,  an  index  of  vessel  wall  stiffness,  represents  the  absolute  change  in  vessel 
diameter or area for a given change in pressure  and decreases  with  age.  Arterial  distensibility,  the 
relative change in area for a given change in pressure, is a measure of vascular elastic behaviour, and 
loss  of distensibility in  adults is related to risk factors  for clinical  vascular disease.  (59-61)  Lower 
distension implies a stiffer artery; beta stiffness index describes the relation between arterial pressure 
and arterial diameter and characterizes the deformation behaviour of the vascular wall, independent of 
intraluminal pressure within the physiological range. (62)
Distensibility and compliance and cardiovascular events
24While  non-invasive  assessment  of  distensibility  and  compliance  represents  an  innovative  way  of 
studying influences on asymptomatic arterial disease, (63;64) relatively few data exist concerning the 
predictive value of distensibility and compliance for future cardiovascular events. (65)
Aortic  pulse  wave  velocity  is  a  measure  of  arterial  stiffness  and  is  inversely  related  to  aortic 
distensibility.  Longitudinal studies have shown its influence on cardiovascular outcomes in patients 
with hypertension, (66) diabetes, (67) end stage renal disease, (58;68) and older healthy individuals. 
(69)
In  patients  with  manifest  cardiovascular  disease  or  cardiovascular  risk  factors,  increased  arterial 
stiffness, as assessed by carotid artery distension, has been shown to be associated with a higher risk 
of cerebrovascular disease and aneurysms of the abdominal aorta. (70)
Intima media thickness
Assessment of atherosclerosis by measurement of intima media thickness
Thickening  of  the  intima  and  media  of  the  vessel  wall  can  be  visualized  by  high-resolution 
ultrasound.  The disturbance  of endothelial  function in atherogenesis that leads to the thickening of 
the intima and media is a generalized process, and carotid intima media thickening therefore provides 
an indirect assessment of atherosclerosis in other elastic or muscular arteries, such as the coronaries. 
(16;71  -73)
25Intima media thickness and cardiovascular events
Previous  reports  have  shown  that  carotid  intima  media  thickness  (IMT)  is  related  to  unfavourable 
levels of cardiovascular risk factors in older, (74) as well as younger populations. (75)  Intima media 
thickness  predicts  subsequent  cardiovascular  morbidity  and  mortality,  (76-79)  a  recent  review  has 
highlighted its prognostic value. (80)
Endothelial function
Endothelial  function  can  be  evaluated  by  measuring  changes  in  arterial  diameter  or cross-sectional 
area in  response to  specific  stimuli.  (16)  Selective  inhibitors of nitric oxide  synthase prevent these 
changes  in  diameter  or  area,  indicating  that  they  provide  an  indirect  assessment  of  nitric  oxide 
production and function.  The gold standard of assessing endothelial function involves measurement 
of  vasomotor  responses  of  epicardial  arteries  by  quantitative  coronary  angiography;  (21 ;81)  an 
invasive method, which is restricted to patients undergoing cardiac catheterization and not suitable for 
population based research.
Flow mediated dilatation
Assessment  of  the  vasodilator  response  to  increased  blood  flow  (flow  mediated  vasodilatation) 
provides  a non-invasive  approach to evaluating endothelial  function.  (21 ;82)  Haemodynamic  shear 
stress during reactive hyperaemia is used to stimulate NO release,  and impairment of flow-mediated 
dilatation  of the  brachial  artery  has  been  shown  to  be  associated  with  coronary  artery  endothelial 
dysfunction, (83) and the extent of coronary artery disease at angiography. (84)  While this provides 
some  evidence  for  the  agreement  between  peripheral  and  systemic  endothelial  function,  the 
intraindividual correlation between coronary and brachial endothelial responses is only modest.  (83)
26Assessment  of non-endothelium  dependent  vasodilatation  can  be  performed  using  nitroglycerin  or 
nitroprusside, and this measures non-specific smooth muscle effects.
Relatively  small  changes  in  vessel  diameter  are  being  estimated,  and  although  some  studies  have 
reported  good  within-scan  and  within-subject  coefficients  of  variation,  (85)  other  authors  have 
expressed concern regarding the potential for interpretative error, especially between observers, (86) 
or  reported  large  within-subject  variability.  (87)  Different  protocols  have  been  used  in  previous 
studies,  affecting  the  magnitude  of  flow  mediated  dilatation,  and  recently  guidelines  have  been 
published to reduce variation between centres. (82)
Endothelial function and cardiovascular events
Clinical studies have demonstrated associations between endothelial function assessed invasively and 
future cardiovascular complications. (88-93)  However, due to small  numbers, selected symptomatic 
populations  and  use  of  composite  endpoints  these  studies  encounter  some  limitations  and  their 
generalizability is limited. (21)
Although  flow  mediated  vasodilatation  in  the  brachial  artery  is  regarded  as  an  indicator  of 
cardiovascular disease risk,  few  studies  have  validated this with prospective events.  These have  so 
far demonstrated that persistent endothelial dysfunction is associated with an increased risk of clinical 
events  in  postmenopausal  women,  (94)  and  patients  with peripheral  arterial  disease.  (95;96)  More 
evidence is needed to assess the value of this emerging technique for the screening for asymptomatic 
early stage disease and its ability to predict clinical events in unselected populations. (80)
27O rigins of co ro nary h eart d isea se risk
Research into early influences  on  adult chronic  disease has  grown rapidly over the past decade.  (7) 
Many  studies  have  focussed  on  cardiovascular  disease,  (97;98)  whose  aetiology  lends  itself to  life 
course  approach,  since  atherosclerotic  changes  of  the  arterial  wall  begin  at  an  early  age,  (16) 
occurring  in  apparently  healthy  children  and  adolescents,  and  progress  with  age.  (2)  Prevalent 
atherosclerosis has been observed in fetal  aortas and fatty streaks, the earliest type of atherosclerotic 
lesion, are common in infants and young children. (1;99)  The clustering of adverse levels of different 
cardiovascular  risk  factors  has  been  demonstrated  in  children,  and  early  levels  of risk  factors  are 
known to persist over time and influence later cardiovascular risk. (5; 100)  This suggests that an early 
acquired risk tracks into adulthood, but the origins of such risk remain unclear.
Poor growth, atherosclerosis and the risk of coronary heart disease and stroke
Cohort studies with long term follow-up have reported associations between poor growth at different 
ages  and  adverse  levels  of  cardiovascular  risk  factors,  cardiovascular  events  and  mortality.  (98) 
Studies  of  children  and  adolescents  have  also  demonstrated  inverse  associations  between  growth, 
particularly  during  the  prenatal  period,  and  early  signs  of  atherosclerosis.  (101-103)  This  has 
stimulated  debate  about  the  contribution  of  growth  limiting  factors  to  early  atherogenesis  and  the 
development of cardiovascular disease. (104-108)
However, growth and cardiovascular disease are both socially patterned, and studies of the influence 
of  growth  on  atherosclerosis  and  cardiovascular  disease  are  complicated  by  accumulating  and 
interacting biological, social, and psychosocial processes. (7)
28Social influences on growth and cardiovascular disease
Many  important  influences  on  growth  are  socially  distributed,  such  as  prenatal  development, 
premature birth,  maternal  health, behaviour and care for the child, early nutrition,  living conditions, 
infections  and  age at puberty.  (109-113)  All  of these factors have the potential to contribute to the 
shorter  height,  and  particularly  leg  length,  of  children  growing  up  in  disadvantageous  social 
conditions. (106; 112; 114; 115)
People  growing  up  in  disadvantaged  childhood  conditions  have  a  higher  risk  of  coronary  heart 
disease,  and  a  recent  systematic  review  concluded  that  socioeconomic  circumstances  during 
childhood  and  adulthood  both  independently  contribute  to  adult  coronary  heart  disease  mortality. 
(116)  Most  prospective  studies  with  information  on  childhood  social  class,  measured  by  father’s 
occupational class or living conditions, have shown associations with total cardiovascular or coronary 
disease,  (117-126).  Few  studies reported no association,  (127; 128) or associations  with  stroke,  one 
aspect of cardiovascular disease, only. (129)  Studies generally found that adult social position did not 
account for this effect of childhood social class, with few exceptions. (130)
Some  authors  suggested  that  a  composite  measure  of lifetime  socioeconomic  position  might  be  a 
better  predictor  of cardiovascular  mortality  than  socioeconomic  position  estimated  at  one  point  in 
time,  which  only  inadequately  accounts  for  socioeconomic  disadvantage  over  the  life  course  or 
changing employment patterns, particularly in the case of women. (131; 132)
Most, (121; 133) but not all, (120) studies have also reported a higher risk of stroke among those who 
experienced  less  favourable  childhood  socioeconomic  circumstances,  independent  of  adult 
socioeconomic position, (129; 134) or height. (135)
A  detrimental effect  of lower childhood  socioeconomic position,  independent of adult position,  has 
also been shown for a number of cardiovascular risk factors, particularly obesity, (136-142) but also
29hypertension,  (136; 137),  dyslipidaemia,  (136-138; 140)  and  insulin  resistance.  (140)  This  supports 
the  hypothesis  that  early  environmental  factors  may  have  long  term  effects  on  specific  biological 
processes influencing metabolic disturbances and cardiovascular disease in adult life. (143)
The question therefore remains, to what degree associations of poor growth with atherosclerosis and 
cardiovascular disease may simply reflect or also mediate and contribute to the risk associated with 
early or later socioeconomic deprivation.  Also, the nature of such risk may manifest itself in different 
forms.
Critical periods, cumulative and interactive effects
First, growth  limiting exposures restricted to a specific early period,  such  as those occurring during 
the prenatal phase or the first years of life, may have long-term influences on cardiovascular disease 
risk.  This early elevation of risk may occur through metabolic adaptation to growth restriction during 
sensitive  periods  of  growth,  leading  to  risk  factor  clustering  and  tracking  and  to  the  initiation  of 
vascular wall changes.
Secondly,  children who fail  to reach their growth  potential through environmental  disadvantage  are 
also  more  likely  to be  less  educated,  exposed to health behaviours  such  as  smoking,  poor diet  and 
insufficient exercise, remain in lower social classes and experience material and other socioeconomic 
disadvantage,  which  in  turn  are  associated  with  an  increased  risk  of coronary  heart  disease.  (144) 
Thus an accumulation of risk may occur, through additive effects of adverse influences on coronary 
heart disease at early and later stages of the life course.
Thirdly,  early  and  later  life  influences  may  interact  in  their effects  on  coronary  heart  disease  risk. 
Such effect modification may establish itself in different ways.  On the one hand, the risk associated 
with  poor  growth  may  be  greater  in  those  who  have  grown  up  and/  or  continue  to  live  in
30disadvantaged  socioeconomic circumstances,  compared to their more  advantaged counterparts.  For 
example, if growth limiting factors contributed to the initial level and tracking of cardiovascular risk 
from  an  early  age,  then  people  with  poor  growth  and  consequently  shorter height,  reflecting  their 
adverse  childhood conditions,  may  be  expected  to  have  greater cardiovascular  vulnerability.  Thus 
continuing social disadvantage and/ or effects of aging on the arterial tree may amplify the initial risk 
associated with poor growth and result in a steeper increase of arterial stiffness over the life course of 
people  susceptible  to  cardiovascular disease.  (145)  Alternatively,  the influence  of poor  growth  on 
cardiovascular risk may be weaker in more disadvantaged groups, who are at greater absolute risk of 
cardiovascular disease.  For example, early occurring growth limiting influences with comparatively 
smaller effect sizes may be overridden or superseded by the comparatively stronger effects of adverse 
adult  living  conditions  and  health  behaviours,  such  as  smoking,  which  are  more  common  among 
those in disadvantaged socioeconomic positions.
Fourthly,  although  many  influences  on  growth  are  socially  distributed,  and  their  influence  may 
explain  part  of  the  association  between  poor  growth  and  cardiovascular  disease,  socioeconomic 
deprivation  and  growth  limiting  factors  may  also  exert  independent  effects  on  adult  disease. 
Hormonal  regulation,  through  the  insulin-like  growth  factor  axis,  may  not  differ  between 
socioeconomic  groups,  but  still  contribute  to  an  increased  risk  in  cardiovascular disease,  (146)  for 
example.
Equally,  while not  all  of the  detrimental  consequences  of childhood  disadvantage  for  adult  disease 
establish  themselves  through  an  influence  on  growth,  growth  limiting  factors  influencing 
atherosclerosis  and  cardiovascular  risk  may  mediate  part  of  the  long  term  effects  of  early  and 
continuing social disadvantage.
31E v id e n c e o f a s s o c ia t io n s b e t w e e n  g r o w t h , a t h e r o s c l e r o s is a n d 
CARDIOVASCULAR DISEASE
Human  growth  occurs  in  four  distinct  phases:  fetal,  infancy,  childhood  and  pubertal  growth, 
(147; 148)  and  several  anthropometric  measures  have  been  used  as  indicators  of  growth  at  these 
different  ages.  The  term  “growth”  is  generally  used  for changes  in  height  as  well  as  weight,  and 
while changes  in  body weight,  overweight  and obesity are  associated  with  levels  of atherosclerosis 
and coronary heart disease, the focus of this study is to investigate the role of markers of linear bone 
growth rather than fat mass or adiposity.
Although  different  hormonal  influences  underlie  the  main  phases  of linear  growth,  (147)  they  are 
interdependent, such that growth in one phase influences subsequent phases. (149)  With regard to the 
association between poor growth and adult cardiovascular disease, the majority of evidence has so far 
come from investigations of the most proximal and distal measures of growth:  size at birth and adult 
height.  Importantly,  as  Lucas et al.  have argued, (150) the size of an  individual  at  any point of the 
continuum  between  fetal  and  adult  size  is  correlated  with  both  earlier  and  later  size,  and  without 
information on different phases and dimensions of growth, it is therefore difficult to establish which 
period or aspect of growth may be most important for future cardiovascular risk.
Poor  growth  and  shorter  height  are  more  common  in  men  and  women  growing  up  and  living  in 
adverse socioeconomic circumstances, and stature can thus be regarded as a marker of socioeconomic 
disadvantage  over  the  life-course.  (115;138;151;152)  Differences  in  attained  height  between 
generations  and  countries  largely  arise  during  the  childhood  phase  of  growth  between  6  and  18 
months  of age,  when  a  divergence  of growth  curves  can  be  observed  that  is  not  seen  immediately 
before and after this phase. (153; 154)
32Increased gain in total body length occurring during this growth hormone dependent phase is largely 
(over 80%) localised in the lower segment of the body. (155)  This is because the growth of the long 
bones, represented in the legs, is more sensitive to growth hormone than other bone structures,  such 
as  the  short  bones  in  the  vertebral  column.  (156)  Socioeconomic,  environmental  factors  play  an 
important  role  for  the  secular  trend  in  height,  as  well  linear  growth  retardation  in  developing 
countries.  Relatively  shorter leg  length  may therefore  be  a better indicator of early environmental 
influences  operating  during the childhood phase  of growth  that are  socially  patterned,  compared  to 
total height.
Thus, leg and trunk length may be used as markers of growth at different phases and the investigation 
of their associations with cardiovascular disease can help our understanding of whether influences on 
or during the childhood phase of growth, in comparison with prenatal or later growth, may underlie 
the link between short height and cardiovascular risk.
Growth  can  be  observed  in  absolute  and  relative  terms.  Epidemiological  investigations  of 
associations between measures of growth at different ages and cardiovascular disease commonly use 
absolute measures of growth; these include weight and length at birth, reflecting the prenatal period, 
heights  and  weights  in  childhood  and  adulthood  and  components  of height,  namely  leg  and  trunk 
length.
Relative growth describes the tempo of growth and includes measures of growth rate and maturation, 
such as age at peak height velocity.  Assessment of relative growth requires measures to be obtained 
repeatedly,  at frequent intervals  for estimation  of age  at peak height velocity,  for example,  and has 
thus rarely been investigated, as such data are uncommon in long term prospective studies following 
participants into adulthood and until the onset of cardiovascular disease.
The  following  section  reviews  the  literature  linking  growth  to  measures  of  atherosclerosis  and 
cardiovascular disease,  including coronary heart disease  and  stroke,  as  well  as  a  short  overview  of
33each of the anthropometric measures used.  Initially, the different absolute measures of growth will be 
introduced, starting in adulthood, going back to childhood, infancy, and fetal life, followed by a short 
section on growth velocity.
Adult height
Height as measure of linear growth
The height that an individual has attained in early adult life indicates linear growth in absolute terms 
and reflects genetic and environmental influences on height up to the point it is measured.
Unlike body weight or obesity, adult height changes little until middle age, and may be used to reflect 
long-term influences of exposures during the growing years.  However, growth impairment at several 
stages  of development  can  lead  to  reduced  height,  and  total  body  height  does  therefore  not  allow 
inference  about  specific  phases  of growth  or  growth  limiting  exposures.  (157)  Height  reflects  the 
length of the long bones of the limb (tibia and femur), the irregular bones of the vertebral column, and 
the skull; it also indicates the amount of lean body mass.  (158)  Adult height is inversely related to 
age, due to secular increases in height in many populations, (159-161) and because of age associated 
height loss through shrinkage after around the age of 40 years. (162; 163)
Height and the risk of cardiovascular disease
Early  case-control,  (164-166)  and  cohort  studies,  (167-170)  reported  inverse  associations  between 
adult height and coronary heart disease.
Supporting  evidence  is  now  available  from  more  recent  cohort  studies  of men,  (151 ;168;171-177) 
women, (178) or both. (179-183)  Although some of these studies have been criticised (184) for using 
self reported height, (173; 178; 179) this is not the case for the majority of cohorts in which height was
34measured.  It therefore seems unlikely that differential recall of height with regard to disease has lead 
to biased results.
One  large  prospective  cohort  study  found  no  significant  association  between  short  height  and 
myocardial infarction after adjustment for age in men; however, such an association was observed in 
women, and this persisted after taking account of several cardiovascular risk factors.  (185)  Stronger 
associations  between  self  reported  height  and  cardiovascular  death  were  also  seen  in  women, 
compared  to  men,  of  another  American  cohort,  and  these  again  remained  significant  after 
adjustments.  (186)  In  contrast,  results  from  a  third  American  cohort  found  a  graded  inverse 
association between stature and both coronary heart disease and stroke in men, but not women, before 
and after multiple adjustments. (187)
A  nested case-control  study among twins found that the shorter twin in  a monozygotic or dizygotic 
twin  pair  was  more  likely  to  die  of heart  disease  than  the  taller,  (188)  and  this  was  interpreted  as 
evidence of an environmental basis for the association between shortness and coronary heart disease 
risk.  Likewise,  recent  evidence  from  a  study  of 35,000  twin  pairs  showed  an  inverse  association 
between height and mortality from CHD within monozygotic discordant twin pairs, pointing towards 
environmental factors directly affecting growth and CHD. (189)
Only a few studies reported no association between height and coronary heart disease, (184; 190-192) 
and two  of those  studies  found  such  associations  with  one  aspect  of cardiovascular disease,  stroke. 
(191; 192)  Only one of these studies included women,  as well  as men.  (184)  Another study,  which 
reported its main results for combined cardiovascular mortality, (193) also suggested that associations 
may  be  stronger for  non-coronary  cardiovascular  mortality,  compared  to  CHD  mortality,  although 
findings  were based on  a  small  number of deaths.  In contrast,  some of the studies  which  observed 
significant  relationships  with  coronary  heart  disease,  failed  to  show  this  for  stroke,  (173; 178)  and 
although  inverse  associations  with  stroke  were  found  in  one  of these  studies,  these  did  not  reach
35conventional levels of significance. (183)  Results from a large British cohort of men found that the 
risk of stroke was  increased only in the shortest group of men,  suggesting a non-linear association. 
(176)
Whilst the evidence regarding stroke seems conflicting, early reports of an association between short 
height  and  non-fatal  and  fatal  stroke  (194; 195)  have  recently  been  supported  by  results  from 
prospective cohorts of both genders, (181; 182; 196) or men only. (197; 198)
Subtypes of stroke
Discrepant results regarding stroke may be explained by the fact that aetiological studies of stroke are 
complicated by the different pathologies underlying its main  subtypes, cerebral  infarct and cerebral 
haemorrhage.  These  are clinically  difficult to  distinguish  and  information  about  stroke  subtype  in 
epidemiological studies, for example from death certificates, is limited, particularly using information 
from  before the time  of diagnostic  brain  imaging.  The majority of strokes  are ischemic;  however, 
studies  of the  atherosclerotic process underlying this type of stroke are complicated by its differing 
vascular  mechanisms,  including  large-artery  atherosclerosis  with  occlusion  and  distal  embolization 
and  small  penetrating  arterial  disease  with  lacunar infarction.  The  mechanism  of ischemic  stroke 
events often remains unclear and a number of infarcts are of undetermined cause. (199)
The  few  studies,  which  were  able  to  analyze  ischemic  and  hemorrhagic  stroke  separately,  have 
provided  limited evidence that the  adverse  effect  of short  height  may  be  stronger for hemorrhagic 
stroke.  (196; 198)  This  may  be  surprising,  as  coronary  heart  disease  and  ischemic,  rather  than 
hemorrhagic stroke, share a similar underlying aetiology. (200)
Height and the prognosis of  people with prevalent coronary heart disease
Few  studies  have explored the influence  of height on  mortality of patients  with  prevalent coronary 
heart  disease,  and  these  yielded  conflicting  results  for  prognosis  after  myocardial  infarction,  with
36some, (201) but not all, (202;203) reporting inverse associations with survival after a coronary event. 
One  case-control  study  found  such  an  association  in  men,  but  not  women,  hospitalized  after 
myocardial infarction. (204)  However, much of this evidence has come from trial or hospital patients 
after  an  acute  infarct,  and  it  remains  unclear  whether  height  affects  the  prognosis  of  prevalent 
cardiovascular disease in the general population.
Height and measures of vascular structure and function
One study suggested that associations between height and dynamic properties of the arterial tree may 
contribute to the increased cardiovascular risk in those of shorter height. (205)  As mentioned above, 
pulse pressure is determined by  arterial compliance and wave reflection.  (23;30;31)  Pressure wave 
reflection during systole boosts systolic pressure in the ascending aorta and increases ventricular load, 
while reflection  during diastole favours  myocardial perfusion.  The travel time of the  arterial  wave 
and  timing  of  wave  reflection  depend  on  arterial  stiffness  and  transmission  path  length.  (51;206) 
Reflected waves in those with poor growth  and  shorter height  may  arrive early and during  systole, 
resulting  in  increased  central  pressure  augmentation,  due  to their greater levels  of arterial  stiffness 
and/  or  shorter  transmission  path  length,  and  this  may  contribute  to  increased  pulse  pressure  and 
cardiovascular risk of shorter individuals. (32;205)
37Childhood height
Linear growth during childhood
Childhood growth before puberty is divided into two partly superimposed phases.  The infancy phase, 
beginning  in  the  middle  of gestation  and  tailing  off at  about  3-4  years  of  age,  and  the  childhood 
phase,  which  usually  starts  during the  second  half of the first postnatal  year,  occurring  on  average 
earlier in  girls than boys.  The rapidly decelerating infancy component is regarded as the postnatal 
nutrition dependent continuation of fetal growth, during which the abrupt start of the childhood phase 
marks  the  age  at  which  growth  hormone  begins  to  exert  a  significant  influence.  (147;153;207) 
Infancy and childhood are sensitive periods  of growth,  and interference with the growth process in 
early years has long term consequences for adult health. (149)
Size at birth is only weakly related to final adult height; (158) however, the correlation between early 
and adult height increases steeply during the childhood phase of growth in the first years of life, and 
children achieve their individual location on a particular height growth centile at around the second 
year of life. (158)  During this time, between 6 and 18 months of age, delayed onset of the childhood 
phase  of  growth  can  lead  to  linear  growth  retardation  and  shorter  final  height,  (149;153;208) 
independent of the timing of puberty. (149)
Malnutrition with inappropriate caloric intake as well  as malabsorption and reduced appetite during 
illness can lead to down-regulated growth, and result in shorter stature.  (209)  Subsequent improved 
nutrition, remission and recovery may accelerate linear growth, (210;211) and this “catch-up” growth 
often exceeds the normal  growth rate for age.  Although  such compensatory growth improves final 
height, it does not necessarily lead to complete recovery of adult stature. (209;212)  Down-regulation 
of  growth  that  reduces  final  height  is  not  limited  to  children  with  chronic  disease,  endocrine 
abnormalities, poverty-related deprivation, or eating disorders; it can be the consequence of relatively 
small, but prolonged, calorie restriction or shortfall in dietary quality. (209)
38The  analysis  of childhood  height  is  further  complicated  by  the  fact  that  differences  in  childhood 
height, even in children of the same age, may reflect differences in the rate of growth and maturation, 
rather than growth potential or attained height.  This will be discussed in more detail in the section 
regarding growth velocity.
Childhood height and cardiovascular disease
One  study  investigating  components  of  height  in  boys  and  girls  aged  2  to  14  years  found  that 
associations between shortness and adult coronary heart disease were weaker in children aged 8 years 
or older, compared to the younger group.  (213)  The authors suggested that this might be explained 
by the onset of the adolescent growth  spurt in the older group, whose height may not reflect earlier 
growth or growth potential, but rather their degree of maturity, i.e. a certain stage during the pubertal 
growth spurt, at least in those children who had entered puberty.
Childhood height and measures of vascular structure and  function
Shorter prepubertal stature, relative to adult height, and interpreted as poor growth in childhood, was 
also  shown  to be  an important determinant of adult pulse pressure  and blood pressure.  (214)  And 
although this study provided some evidence of the importance of early growth for the development of 
arterial stiffness, it included only 300 survivors of an originally large cohort, was unrepresentative of 
the general population and, due to small numbers, men and women could not be analysed separately.
A study of prepubertal children aged 9-11  years, designed to investigate the influence of cholesterol 
on arterial distensibility in childhood, found that of all risk factors under investigation, height was the 
second most important influence on distensibility (after diastolic blood pressure),  and this was  only 
partly explained by the association of increased height with lower cholesterol and greater vessel size. 
(6)  Prenatal  growth,  estimated  by  ponderal  index  at  birth,  was  not  significantly  associated  with 
distensibility.  Birthweight,  but  not  ponderal  index  or  childhood  height,  was  associated  with
39endothelial  function,  as  indicated  by  flow  mediated  dilatation,  in  these  children.  (102)  A  similar 
investigation  of children  aged  13-15  years  showed  no  significant  associations  between  height  and 
distensibility at these older ages,  when  70%  of boys  and  girls  were  at Tanner stages 4  or 5,  while 
adiposity  and  its  metabolic  consequences  were  strongly  related  with  distensibility  during  teenage 
years. (215)
One study of girls and boys aged  10-18 years  showed that augmentation index,  an estimate of early 
pulse  wave reflection  and reduction in the elastic  properties of arteries,  was  significantly higher in 
those  of low birthweight,  short stature,  low heart rate  and female gender,  after mutual  adjustments. 
(145)
Components of height
Leg and trunk length as markers of growth at different ages
The  growth  of  the  two  main  components  of  height,  leg  and  trunk  length,  differs  in  timing  and 
magnitude. (154)  As mentioned above, a large amount of the dramatic changes in body proportions 
during the first years of life is due to the growth of the long bones of the leg (figure 3), and increases 
in total height before puberty are to a larger degree caused by gains in leg length, compared to trunk 
length. (157;216)  This is illustrated by increases in the ratio of leg length to total height from birth to 
puberty (figure 2), (157) and is caused by the faster growth of the legs, which ceases at an earlier age, 
compared to the trunk. (159;217)
Growth hormone contributes to growth in length during infancy and childhood through influences on 
cartilage cells of the long bones, (218) and leg length can be regarded as a marker of early growth of 
the long bones  at specific hormonally controlled phases of development.  Leg growth is particularly 
sensitive to postnatal  environmental  influences,  and  short  leg  length has  been  suggested  as  a more
40sensitive indicator o f early environm ental influences that lim it grow th,  such as m alnutrition, than total 
height.  (106;115;219)
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Secular increases  in  height in industrialised countries  over the past century have been  attributed to 
greater leg length, rather than trunk length, (159) caused by earlier onset and/ or increases in growth 
tempo during the childhood phase of growth. (153)  These secular increases in height and leg length 
have been more pronounced in children from low socioeconomic backgrounds, and this suggests the 
importance  of environmental  improvements  for  secular changes  in  leg length;  decreased childhood 
infection rates, improved nutrition, social and living conditions seem to play an important role. (161) 
These early life factors may, through influences during the hormonally controlled childhood phase of 
growth, simultaneously influence growth spurts of long bones of the leg and changes in the structure 
and function of the developing vasculature, (220;221) and thereby increase the risk of coronary heart 
disease.
Components of adult height may therefore be used as markers of growth with different determinants 
and  duration  and  recent  studies  have  advanced  research  investigating  the  association  between 
shortness and cardiovascular disease by exploring specific associations with components of height.  In 
addition,  studies  analysing  adult  leg  length,  rather  than  total  body  height,  also  avoid  measurement
42bias introduced by age related shrinkage, which reduces total height mainly as a result of decreases in 
trunk length through the osteoporotic collapse of vertebrae.
Components of adult height and cardiovascular disease
To date, only a small number of studies have investigated associations between components of adult 
height and coronary heart disease, (222;223) including one study of middle aged men (222) and one 
study  of postmenopausal  women,  (223)  both  of which  suggested that leg  length,  rather than  trunk 
length,  is the component of height most  strongly associated with coronary heart disease.  Evidence 
from these studies of men, (222) and women, (224) also suggested that those with poor growth of the 
long  bones  of the  leg  show  a higher prevalence  of the metabolic  syndrome,  insulin  resistance  and 
non-insulin dependent diabetes, as well as other cardiovascular risk factors, which are components of 
the metabolic  syndrome.  (225;226)  However, it has also been  suggested that differences in insulin 
sensitivity and levels from early life on may influence stature through the growth promoting effects of 
insulin.  (227)  Associations between  adult components  of height  and  metabolic risk  may therefore 
reflect  insulin  responses  to  glucose  in  earlier  life  influencing  both  growth  and  metabolic  and 
cardiovascular risk.
Components of childhood height and cardiovascular disease
Childhood leg length, but not trunk length, was found to be inversely associated with CHD mortality 
over 52 years in one prospective cohort, which measured components of height in boys and girls of 
less than 14 years of age. (213)
43Components of height and measures of vascular structure and  function
Recent  data from the ARIC cohort  has  provided  some evidence  of an  inverse  association  between 
adult leg length  and intima media thickness in  12254  middle  aged participants.  Differences in the 
magnitude of the inverse association between leg length and intima media thickness between ethnic 
groups  and  sexes  were reported,  being  strongest  in  black men  and positive  and  non-significant  in 
black women,  before  and  after  multivariate  adjustments.  In  univariate  analyses,  trunk length  was 
inversely associated with intima media thickness in black and white men and women in this study; 
however, significant positive associations emerged in white men and women after adjustment for leg 
length,  field centre  and  age,  while estimates  were  attenuated to non-significance in black men  and 
women.
No evidence exists regarding components of height and vascular structure and function in childhood; 
however,  one previous  study reported  an  association between fetal femur length  and  systolic blood 
pressure at age 6 years. (228)
Prenatal growth
Size at birth as a measure of  prenatal growth and development
Information on size at birth with regard to length, but particularly weight, has been used in studies of 
prenatal growth and its consequences for adult disease.
Size at birth and cardiovascular disease
Many  genetic  and  environmental  factors  affect  size  at  birth,  and  since  early  suggestions  of  an 
association  between  poor  growth  in  utero  and  increased  coronary  heart  disease  mortality,  (11)  an 
extensive amount of literature has been published investigating the role of prenatal influences on, or
44markers of, growth and coronary heart disease and associated risk factors, particularly blood pressure. 
(229;230)
However, a recent systematic review, including a meta-analysis, concluded that reports of an inverse 
association between birthweight and  subsequent blood pressure might reflect the impact of random 
error, publication bias and inappropriate adjustment for current weight and other confounding factors. 
(231)  A  systematic  review  of the  association  between  birthweight  and blood  cholesterol  level  in 
adolescents also concluded that the importance of fetal nutrition for total cholesterol was weak and of 
limited public health importance compared to childhood obesity. (232)  And although several studies 
investigating the association between size at birth and coronary heart disease have reported an inverse 
association,  (128;233-243)  no  systematic  review  of the  literature  has  yet  been  conducted.  Some 
studies  have  found no  or non-linear  associations,  (240;244-246)  or interactions  suggesting  that the 
adverse  effect  of low  birthweight  may be restricted  to those  with  high  body  mass  index,  (237)  or 
lower  social  class  in  adult  life.  (124)  Inverse  associations  of birthweight  have  been  shown  with 
stroke  mortality in  studies  of men  and women,  (135;239;240;247;248)  and differential  associations 
with stroke subtypes have been suggested. (98)
In the light of this conflicting evidence, Barker’s hypothesis that metabolic adaptation of the foetus to 
growth restriction programmes the risk of adult disease has not remained undisputed, and it is unclear 
which  particular  phase  of  growth  is  most  important  for  the  development  of  atherosclerosis  and 
cardiovascular risk.
Size at birth and vascular structure and function
Few studies have investigated the influence of size at birth on arterial stiffness, and these have mostly 
used pulse wave velocity, which represents regional arterial visceroelastic properties and is inversely 
proportional to arterial compliance.  In some of these studies decreased compliance in adult life was 
apparent in those with impairment of fetal growth, (101;249) and Martyn et al. hypothesized that this
45may be caused by impaired elastin synthesis in blood vessels of children with poor prenatal growth, 
which  -   over  their  life  course  -   could  lead  to  increased  left-ventricular  mass  and  cardiovascular 
disease. (105)  However, others have yielded conflicting results, reporting no associations, (250-252) 
or of opposite directions in men and women. (253)
One study investigating the association between birthweight and arterial stiffness using measures of 
distensibility and compliance at three different vascular beds found only weak positive associations 
between  birthweight  and  arterial  compliance,  and  these  were  accounted for by  adult height.  (103) 
Furthermore, birthweight was not associated with distensibility in any vascular bed and this was also 
observed in one study of prepubertal children aged 9-11  years, which found no association between 
prenatal growth, estimated by ponderal index at birth, and distensibility. (6)  In contrast, birthweight 
was associated with endothelial function, as indicated by flow mediated dilatation, in these children; 
however,  no  relationship  was  observed  when  ponderal  index  was  used  as  a  measure  of  prenatal 
growth. (102)  Associations between birthweight and endothelial function were described to be most 
marked in individuals with the lowest risk factor burden in one small study of young adults, and this 
was interpreted as early effects being “overwhelmed” by the presence of classic cardiovascular risk 
factors.  (254)  However, the relatively small sample and low response rate of this study require the 
reported interaction to be interpreted with some caution.
Another study, using ambulatory brachial pulse pressure as an indirect estimate of aortic compliance, 
found  a  significant  inverse  association  with  birthweight  in  girls  and  boys  aged  10-18  years, 
independent of their height.  (255)  However,  it remained unclear whether the increased peripheral 
pulse pressure was accompanied by an increment in central aortic pressure and/ or modifications in 
the  waveform,  and  this  was  addressed  by  a  subsequent  study.  This  analysis  showed  that 
augmentation index, an estimate of early pulse wave reflection and reduction in the elastic properties 
of  arteries,  was  significantly  higher  in  those  of  low  birthweight  and  short  stature,  as  mentioned
46earlier. (145)  The authors hypothesized that these early alterations may be amplified throughout life 
and contribute to the increased cardiovascular risk associated with low birthweight, but this has not 
yet been investigated.
Studies assessing associations between prenatal growth and intima media thickness in adulthood have 
been inconclusive,  (256)  so far providing little evidence of a clinically  significant relation between 
birthweight and carotid atherosclerosis. (257;258)
It has been  suggested that an  association between birthweight and endothelial function in neonates 
(259)  may persist into childhood  (102;260)  and  young  adult life,  (254;261;262).  However  studies 
have  used  a  variety  of measures  to  assess  endothelial  function,  and  some  included  only  very  few 
participants.  Studies  in infants  have  also  yielded  negative results,  (263)  and  associations  between 
birthweight and endothelial function in older adults remain to be shown.
Importance of prenatal versus postnatal growth
Several  studies  investigating  whether  poor  prenatal  growth  may  contribute  to  or  explain  the 
association between  short height or leg  length  and coronary heart disease have not provided much 
support  that  poor  prenatal  growth  may  be  responsible  for  the  association  between  shortness  and 
cardiovascular risk.  First, studies with information on height as well as birthweight for either all or a 
subsample of participants, have found that the relationship between height and coronary heart disease 
was robust to  adjustment for birthweight.  (172;178;223)  This  supports the notion that size at birth 
and height, although weakly correlated, are markers of growth phases with different determinants and 
duration,  and  may  represent  separate  influences  on  cardiovascular  risk.  Secondly,  Gunnell  et  al. 
compared correlations between birthweight and components of stature in four different cohorts to test 
whether  stronger  associations  between  birthweight  and  leg  length,  compared  to  trunk  length,  may
47explain the specific association observed between leg length  and coronary heart disease.  (264)  No 
consistent evidence was found that birthweight might underlie the association.
Growth velocity: rate of growth and maturation
Although  the  evidence  discussed  so  far  points  towards  a  distinct  influence  of  prepubertal  linear 
growth during childhood on cardiovascular risk, it remains to be shown that growth at a specific age 
or phase is of particular importance.  Furthermore, the rate, i.e. speed, of growth changes substantially 
throughout the different growth phases and this can be visualized through the change of height with 
time: growth velocity (figure 4).
48Figure 4 Growth velocity in boys and girls
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Two characteristic growth spurts occur, a small juvenile or mid-growth spurt at around six to eight 
years (not visible in figure 4), and a larger adolescent growth spurt.  The latter is caused by the onset 
of puberty  during  the  phase  of childhood  growth.  The  tempo  of growth  increases  markedly,  and 
accelerates up to peak height velocity, the age after which growth starts to decelerate until it finally 
ceases.  Age at takeoff (acceleration) is highly variable and sex-dependent, occurring at a younger age 
in  girls,  who  also  experience  earlier  and  lower peak  height  velocity,  compared  to  boys.  (265)  A 
review of growth characteristics of boys and girls concluded that peak height velocity occurred at a
49mean age of 11.5 years in girls and 13.5 years in boys.  These gender differences in the timing and to 
a  lesser  degree  the  extent  of the  adolescent  growth  spurt  contribute  to  differences  in  final  height 
between men and women. (217;218)
As  discussed  above,  secular trends  of earlier  sexual maturity  and  age  at peak height velocity have 
been  accompanied by increases  in  leg  length.  (266)  Tempo of growth,  timing and rate of skeletal 
maturation  and sexual development may therefore play a role for associations between poor growth 
and adult disease risk;  however, research is limited by the availability of longitudinal data required 
for the analysis of velocity. (267)  Participants of the oldest ongoing birth cohort study with repeated 
measures of anthropometry were bom in  1946, and number of cardiovascular events in this study is 
still  insufficient for analysis;  in  addition,  identification of age  at peak height velocity requires  very 
frequent measures of height throughout puberty, which are generally unavailable.  One recent report 
from  the  1946  cohort  showed  that  age  at puberty  was  inversely  associated  with  adult  systolic  and 
diastolic blood pressure in men, but not women.  Adjustments for prenatal growth, prepubertal and 
adult body mass index and height did not account for these associations, despite those maturing early 
being heavier and shorter in terms of total height and relative leg length in adult life. (268)
The interpretation  of the influence of age at peak velocity on adult height is complex.  On the one 
hand faster linear growth during infancy and childhood is associated with earlier peak height velocity, 
with short children entering puberty later than tall children. (147)  On the other hand, earlier puberty 
leads to earlier cessation of growth,  fusion of epiphysial  growth plates  and restricted acquisition of 
lean body mass.  Extended growth prior to adolescence due to later maturity therefore increases final 
height;  however,  children  with  delayed  maturation  attain  a  height  somewhat  below  their  genetic 
target.  (158)  In  summary,  the importance of growth  velocity for adult cardiovascular risk remains 
uncertain.
50Attained versus expected height
The analysis of height at one point in time does not account for growth at different phases and rates, 
which may differ in their importance for cardiovascular risk.  Moreover, in  adults of similar height 
some  will  have  fulfilled  their  genetic  growth  potential,  but  others  will  have  experienced  limited 
growth  due  to  environmental  restrictions,  including  malnutrition,  infections  and  psychosocial 
deprivation.  This  fundamental  difference  is  likely to be unequally  distributed  among  the  different 
socioeconomic strata.  If higher rates of cardiovascular disease were only observed in people who fail 
to reach their expected height, this would be more consistent with an environmental exposure as the 
underlying cause, and recent evidence from twin studies has been in support of this. (189)
51A lternative explanatio ns for th e asso ciatio n betw een po o r grow th 
AND CARDIOVASCULAR RISK
Several  alternative  explanations  exist  for  the association  between  poor  growth  and  cardiovascular 
disease.
Chance
As  demonstrated  above,  a  large  number  of  studies  have  found  highly  statistically  significant 
associations between different indicators of poor growth and coronary heart disease risk in adulthood, 
suggesting that observations are unlikely to have occurred by chance alone.
Bias
However,  systematic errors in the design, collection and analysis of data,  and the interpretation and 
publication of results may lead to biased estimates.  These distortions are likely to influence findings 
from case-control studies more in comparison to those from prospective cohorts, which have provided 
the  majority  of  evidence  for  the  association  between  short  stature  and  coronary  heart  disease. 
However, recent examples in the literature demonstrate that even findings that were consistent across 
a number  of cohort  studies  could not be confirmed in  randomised  controlled trials,  which  are  less 
prone  to  the  effects  of bias  and  confounding.  (269-271)  This  highlights  that  results  from  cohort 
studies,  even  if  carefully  adjusted  for  potential  confounding  factors,  have  to  be  interpreted  with 
caution, particularly when studying exposures that are socially patterned.
Publication bias
As mentioned above, publication bias of studies relating birthweight to adult blood pressure has been 
suggested.  (231)  This  may  also be the  case  investigating the  effects  of height,  which  is  a routine 
measure in many studies of different designs, and only authors with significant findings may decide 
to report those.  The lower number of smaller studies with negative findings that have been published
52potentially  reflect  this.  However,  publication  bias  seems  less  likely  for  studies  investigating 
components of height, as these are not commonly measured and results from cohort studies with this 
information may therefore be more systematically represented in the literature.
Survival bias
Studies have  included non-fatal  as  well  as  fatal  coronary heart disease  and  stroke events,  and it is 
therefore unlikely that better survival of taller people plays a major role in findings of an association 
between  shortness  and  cardiovascular mortality.  A  healthy  survivor effect before recruitment into 
cohort studies is also unlikely to cause associations biased in favour of a protective height effect, as 
first,  only a small proportion of people in  developed countries die before adulthood,  and  secondly, 
early accidental  or violent causes  of death  are more common in  socially disadvantaged and  shorter 
people, making taller people more likely to survive into adulthood and develop chronic disease.
Selection bias and reverse causality
Analyses  of data from the  original  Whitehall  study  suggested  an  attenuation  of height effects  with 
increasing  duration  of follow-up.  (272)  This  was  attributed to  differential  height reduction  before 
study  entry.  Impaired  growth  through  childhood  illness  and  shrinkage  in  adulthood  owing  to 
morbidity  will  result  in  shorter  adult  stature.  Both  situations  may  lead  to  selective  premature 
mortality, and the apparent protective effect of taller stature would diminish with increasing follow- 
up  time if the  association between  height  and  mortality  was  restricted to  participants  whose  short 
height  was  a  result  of  existing  disease  in  childhood  or  adulthood.  Although  it  has  not  been 
investigated  whether  this  assumption  holds  with  longer  term  follow-up  of the  Whitehall  or  other 
cohorts,  evidence from  analysis  of leg length  or height measured in childhood or young adulthood 
contradict the notion that bias  introduced by shrinkage of ill participants  and thus reverse causality 
play a major role in the association between height and coronary heart disease.
53Confounding
Anatomical  and  physiological  characteristics  associated  with  tall  stature  may  confound  the 
association between poor growth and cardiovascular risk.
Small-calibre arteries
First,  the  vessel  diameter  of  taller  people  is  larger,  and  this  has  been  associated  with  improved 
survival in studies of hospitalized patients after myocardial infarct. (273)  The same absolute degree 
of  atherosclerosis  may  result  in  clinical  disease  earlier  or  present  with  more  severe  symptoms  in 
shorter people with relatively smaller vessel diameters.  Although information on  vessel  size is not 
commonly available, studies using ultrasound measures of vascular function have found associations 
after accounting for vessel size. (6)
Lung function
Secondly,  taller  people  have  a  larger  lung  volume,  and  thus  for  mechanical  reasons  better  lung 
function,  for example  as measured in forced expiratory volume in one minute (FEVi).  Because of 
this  strong  relation,  estimates  of FEVi  in  clinical  assessment  or  for  research  purposes  commonly 
account for height.  (274)  Because lung function is  an important predictor of cardiovascular risk, in 
both smokers and life long non-smokers, (275) it has been regarded as a confounder of the association 
between  height  and  cardiovascular  disease.  In  some,  (171;172;181;275)  but not  all  studies,  (186) 
adjustment for lung function attenuated or explained differences in cardiovascular disease according 
to height.
It has been argued that the specific association between leg length and CVD mortality is unlikely to 
be explained by lung function, as trunk length would be expected to show a stronger association with 
lung volume and function. (222)  Contrary to this, one recent study found that the association between 
leg length and FEVi  was slightly greater than the association between trunk length and FEVi.  (223)
54However,  the  same  study  also  showed  that  although  adjustment  for  both  smoking  and  FEVi 
attenuated the observed effects,  some association between leg length and CHD remained.  This and 
previous  studies have suggested that height and lung function may both act as indicators of adverse 
exposures in early life which in turn increase cardiovascular risk, (276;277) and that accounting for 
lung function in studies of height may represent overadjustment. (223;225)
Common genetic polymorphisms
It is possible that genetic factors that influence growth also have a role in early programming of CHD. 
However,  there is  little evidence of shared  genetic  determinants.  (278)  Gunnell  et al.  investigated 
associations between components of height and cardiovascular risk factors and found that controlling 
for  parental  stature  had  little  effect  on  their  findings,  (225)  and  this  was  interpreted  as  evidence 
against  underlying  genetic  influences.  Data  from  the  STANISLAS  family  study,  investigating 
familial clustering between height and cardiovascular risk factors has provided further evidence that 
genetic influences do not seem to play a major role. (279)
Twin  studies,  leaving  their  own  limitations  aside,  provide  a  more  powerful  way  of  disentangling 
genetic  and  environmental  effects.  For example,  if in  a twin  study  differences  in  height  between 
monozygotic twins were associated with different rates of cardiovascular disease, this would strongly 
suggest pre- or postnatal environmental exposures as the cause.  Indeed, one nested case-control study 
among twins found that the shorter twin in a monozygotic or dizygotic twin pair was more likely to 
die  of heart disease than the taller,  (188)  and this was interpreted as evidence of an environmental 
basis for the association between shortness and coronary heart disease risk.  In support of this, recent 
evidence  from  a  study  of  35,000  twin  pairs  showed  an  inverse  association  between  height  and 
mortality from CHD within monozygotic discordant twin pairs, also pointing towards environmental 
factors directly affecting growth and CHD, as discussed earlier. (189)
55In  summary,  owing  to  the  multifaceted  aetiology  of coronary  heart  disease,  it  seems  likely  that  a 
combination of factors from different stages of the life course contributes to the association between 
poor growth and cardiovascular risk.  The aim of this thesis is to shed light on which period of growth 
may be particularly important for atherosclerosis and cardiovascular risk.  This may help to identify 
specific growth limiting factors that are important and understand aetiological mechanisms involved.
56Chapter 4: F irst O bjective
O bjective
To identify which specific period of growth is particularly important for the development of arterial 
stiffness,  I will use components of adult height as markers of growth at different ages  and compare 
their associations with arterial stiffness, as indicated by high peripheral pulse pressure.
Study desig n of the MRC N a tio n al Survey of H eath and D evelo pm ent 
Participants
The Medical Research Council’s National Survey of Health and Development is a prospective birth 
cohort  study  of a  class  stratified  sample  (5362  births;  2547  women,  2815  men)  of all  births  that 
occurred in the first week of March 1946 in England, Scotland and Wales.
Follow up included 20 contacts with the whole cohort between birth and 53 years of age, when 3035 
participants (1472 men,  1563 women) provided information.  The majority of participants (n=2989) 
were  then  interviewed  and  measured  at  home  by  trained  research  nurses  using  a  standardized 
protocol.  Those not visited at home completed a postal questionnaire (n=46).  The participation rate 
was 70.4 percent among survivors still resident in England, Wales or Scotland, and 89.6 percent for 
whom contact was  attempted.  Contact was not attempted for those previously refusing to take part 
(n=640),  living  abroad  at time of interview  (n=119),  emigrated  (n=461),  or those who had  already 
died (n=469).
57The data collection received MREC approval, and respondents gave informed consent to each set of 
questions  and measures.  The  sample is reasonably representative of the national  population  of the 
same  or  similar  age.  (280)  Similar  data  collections  occurred  at  ages  36  (n=3322)  and  43  years 
(n=3262). (281)
Measurements
Anthropometry
At  age  53  years  measures  of  weight  (kg),  height  (cm),  trunk  length  (cm),  waist  (cm)  and  hip 
circumference  (cm)  were  obtained.  Weight  was  measured  to  the  nearest 0.1  kg  with  participants 
wearing  light  indoor clothing  and  no  shoes.  Height was  measured to  the  nearest  0.5  cm,  using  a 
portable stadiometer with participants standing without shoes and with heels against the wall as tall as 
possible  with  the  head  in  the  Frankfort  plane.  Sitting  height,  used  to  represent  trunk  length,  was 
measured to the nearest 0.5  cm.  Participants were  asked to  sit upright,  with their back against the 
vertical  stand of the stadiometer,  on the base plate located on  a hard, flat seat, with the head in the 
Frankfort  plane  and  their  feet  on  the  floor.  Leg  length  was  calculated  as  the  difference  between 
standing  and  sitting  heights.  Waist-hip  ratio  (WHR,  waist  circumference  (cm)  divided  by  hip 
circumference  (cm))  and  body  mass  index  (weight  (kg)  divided  by  height  squared  (m2))  were 
considered as possible confounding factors of the associations between shortness and arterial pressure 
measures.
Blood pressure
At age 53  years,  peripheral blood pressure was  measured, in duplicate, in the brachial artery of the 
upper  left  arm  with  the  validated  Omron  HEM-705  automated  digital  oscillometric 
sphygmomanometer after 5 minutes of rest, with the participant sitting.  The second reading was used
58in the analysis.  Pulse pressure was calculated as the difference between systolic and diastolic blood 
pressures.  For  comparison  purposes,  all  blood  pressure  outcomes  were  converted  into  internally 
derived sex specific standard deviation scores (z-scores).
Birthweight
Birthweight  was  used  as  an  indicator  of prenatal  development.  It  was  recorded  by  midwives  or 
obstetricians at birth, and taken from records by health visitors.
Social class
Father’s social class was based on his occupation when survey members were 4 years old, according 
to  the  Registrar  General’s  Classification.  If this  information  was  unavailable,  father’s  occupation 
when survey members were aged  11  years (n=125) was used instead.  The six classes were collapsed 
to four groups for the analysis, the highest classes I and II (professional and intermediate occupations) 
were combined, as were the lowest classes IV and V (semi-skilled or unskilled occupations).
Smoking
At  age  53  years  participants provided information  on  smoking  status,  and  “current”  smokers  were 
distinguished from “previous” and “never” smokers.
Medication
During the interview  at  age  53  years,  the nurses recorded  any information  on participants’  current 
medication.  This information was coded according to the British National Formula (BNF) Number 
40 (2000).  In this  analysis information on current use of antihypertensive  medication  (taking drug 
versus not taking any drug of the following BNF sections:  2.2 - Diuretics, 2.4 -  Beta blockers, 2.5 -  
Drugs affecting the renin-angiotensin system and some other antihypertensive drugs, 2.6.2- Calcium- 
channel blockers) was used.
59Statistical analyses
Means  or  percentages  of  selected  characteristics  of  men  and  women  participating  at  the  53  year 
follow-up visit were calculated; t-tests or Pearson chi-squared tests were performed to test differences 
between the sexes, respectively.  Linear regression models were used to compare differences in pulse 
pressure, systolic and diastolic blood pressure according to adult trunk length, leg length and height at 
53 years.  For the purpose of this analysis sex specific quartiles were used as cut-points to obtain four 
equal  sized  categories  for each  component  of stature;  these  are  included  in  Table  2.  Mean  pulse 
pressure, systolic and diastolic blood pressure were calculated for each group, including participants 
using  antihypertensive medication  (14.7%),  and tests  for linear trend across  categories  carried out. 
Multiple  regression  models  of  standardized  blood  pressure  outcomes  were  then  used  to  test  the 
associations of interest, adjusted for characteristics thought to confound the association.  First, current 
use  of  antihypertensive  medication  body  mass  index,  waist  to  hip  ratio  and  smoking  status  were 
included (model A).  Second, to investigate the separate and joint influences of components of height 
and early social conditions for adult blood pressure, childhood social class was additionally included 
in  the model  (model  B).  Finally,  the role  of prenatal  growth,  as indicated by weight  at birth,  was 
considered (model C).
All analyses were undertaken separately for men and women and were restricted to participants with 
complete information on all measures (1363  men,  1355  women).  Analyses were repeated restricted 
to  those  without  any  antihypertensive  medication  to  test  the  robustness  of  our  findings  in  the 
untreated group.  All analyses were performed using SPSS for Unix version  10 (SPSS Inc., Chicago, 
Illinois).
60Results
Information on contact and response rates  at the most recent follow-up at 53  years  of the National 
Survey of Health and Development at are shown in appendix  1; characteristics of the sample at age 
53 years are shown in table  1.  Men were heavier at birth and age 53 years, taller in terms of height, 
leg and trunk length, had larger waist circumferences, and higher pulse pressure, systolic and diastolic 
blood pressure, compared to women.  On average, men were more likely to be educated at A levels or 
above, while women were more likely to currently be in non-manual occupations.
No significant differences were observed in terms of BMI, father’s social class, antihypertensive drug 
use, current smoking and exercise levels.
[T a b l e 1]
Pulse pressure increased linearly with decreasing height and leg length (figure 5, table 2) in men and 
women  (shortest compared with the tallest height (leg length)  group,  men 54.6  versus  51.0  mmHg 
(55.8 versus 50.7 mmHg), women 52.9 versus 48.4 mmHg (53.3 versus 48.6 mmHg); p-value < 0.001 
in each case).
61Figure 5 M ea n pu lse pr essu re ac ro ss groups of height a n d leg length
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Adjustment for adult confounding factors, current use of cardiovascular medication, central and total 
obesity and  smoking  status  (model  A)  did not  alter the results  and  levels  of significance remained 
generally unchanged.  Additional inclusion of either childhood social class (model B) or birthweight 
(model C) attenuated the effect of height on pulse pressure only slightly and in men only (p-value < 
0.01).
[Ta b le 2]
Systolic blood pressure showed the same trends as pulse pressure for height and leg length in women 
and leg length in men (p-value < 0.001  in each case).  The association between height and systolic
62pressure was slightly weaker in men (p-value=0.006) and lost statistical significance after inclusion of 
either birthweight or childhood social class in the model.
[Ta b l e 3]
In  each  model,  for  both  men  and  women,  the  observed  differences  in  z-scores  of  systolic  blood 
pressure  between  groups  of height  or  leg  length  were  smaller  in  comparison  with  pulse  pressure. 
Diastolic blood pressure was associated with height in women before, but not after adjustment.
[Ta b l e 4]
Trunk length was not associated with any outcome measure in men or women (data not shown).
Sensitivity analysis showed that results were unaltered when analyses were restricted to those without 
antihypertensive treatment.
Conclusions
Short height and leg length are associated with increased pulse pressure and systolic blood pressure, 
but not diastolic blood pressure, in middle aged men and women.  Measures of differential prenatal 
growth  or  childhood  social  conditions  contributed  little  to  these  associations.  Greater  levels  of 
arterial stiffness and blood pressure in men and women with shorter height and leg length may be due 
to greater initial levels, a steeper increase in these measures as they rise with age, or a combination of 
both.  This has not previously been investigated and will be addressed in the next chapter.
63Chapter 5: Second O bjective
O bjective
To  investigate  whether  poor  growth  contributes  to  the  age  related  increase  of pulse  pressure  and 
systolic blood pressure,  I will investigate associations between components of height as markers of 
growth  at  different  phases  and  the  tracking  of arterial  stiffness,  using  repeated  measures  of pulse 
pressure and blood pressure.
S tu d y d esig n  o f  t h e  MRC N a tio n a l S u rv ey  o f  H ea th  and D ev elo p m en t 
Participants
Data collections  similar to those described in chapter 4 occurred at ages  36  (n=3322)  and 43  years 
(n=3262) in the MRC National Survey of Health and Development. (281)
Measurements
Anthropometry
The measurement techniques of height, weight and components of height at 53 years are described in 
chapter 4; corresponding measures were obtained according to the same standardized protocol at age 
43 years.  Trunk length was not measured at 36 years and so leg length was also unavailable at this 
age.  For all analyses, information on height, leg and trunk length as measured at 53 years, and only if 
not  available,  at 43  years  (n=474),  was  therefore  used,  corresponding  to  analyses  described in the
64previous chapter.  For descriptive purposes, sex specific tertiles were used as cut-offs, to divide these 
variables into three equally sized groups.
Blood pressure
In  addition to blood pressure measures  described in chapter 4,  systolic and diastolic blood pressure 
was measured in duplicate by trained research nurses at 36 and 43 years, according to a standardized 
protocol.  At  these  ages  blood  pressure  was  measured  using  the  Hawksley  random  zero 
sphygmomanometer.  At each  age, the  second blood pressure reading was  used for analysis unless 
only the first measurement was available.  Pulse pressure was calculated as the difference between 
systolic and diastolic pressure at each age.
Medication
In addition to participants’ current medication at 53 years, as described in chapter 4, participants were 
asked at ages 43  and 36 years whether they had taken  any prescribed medicines or tablets  for high 
blood pressure in the last year.
Other variables
Measures of birthweight, social class, education, smoking and exercise are described in chapter 4.
Statistical analyses
To describe the sample and identify potential confounding factors, the mean or percentage of selected 
variables that have previously been suggested to influence blood pressure were calculated for each of 
three equally  sized  categories  of height,  leg  and  trunk  length.  Pearson  chi-squared  tests  for trend 
across  these  categories  were  performed  to  investigate  statistical  associations.  Linear  regression 
analysis  was  used  to  estimate  cross-sectional  relationships  between  the  explanatory  variables  and
65blood pressure measures.  Models were fitted including both men and women and an interaction term 
between  sex  and  either  height,  leg  or  trunk  length  was  used  to  investigate  whether  the  effect  of 
anthropometry  on  blood  pressure  differed  significantly  between  the  sexes.  These  analyses  were 
performed using Stata 7.0 software (StatCorp. Stata Statistical Software: Release 7.0 College Station, 
Texas: Stata Corporation, 2002). (282)
Multilevel models were then used,  (283) with blood pressure as a repeated outcome measure, using 
the package MLwiN.  (284)  In these models, repeated measures of blood pressure at different ages 
(level  1) are nested within individuals (levels 2), taking account of the correlation between repeated 
measures  on  the  same  individual  and  allow  for  incomplete  outcome  data  as  long  as  a  missing  at 
random process can be assumed. (283;285;286)
First, the change in blood pressure with age was modelled.  The intercept (mean blood pressure at 36 
years),  and  linear  and  quadratic  terms  for  age  were used to  model  the  non-linear change  in blood 
pressure over time.  In  all  models,  the variance  of blood pressure was  allowed to change with  age 
(level  1  random  variation),  and both  intercept  and  slope  were  allowed to  vary  between  individual 
cohort members (level 2 random variation).
In all analyses, separate curves were modelled for men and women by including sex in the model and 
also interaction terms between sex and the linear effect of age, and sex and the quadratic effect of age.
66Random effects
The level 2 variance parameters  correspond to estimates of the population  variance of the intercept 
(blood pressure at 36 years) and slope (change in blood pressure between 36 and 53  years).  These 
variances were used to calculate expected ranges (95% ER) for the intercept and slope.
Examining residuals
Before developing this model further, the appropriateness of the model assumptions and evidence of 
outliers  was  examined.  Normal  scores  plots  of level  1  and  2  residuals,  presence  of  outliers  and 
heteroscedasticity were assessed graphically.
Effect of components of height on blood pressure
The intercept was then allowed to vary according to height, leg or trunk length, respectively.  To test 
whether associations between components of height and blood pressure changed with increasing age, 
interaction terms between the anthropometric measures and age were added to each model.
Significance tests
Chi2-tests based on  (/? /se( ft ))2,  where  ft  is  the regression coefficient,  were carried out to assess 
levels of significance for the fixed effect parameters as suggested by Goldstein. (283)
Analyses  were  first  performed  with  the  maximum  number  of  observations  (9086)  and  repeated 
including only observations from participants with information on all covariates (7304), required for 
adjusted analyses.
Adjustments  were  performed  introducing  potential  confounders  (or  groups  of  confounders 
representing  similar  underlying  mechanisms)  one  at  a  time  and  all  together,  to  investigate  their 
separate and joint effects on the associations of interest.  First, antihypertensive treatment status for 
each  time  point  was  considered.  Interactions  between  components  of height  and  treatment  status
67were also added to assess whether associations differed according to treatment status.  Secondly, body 
mass index at each time point was added to the model, influencing both intercept and slope, as a time 
varying  covariate,  as  separate  analyses  of this  cohort  had  indicated  the  importance  of body  mass 
index on blood pressure and its change with age. (281)  Thirdly, the influence of several other adult 
factors,  including  social  class,  smoking,  exercise  and  educational  attainment  was  considered. 
Fourthly,  corresponding  to  earlier  analyses,  the  impact  of  early  life  factors  was  investigated  by 
introducing birthweight and father’s social class into the model.  Lastly, a model was fitted including 
all variables.
Additional analyses were carried out using sex-standardized measures of blood pressure (z-scores) to 
assess whether any change in the variance of blood pressure with age, potentially due to the different 
measurement instruments used, had an impact on the findings.
Results
A total  of 3414  participants  (1721  men,  1693  women) had  at least one measure  of blood  pressure 
(both systolic and diastolic blood pressure) and corresponding height and leg length measures.
68Characteristics of the sample in relation to height, leg and trunk length
Participants’ birthweight was found to be equally and positively associated with total height and both 
of its components, while body mass index at 36, 43 or 53 years was negatively associated with height 
and leg length, but not trunk length.
[T a b le 5]
In  contrast,  central  obesity  (waist-hip ratio)  measured at the most recent home  visit was related to 
upper body (trunk) length only.  Higher proportions of participants with taller height, longer legs or 
trunks were found to have fathers from non-manual social classes, have education at A-level or above 
and to be working in non-manual occupations.  They were also more likely to exercise regularly and 
not to be current smokers, when compared to those of shorter height, leg or trunk length.  Chi-squared 
tests  for trend  across  groups  of height,  leg  and trunk length  showed  that  associations  were  highly 
statistically significant (p-value < 0.007 in all cases, except for the association between leg length and 
exercise,  p-value=0.02),  with  the  only  non-significant  association  being  between  leg  length  and 
smoking (p-value=0.44).
Participants  of taller height were also less  likely to be treated for hypertension  at each  of the  ages 
considered  (p-value  <  0.002  in  each  case).  Leg  length  was  significantly  associated  with 
antihypertensive treatment at 43 and 53 years, and trunk length with treatment at 36 years.  None of 
the significant associations showed deviation from linearity.
Associations between height, leg and trunk length and blood pressure at each age
As  shown  in  the  previous  chapter,  pulse  pressure  and  systolic  blood  pressure  at  53  years  were 
significantly lower in men and women with greater height and leg length, but not trunk length; similar 
relationships were also observed at age 43 years.
69[Ta b l e 6]
Regression estimates for all three measures of blood pressure were smaller at 43 years for both height 
and leg  length,  compared to those  at  age  53  years.  Taller height was  also  significantly  associated 
with  lower  systolic  and  diastolic  blood  pressure  at  36  years,  as  was  shorter  leg length  with  lower 
diastolic blood pressure.  Although regression coefficients for pulse pressure at this age were in the 
same direction, effects were smaller and not statistically significant.
Of 27 tests for interactions that were carried out to assess whether the effect of components of height 
differed between the  genders,  only  3  were  statistically  significant  (p-value  < 0.05).  At 53  and 43 
years,  none  of  the  tests  for  interaction  reached  conventional  levels  of  statistical  significance. 
Estimates  for  men  and  women  are  therefore  presented  combined,  adjusted  for  sex,  in  all  further 
analyses.
Multilevel modelling  of the associations  between  components  of height and repeated measures  of 
blood pressure at 36, 43 and 53 years
Effect of age and sex on blood pressure (basic model)
A  multilevel  model  was  built  successively,  first  in  the  sample  with  the  maximum  number  of 
observations (9086).  The basic model included the constant (intercept) and the effect of age (slope), 
both of which were allowed to vary randomly within and between individuals, as well as fixed terms 
for  the  quadratic  effects  of age,  sex,  and  interaction  terms  between  sex  and  age  and  sex  and  the 
quadratic  effect  of  age.  The  random  effect  of the  quadratic  increase  of blood  pressure  was  also 
considered,  but  found  to  be  non-significant  and  therefore  not  included  in  the  model.  Regression 
equations from each model and estimates obtained for all parameters included are given in appendix 
2.
70Examining residuals
Plotting standardized residuals from each basic model against their normal scores resulted in a nearly 
straight line, indicating that level  1  and 2 residuals were approximately normally distributed.  There 
was no evidence of a non-linear trend of level  1 residuals with age (from a model excluding the level 
1  random variation with age), thus no evidence of heteroscedasticity.  Plotting  standardized level 2 
residuals for the intercept term against standardized level 2 residuals for the slope showed a negative 
correlation,  as  also  seen  from  the  negative  covariance  between  the  two  terms  in  the  regression 
equation  (appendix  2).  This  indicates  that  participants  with  lower  blood  pressure  at  age  36 
experienced  a  steeper  increase  of  blood  pressure  over  time,  possibly  representing  the  effect  of 
regression to the mean.  Plots of level 2 ranks with  1.39 standard error intervals around them, (283) 
indicated significant differences between person specific intercepts (blood pressure at 36 years) and, 
slightly less pronounced, person specific slopes.
Pulse pressure
Men’s average pulse pressure at age 36 years (intercept) was significantly higher than women’s pulse 
pressure at the same age (appendix 2 and figure 6).
F ig u re 6 P u lse  p r e ssu r e  o f  m en a n d  w om en  b e tw e e n  th e  a g e s 36 a n d  53 y e a r s
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71Figure 6  also shows that the effect of age on pulse pressure differed significantly between men and 
women.  The greater linear and smaller quadratic increase in women compared to men, leads to lower 
pulse pressure at age 43 years in men compared to women, despite their higher levels at the previous 
measurement (36 years).
Random variation
As all models include sex interactions, the following results are given here for the baseline group, in 
this case men, for easier comparisons with the corresponding equation in appendix 2.  The between 
person variance in pulse pressure at age 36 years was 36.593.  This gives a 95% expected range (ER)) 
in intercepts from 32.39 to 56.10 mmHg (44.25 +/-  1.96V 36.593).  The between person variance in 
slope was 0.146, indicating a 95% ER from -1.374 to 0.124 mmHg per year.  The covariance (SE) of 
-0.711  (0.284) between individuals’ intercepts and slopes implies that lower pulse pressure at age 36 
years was associated with a steeper increase and vice versa, as previously indicated by the residuals. 
There  was  also  significant  variability  of  pulse  pressure  around  person-specific  predicted  pulse 
pressure at age 36 (level  1  residual standard deviation of 9.28 mmHg (V 86.036), which was allowed 
to vary with age.
Systolic blood pressure
Similarly to pulse pressure, systolic blood pressure at age 36 years was lower in women compared to 
men,  and  significant  interactions  were  observed  between  sex  and  both  the  linear  and  quadratic 
increase of blood pressure with age (figure 7).
In  contrast  to  pulse  pressure,  men’s  levels  of  systolic  blood  pressure  were  consistently  higher 
compared to those in women.  Estimates  and more detailed information on the random variation in 
this model are presented in appendix 2.
72F ig u re 7 S y s t o lic  b lo o d  p r e ssu r e  o f  m en a n d  w om en  b e tw e e n  th e  a g e s  36 a n d  53 y e a r s.
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Diastolic blood pressure
In contrast, the change in diastolic blood pressure with age was found to be linear and the quadratic 
increase  observed  for  pulse  pressure  and  systolic  blood  pressure  was  non-significant.  Again,  the 
intercept (diastolic blood pressure at 36 years) was higher in men compared to women.  The increase 
of diastolic blood pressure with age was steeper in men, compared to women.  Results are displayed 
in figure 8 and more detail is presented in appendix 2.
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73Effects of height, leg and trunk length on pulse pressure, systolic and diastolic blood pressure
Separate inclusion of height, leg or trunk length and interactions between each of the components of 
height and age in the basic multilevel model showed that the effects of both height and leg length on 
pulse pressure became significantly stronger with age.
[Ta b l e 7]
The linear change in pulse pressure (95% Cl) was found to be -0.020 mmHg (-0.026; -0.014) per year 
lower for every centimeter increase in leg length.  The change in systolic blood pressure was found to 
be -0.021  mmHg (-0.029;  -0.013) per year lower for every centimeter increase in leg length.  The 
model  leads  to  an  estimated  effect  of leg  length  on  systolic blood pressure  at  36  years  of -0.086 
mmHg (-0.18;  0.012) per centimeter increase in leg length and one of -0.44 mmHg per centimeter 
increase in leg length at 53 years.  These estimates are of similar magnitude to those observed in the 
earlier cross-sectional analyses.
Diastolic blood pressure at 36 years (intercept) was significantly influenced by height and leg length, 
however, these effects did not appear to get  stronger over time,  as indicated by the non-significant 
results for the slope (p-value > 0.5 in both cases).
Trunk length was not related to any of the blood pressure measures  at 36  years,  and none of these 
associations changed with age.  Trunk length was therefore omitted from all further analyses.
Adjusted analyses
Results from analyses of the restricted sample with complete information (7304 observations) showed 
that  estimates  for  the  amplification  of the  effect  of height  and  leg  length  on  pulse  pressure  and 
systolic blood pressure with age were of similar magnitude compared to previous analyses.  Levels of 
significance remained identical.
74[Ta b l e 8]
For pulse pressure, individual adjustment for confounders or groups of confounders had only a small 
effect on the estimates; coefficients were reduced only slightly more when all variables were included 
simultaneously in the same model and levels of significance remained unchanged (p-value < 0.001 in 
all  cases).  For  systolic  blood  pressure,  body  mass  index  and  its  increasing  importance  for  blood 
pressure with  age had the largest impact  on  the  amplification  of the effect  of height or leg  length. 
Full  adjustment including  all  variables  under consideration  did not reduce estimates  much  further. 
Again, levels of significance remained high  (p-value < 0.01  in all cases).  In  addition,  no evidence 
was found that the associations between either height or leg length and blood pressure were modified 
by treatment status (results not shown).
Sensitivity analysis
Replacing the blood pressure measures by their internally derived standard deviation scores did not 
alter associations between both height and leg length and pulse pressure or systolic blood pressure or 
the p-values.
Co nclusions
These  results  support  the  hypothesis  that  greater  levels  of  pulse  pressure,  a  measure  of  arterial 
stiffness, and systolic blood pressure in men and women with shorter height and leg length are due to 
a steeper rise of these measures with age.  Growth limiting factors may increase susceptibility to the 
effects  of  ageing  on  the  arterial  tree  and  thus  contribute  to  the  tracking  of  cardiovascular  risk 
throughout life.
75Ch a pter 6: T h ird O bjec tiv e
Objective
To  explore  whether  associations  are  specific  to  pulse  pressure,  i.e.  arterial  stiffness,  cross- 
sectional  associations  between  markers  of  growth  and  a  range  of  cardiovascular  risk  factors 
available in the Whitehall II Study will be investigated; this will also allow to replicate (validate) 
associations between components of height and pulse pressure in another cohort.
S tu d y  d e sig n  o f  th e  W h it e h a ll II S tu d y  
Participants
The target population for the Whitehall II study was all the London-based office staff, aged 35- 
55,  working  in  20  Civil  Service  departments.  With  a  response  rate  of 73%,  the  final  cohort 
consisted of  10308 participants  (6895  men,  3413  women) at the first phase of data collection in 
1985-88.  (287)  However, the true response rate was higher as around 4% of those invited were 
not eligible  for inclusion.  Although  mostly  white  collar,  respondents  covered  a  wide  range  of 
employment grades from office support to permanent secretary.  Participants were predominantly 
white European 91.5%, 2.8  % were Afro-Caribbean, 4.3% South Asian, and  1.4% reported other 
ethnic  origins.  Ethical  approval  for  the  Whitehall  II  study  was  obtained  from  the  University 
College London Medical School committee on the ethics of human research.
The  screening  at  baseline  (phase  1)  involved  a  clinical  examination,  and  a  self-administered 
questionnaire  containing  sections  on  demographic  characteristics,  health,  lifestyle  factors,  work 
characteristics,  social  support,  and  life  events.  Since  the  baseline  screening,  six  more  data
76collection rounds have been completed;  successive phases alternated between collecting data by 
self-administered  questionnaire  only  and  clinical  screening  in  addition  to  questionnaire 
completion.  Clinical examinations  were carried  out in  1992-3  (phase  3),  1997-9  (phase  5)  and 
2003-4  (phase 7).  Of the  10308  participants  at baseline in the Whitehall II  study,  8354  (81%) 
responded at phase 3,  7824  (76%)  at phase 5  (7269  attending the clinic examination)  and 6944 
(67%) at phase 7 (5743 attending the clinic examination, 741  having a home visit and 4112 with 
vascular measures).
Measurements
Anthropometry
Measurements  of height  and  weight  were  carried  out  according  to  a  standard  protocol  at  each 
clinic  examination;  standardized  assessment of waist and hip circumference  were carried  out at 
the  phase  3  (1991-93),  5  (1997-99)  and  7  (2003-4)  examinations.  (288)  Body  circumferences 
were measured with  subjects  in the  standing position and unclothed,  utilizing  a fibreglass tape- 
measure  at 600  g tension.  The  waist  circumference  was  measured halfway between  the  costal 
margin  and  iliac  crest  and  hip  circumference  at  the  level  of the  greater  trochanter.  BMI  was 
calculated  as  weight divided by  height  squared  (kg/m2)  at each  phase.  Waist to  hip ratio  was 
calculated as waist divided by hip circumference and expressed as a percentage.
At phase  5,  sitting height,  used to  represent trunk length,  was  measured to the nearest 0.5  cm. 
Participants were asked to sit upright, with their back against the vertical stand of the stadiometer, 
on the base plate located on a hard, flat seat, with the head in the Frankfort plane and their feet on 
the floor.  Leg length was calculated as the difference between standing and sitting heights.  Self 
reported  birthweight  was  obtained  from  questionnaires  and  data  collected  at  phases  3  and  5 
combined.  For comparison purposes, all anthropometric measures were converted into internally 
derived sex specific standard deviation scores (z-scores).
77Cardiovascular risk factors (phase 5)
Measurements cardiovascular risk factors were carried out according to a standard protocol at the 
phase  5  examinations  (1997-99).  (289)  Systolic  and  diastolic  blood  pressures  were  measured 
twice in seated resting subjects; pulse pressure was calculated as the difference between systolic 
and diastolic blood pressures.  Participants reported whether they ever received treatment for high 
blood pressure (men 12.4 %, women 15.9 %).  A venous blood sample was obtained following an 
overnight fast in the morning or in the afternoon after no more than a light fat-free breakfast eaten 
before 8 am.  Glucose was determined in fluoride plasma by an electrochemical glucose oxidase 
method.  Cholesterol  and  triglycerides  were  measured  in  a  centrifugal  analyzer  by  enzymatic 
colorimetic methods.  HDL cholesterol was determined after dextran sulfate-magnesium chloride 
precipitation  of non-HDL cholesterol.  An  oral  glucose tolerance test (75  g  anhydrous  glucose) 
was administered and post load glucose measured in citrated plasma after 2 hours.  Diabetes was 
defined  according  to  1999  World  Health  Organization  (WHO)  criteria.  (290)  A  person  was 
regarded as having diabetes if the fasting plasma glucose was > 7 mmol/1 (126 mg/dl) or the 2-h 
glucose after the oral glucose tolerance test was >11.1  mmol/1 (200 mg/dl),  or if he or she was 
using  diabetes  medication  (oral  or  insulin).  People  with  missing  information  on  the  2  hour 
glucose and/ or drug use were classified as having diabetes if they reported a history of diabetes, 
even in the absence of an abnormal fasting glucose.
78Socioeconomic indicators and health-related behaviour
Childhood social class was based on father’s occupation, and grouped according to the Registrar 
General’s  Classification;  participants  with  the  highest  social  classes  (I/II)  in  childhood  were 
distinguished from  all  others.  On the basis  of salary and work role,  the civil  service defines  a 
hierarchy  of employment  grades,  and participants  were  assigned to  one  of three  levels:  unified 
grades 1-7 (high employment grades), executive officers (middle grades), and clerical and support 
staff (lower grades). (127;291)
Health-related behaviours  were reported at Phase 5.  Alcohol intake was based on consumption 
during the week prior to the interview with high intake defined as  15 or more units per week for 
women  and  22  or more  units  per  week for men,  based  on  sensible  drinking recommendations. 
(289)  Smoking status distinguished never-smokers from previous and current smokers.
Sta tistic a l a n a ly ses
Of the  7269  (5090  men,  2179  women)  participants  attending  the  phase  5  clinic  examination, 
participants with missing data for any component of stature (2278 missing) were excluded from 
analyses  of cross-sectional  associations  between  anthropometry  and cardiovascular risk factors, 
leaving a total of 4991 participants (1534 women, 3457 men).
Differences  in  means  of continuous  and proportions  of binary  characteristics  between  men  and 
women included in the study were assessed using t-tests and chi-squared tests, respectively.
Pearson  correlation  coefficients  were  calculated  for  the  anthropometric  variables  in  both  the 
NSHD and the Whitehall II Study (age adjusted), in order to compare correlations of components 
of height  with  birthweight  obtained  from  hospital  records  at  the  time  of birth  (NSHD)  versus 
recalled in adult life (Whitehall II Study).
Linear  regression  analysis  was  then  used  to  assess  cross-sectional  associations  of  the 
anthropometric  markers  with  continuous  cardiovascular  risk  factors.  The  distribution  of 
triglycerides  was  skewed  and  required  transformation;  the  natural  logarithm  was  used  in
79regression  models.  Coefficients  from  linear  regression  analyses  represent  the  age  adjusted 
absolute change in each continuous risk factor associated with one standard deviation increase in 
the  anthropometric  measure  of interest;  in the case  of log transformed  variables,  100 times the 
coefficient represents the percentage change in the risk factor of interest.  Age adjusted analyses 
were  conducted  separately  in  women  and  men;  first,  using  the  complete  sample  and  second, 
restricted to participants with complete information on covariates.  Fully adjusted analyses of the 
restricted  sample  were  then  performed  including  adjustments  for  birthweight,  childhood  social 
class, adult grade, health behaviours (smoking, alcohol intake) and antihypertensive treatment for 
blood pressure outcomes.
Re su lts
Women and men differed significantly with respect to most measures; the most notable difference 
being  the  proportion  in  low  employment  grades.  In  participants  attending  both  phases,  mean 
height at phase 1 and 5 was similar in both men and women.
[T a b l e 9]
Correlations between components of height and birthweight recorded at the time of birth (NSHD) 
versus recalled in adult life (Whitehall n  Study) are presented in table  10.  Overall, age adjusted 
correlations between height and both leg and trunk length were high, reflecting the fact that the 
latter two are components  of the former.  Correlations  between birthweight  and components  of 
height were weaker and similar for leg and trunk length in men and women, ranging from 0.13- 
0.20  in  both  studies  and  sexes.  While  leg  and  trunk  length  were  positively  and  moderately 
correlated  in  Whitehall  II  participants,  they  showed  weak  inverse  correlations  in  the  NSHD 
cohort.
[Table 10]
80Anthropometry and cardiovascular risk factors
As  expected,  shorter  height  was  associated  with  older  age  (table  11).  Significant  inverse 
associations  were  also  observed  between  total  body  height  and  all  blood  pressure  measures  in 
women, and pulse pressure in men.  In fully adjusted models, height was significantly associated 
with  all  blood  pressure  measures  and  waist-hip  ratio  in  women,  while  it  also  showed  inverse 
relationships with cholesterol, triglycerides and 2 hour glucose in men.
[Ta b l e 11]
Leg  length  was  not  associated  with  age  at  measurement  in  women,  and  only  weakly  in  men. 
Strong  inverse  associations  were  observed  between  leg  length  and  pulse  pressure  and  systolic 
blood pressure in both sexes and diastolic blood pressure in women, before and after adjustments.
[T a b l e 12]
Likewise, longer leg length was associated with lower levels of triglycerides in men and women, 
and  lower  cholesterol,  2  hour  glucose  and  waist-hip  ratio  in  men  only,  before  and  after 
adjustments.  In contrast to results  obtained for leg length,  strong associations between age  and 
trunk length were found in both sexes, such that shorter trunks were observed at older ages.
[T a b l e 13]
Age and waist-hip ratio were the only measures significantly associated with trunk length in men 
and  women  before  and  after  adjustments;  a  significant  association  was  observed  for  2  hour 
glucose in men, too.  Associations that were initially found in age adjusted analyses between trunk 
length  and  the  blood  pressure  measures,  triglycerides  and  2  hour  glucose  in  women,  were 
attenuated  in  the  restricted  sample  and  none  remained  statistically  significant  in  fully  adjusted 
models.
81C o nclu sio n s
Correlations between components  of height and birthweight were  weak and comparable for leg 
and trunk length; similar results were observed in the Whitehall II Study, where birthweight was 
recalled in adult life, and the NSHD, where birthweight was recorded at the time of birth.  Shorter 
leg  length  was  strongly  and  inversely  associated  with  higher pulse pressure  and  systolic  blood 
pressure  in  both  men  and  women  of the  Whitehall  II  cohort,  before  and  after  adjustment  for 
several potentially confounding factors, in accordance with earlier findings from the NSHD.  As 
suggested in previous studies, height and both of its components showed significant relationships 
with  several other cardiovascular risk factors linked to lipid and glucose metabolism, indicating 
that associations are not restricted to blood pressure measures and are not entirely specific to leg 
length.
82Ch a pter 7: F o urth O bjective
O bjec tiv e
To  advance  the  understanding  of  the  aetiological  mechanisms  linking  poor  growth,  arterial 
stiffness and coronary heat disease risk,  and to avoid potential biases due to misclassification of 
CHD  outcomes  that  rely  on  self report  and  routinely  recorded  information,  I  will  investigate 
associations between adult markers of growth and objective measures of atherosclerosis, including 
specific  non-invasive  measures  of  vascular  wall  thickness  (intima  media  thickness),  arterial 
stiffness (beta stiffness index) and distensibility (distensibility coefficient).
S tu d y  d e sig n  o f  th e  W h it e h a ll II S tu d y  
Participants
Data collections  similar to those described in  chapter 6  occurred  at phase  7  of the  Whitehall II 
Study, when vascular measures were obtained.
Measurements
Ultrasound vascular measures
Ultrasound vascular measures were performed from July 2003  to October 2005  (phase 7) in the 
Vascular Physiology Unit,  Institute  of Child  Health,  London,  United Kingdom.  Measurements 
were  taken  in  a  quiet,  temperature  controlled  (22-26  degrees  centigrade)  room,  using  a  non- 
invasive,  high-  resolution  ultrasound  system,  the  Aloka  5500  with  a  7.5  MHz  transducer.
83Participants were examined in a supine position, with the head turned at a 45 degree angle away 
from the side to be scanned.
Intima media thickness
Intima  media  thickness  (IMT)  was  measured  in  the  right  and  left  common  carotid  arteries. 
Longitudinal  images  of the common carotid  artery,  triggered  on  the R-wave  of the ECG,  were 
magnified  and  recorded  in  DICOM  format  as  a  cine  loop  and  saved  on  the  hard  drive  of the 
ultrasound machine for later analysis.  Common carotid artery IMT was measured at its thickest 
part 1 cm proximal to the bifurcation.  A measurement was taken between the leading edge of the 
intima  and  the  media-adventitia  interface  on  3  separate  images  on  each  side  using  electronic 
calipers and the mean of the 6 measures was used for analysis.
Arterial stiffness index and distensibility coefficient
Arterial wall movement was tracked and vessel diameter and distension determined on a beat-by- 
beat  basis.  Blood  pressure  was  measured  on  the  ipsilateral  arm  synchronous  with  the  carotid 
distension measurement using an automatic oscillometric sphygmomanometer. The distensibility 
coefficient was calculated for each side and averaged.
The distensibility coefficient reflects  intrinsic  vascular wall elasticity and is  expressed  as  mean 
percent  change  in  cross-sectional  area  between  diastole  and  systole  relative  to  the  area  during 
diastole  per  unit  change  in  blood  pressure  (kPa),  it  is  calculated  as  DC=(2*dD)/(Dd*dP);  dD 
denotes  the  change  in  arterial  diameter  during  the  heart  cycle,  Dd  the  arterial  diameter during 
diastole, and dP the difference in blood pressure, i.e. pulse pressure.
Carotid  artery  stiffness  was  calculated  by  the  pressure  independent  beta  stiffness  index  and 
calculated as |3=ln(SBP/DBP)/(dD/Dd).
Logarithmic  transformations  were performed  for all three  vascular outcomes to normalize their 
distributions.
Cardiovascular risk factors (phase 7)
84Systolic  and  diastolic  blood  pressure  were  measured  twice  in  seated  resting  subjects  and 
hypertension defined as blood pressure > 140/90 mmHg or use of antihypertensive medication.  A 
75-g oral glucose tolerance test was performed in the morning after a requested 8 hour fast; blood 
samples  were  obtained  by  venipuncture  at  0  and  2  h,  as  described  in  the  previous  chapter. 
Diabetes was defined according to  1999 WHO criteria.  (290)  A person was regarded as having 
diabetes if the fasting plasma glucose was > 7 mmol/1 (126 mg/dl) or the 2-h glucose after the oral 
glucose  tolerance  test  was  >  11.1 mmol/1  (200  mg/dl),  or  if  he  or  she  was  using  diabetes 
medication (oral or insulin).  People with missing information on the 2 hour glucose or drug use 
were classified as having diabetes if they reported a history of diabetes, even in the absence of an 
abnormal fasting glucose (34 men, 32 women).
Fasting plasma lipids and lipoproteins were measured as described in the previous chapter.  LDL 
cholesterol  was  calculated using the  Friedewald  formula.  Dyslipidaemia  was  defined  as  either 
LDL  cholesterol >160  mg/dl  (4.14 mmol/1)  or HDL cholesterol  < 50 mg/dl  (1.295  mmol/1) in 
women and < 40 mg/dl (1.036 mmol/1) in men, respectively, or statin use.
Coronary heart disease at phase 7
Potential  cases  of  definite,  non-fatal  myocardial  infarction  were  ascertained  by  questionnaire 
items  on  chest  pain,  (292)  and  doctor’s  diagnosis  of  heart  attack  at  each  phase.  Details  of 
physician diagnoses  and investigation results  were  sought from clinical records  for all potential 
cases of myocardial infarction.  Twelve-lead resting electrocardiograms were performed at each 
clinic  visit (Siemens  Mingorec)  and coded according to Minnesota criteria.  (293)  Based on  all 
available data (questionnaires,  study electrocardiograms,  electrocardiogram and cardiac  enzyme 
results from hospital records), non-fatal myocardial infarction was defined according to MONICA 
criteria.  (294)  Classification  was  carried  out  blind  to  other  study  data  independently  by  two 
trained coders,  with adjudication by a third in the (rare) event of disagreement.  Definite angina 
was  recorded  for  participants  who  reported  symptoms  of  angina,  (295)  together  with
85corroboration in clinical records  or abnormalities  on  a resting ECG,  exercise ECG,  or coronary 
angiogram.
Socioeconomic indicators and health-related behaviour
Information on demographic, socioeconomic and behavioural variables was obtained from the self 
completed  questionnaires  administered  either  at  phase  1  (ethnic  group,  childhood  social  class, 
employment grade) or phase 7 (all other variables).
Childhood social class and employment grade were defined as described in the previous chapter. 
Education level was based on the highest educational qualification achieved and higher education 
distinguished from advanced  secondary qualifications,  ordinary  secondary qualifications  and no 
academic qualification.  Financial indicators were derived from phase 7 questionnaires, using pre- 
coded categories.  Annual personal income included the "amount received annually from salary or 
wages,  pensions,  benefits  and  allowances  before  deduction  of tax";  annual  household  income 
included  the  "total  annual household  income  from  any  source,  including personal  income"  and 
household wealth included the "amount of money the respondent would have if s/he cashed in all 
household assets and paid off all debts".
Smoking  status  and  high  alcohol  intake  were  defined  as  described  in  the  previous  chapter. 
Physical  activity  distinguished  participants  with  >  2.5  hours  of  vigorous  physical  activity  per 
week (“sufficient”)  from those who were less  physically active.  (296)  A healthy diet indicator 
(scored 0-3) was constructed as previously reported. (297)
Sta tistic a l an a ly ses
Age  adjusted  means  and  proportions  of  cardiovascular  risk  factors,  health  behaviours, 
socioeconomic and anthropometric measures were calculated separately for men and women and 
differences assessed using t-tests or chi-squared tests, as appropriate.
Differences in cardiovascular risk factors, health behaviours and socioeconomic variables  across 
quartiles of intima media thickness,  arterial  stiffness  and distensibility were obtained,  separately
86for men and women, and adjusted for age; p-values are based on Mantel-Haenszel tests for trend. 
Associations between standardized scores (z-scores) of the anthropometric measures and the log 
transformed continuous vascular outcomes were examined using multiple regression analyses.
Adjustments  were  performed  in  several  steps:  a)  adjusting  for  age,  b)  additionally  including 
concurrent  weight,  and c)  adding  ethnic  group  and  cardiovascular risk factors  (prevalent  CHD, 
diabetes,  hypertension,  dyslipidaemia,  and  smoking).  Further  adjustments  for  socioeconomic 
variables that emerged as potentially important mediators or confounders in earlier analyses (see 
above) were performed for associations significant in age- and multiple adjusted analyses.
Sensitivity analyses were performed repeating final models restricted to white Europeans.  Results 
for intima media thickness, distensibility and stiffness are reported as percentage difference for a 
1  standard  deviation  increase  in  the  exposure  variables  in  these  and  the  following  analyses. 
Estimates  were  obtained  from  regression  coefficients  using  the  formula  (exp((3)-l)*100.  All 
analyses were performed using the SAS statistical program (SAS Institute, Cary, NC, USA).
Resu lts
Sex differences
Geometric  means  of  intima  media  thickness  (mm),  beta  stiffness  index  and  distensibility 
coefficient  (10_3*kPa_1)  were  0.780,  10.90  and  13.92  in  men  and  0.766,  10.31  and  15.08  in 
women,  respectively.  Age adjusted geometric  means  of all three  vascular measures  and means 
and  prevalences  of cardiovascular  risk  factors  differed  significantly  between  men  and  women, 
with adverse levels generally observed in men, except for age (p-value=0.08), pulse pressure (p- 
value=0.56), diabetes (p-value=0.88), and hypertension (p-value=0.07), which showed borderline 
or non-significant differences.
[Table 14]
87Women were more likely to have a history of CHD before (16.4%  versus 20.5%,  p=0.002), but 
not  after  excluding  those  with  angina pectoris  (10.8%  versus  9.9%,  p=0.40).  Men  were  more 
likely than women to be white European (93.5% versus 85.3%) and were less likely to have never 
been a smoker (52.2%  versus 62.7%); in contrast, more women reported current smoking (6.4% 
versus 8.3%).
There was  strong evidence of sex differences in the distribution of all socioeconomic indicators 
(all  p-values  <  0.001),  with  higher  proportions  of  women  in  the  more  disadvantaged  groups, 
adjusting for age.  Gender differences were also observed for measures of body size;  men were 
heavier at birth and taller as adults, in terms of total height, leg and trunk length (all p-values < 
0.0001).  While on average, men were heavier and had larger waist circumferences, women had 
higher levels of BMI at each phase (all p-values < 0.0001).Cardiovascular risk factors and vascular outcomes
White European men and women were significantly less likely to have adverse levels of carotid 
intima media thickness, distensibility and stiffness in age adjusted analyses.
[Table 15, Table 16, Table 17]
Women with a history of CHD had higher levels of intima media thickness  (p-value=0.04), this 
trend  was  somewhat  weaker  after  exclusion  of those  with  angina  pectoris  (p-value=0.06);  no 
significant associations were seen for distensibility and stiffness or any vascular measure in men. 
Men with diabetes, hypertension and dyslipidaemia were significantly more likely to have adverse 
levels  of all three vascular outcomes,  while in women this was  observed for hypertension  only. 
Associations  between  health  behaviours  (smoking,  alcohol  intake,  diet  and  exercise)  and  the 
vascular  outcomes  were  weak  and  inconsistent  in  both  men  and  women,  with  only  women 
reporting greater levels of exercise being significantly more likely to have lower levels of intima 
media  thickness  (p-value=0.002);  however,  no  associations  were  found  between  exercise  and 
distensibility and stiffness or any vascular measure in men.
Socioeconomic variables and vascular outcomes
The carotids of men with lower personal income, household income and wealth were significantly 
less distensible and showed greater levels of stiffness, while the opposite was true for men in the 
highest employment grades.  Men with less wealth also had significantly greater levels of intima 
media thickness, but the association with household income was weaker (p-value=0.07) and non­
significant for employment grade (p-value=0.47).
[Table 15, Table 16, Table 17]
Intima  media  thickness  was  the  only  measure  that  differed  significantly  according  to  father’s 
social  class  in  men  (p-value=0.02);  surprisingly,  a  positive  association  was  found  for  greater 
educational attainment.  Except for an associations between employment grade and intima media
89thickness  (p-value=0.05)  and  distensibility  (p-value=0.07),  associations  between  the 
socioeconomic markers and vascular outcomes were weak or absent in women.
Anthropometry and vascular outcomes
Birthweight was not associated with any vascular outcome in men, before or after adjustments.  In 
contrast, men’s height, leg and trunk length were each negatively associated with arterial stiffness 
and positively with distensibility; these associations were strengthened after adjustment for weight 
and remained strong and significant in multiple adjusted models.
[Table 18]
Estimates  for  total  height  were  larger  than  those  for  its  components,  with  stiffness  and 
distensibility being 2.47% lower and 3.67% higher, respectively, for a  1  standard deviation (SD) 
increase in height.  There was a suggestion of inverse relationships of height and leg length, but 
not trunk length, with intima media thickness in analyses adjusted for age and weight; however, 
both were attenuated and non-significant in fully adjusted models.
Women with greater birthweight showed greater levels of arterial stiffness (2.74% greater for a  1 
SD increase in birthweight)  and lower levels  of distensibility (2.41%  lower for an increase in  1 
SD of birthweight); these associations remained strong and significant in fully adjusted models (p- 
value=0.001  and  0.004,  respectively).  Estimates  were  similar  adjusting  for  BMI  instead  of 
weight,  and no evidence was found for effect modification by current body size (normal weight 
versus  overweight and obesity) for either stiffness  or distensibility (interaction p=0.42 and 0.43, 
respectively).  Women’s  trunk  length  was  significantly  and  positively  associated  with 
distensibility in age or age and weight adjusted analyses; however, this association did not remain 
in fully adjusted models.  Sensitivity analyses restricted to white Europeans showed results similar 
to those obtained including all participants (not shown).
90Associations between men’s height,  leg and trunk length  and arterial stiffness  and distensibility 
were  unaltered  in  final  models  additionally  including  separate  and  joint  adjustment  for  the 
socioeconomic markers.
[Table 19]
In contrast, none of the socioeconomic variables was significantly associated with distensibility or 
stiffness  in  these  fully  adjusted  models,  the  only  exception  being  the  greater  levels  of 
distensibility in men with the highest household income  (p-value=0.04, data not shown).
Co nclu sio n s
These results provide some evidence that growth limiting factors, including, but not restricted to, 
determinants  of  long  bone  growth,  contribute  to  arterial  stiffness  and  distensibility  in  men. 
Prenatal  growth  and  socioeconomic  markers  considered  here  do  not  account  for  the  observed 
associations, despite evidence for adverse levels of vascular distensibility and stiffness in those in 
less  advantaged  socioeconomic  positions.  Conversely,  adult  measures  of  poor  growth  were 
shown  to  contribute  to  associations  between  socioeconomic  factors  and  subclinical 
atherosclerosis.
91Ch a pter 8: F ifth O bjec tiv e
O bjec tiv e
To investigate whether socioeconomic disadvantage and poor infant growth, resulting in short leg 
length,  may contribute to the dramatically increased risk of diabetes and coronary heart disease 
(CHD) in Filipino-American women, a comparatively short population.
Stud y d esig n o f th e Ra n c h o B er n a r d o F ilipin a Stud y 
Participants
Self-identified  Filipinas,  ages  40-86  years,  were  recruited  between  October  1995  and February 
1999 for a cross-sectional study designed to estimate the prevalence of several chronic diseases. 
Most lived in north  San Diego County,  primarily Mira Mesa,  a middle-class community with a 
high proportion of Filipino residents; all except 4 women were bom in the Philippines.  Random 
sampling of the entire county was not feasible because Filipinos are not identified separately in 
the  San  Diego  census  and  recruitment  strategies  have  previously  been  described  in  detail. 
(298;299)  Clinical  evaluations  took  place  at  the  University  of California,  San  Diego  Rancho 
Bernardo Research Clinic.  All participants gave written informed consent.
Measurements
Standardized  questionnaires  were  used  and  administered  by  a  Philippine-bom,  native  Tagalog- 
speaking female nurse.  All participants spoke functional English.  Demographic characteristics, 
including  age,  childhood  and  adult  income,  education,  occupation,  birthplace,  marital  and
92employment  status,  years  of U.S.  residence,  and  ethnic  identity,  were  elicited  for  each  group. 
Cigarette  smoking,  alcohol use,  physical activity,  parity,  menopausal  status,  medication history, 
family history of heart disease (in either parent) and diabetes (in either a parent or in siblings after 
age  40  years)  and  other  selected  chronic  diseases  were  determined  using  structured 
questionnaires.  Participants  who  were  using  medications  (prescription  or  non-prescription)  or 
nutritional supplements in the month before the clinic visit brought their pills and prescriptions to 
the  clinic  to  be  verified  and  recorded  by  a  nurse.  Systolic  and  diastolic  blood  pressure  were 
measured  twice  in  seated  resting  subjects  using  the  Hypertension  Detection  and  Follow-Up 
Program protocol,  (300)  and  hypertension  defined  as  blood pressure  >140/90 mmHg  or use  of 
antihypertensive medication. (301)
Anthropometry
Weight was measured to the nearest 0.1 kg with participants wearing light indoor clothing and no 
shoes.  Height was measured to the nearest 0.5 cm, using a portable stadiometer with participants 
standing  without  shoes  and  with  heels  against the  wall  as  tall  as  possible  with the head in  the 
Frankfort plane.  Participants were seated upright, with their back against the vertical stand of the 
stadiometer, on the base plate located on a hard, flat seat, with the head in the Frankfort plane and 
their  feet  on  the  floor  to  assess  sitting  height,  a  measure  of  trunk  length.  Leg  length  was 
quantified  as  the  difference  between  standing  and  sitting  heights.  Waist  circumference  was 
measured in centimetres at the participant's natural waist, and hip measurements at the iliac crest. 
BMI was calculated as weight divided by height squared (kg/m2).  Waist-hip ratio was calculated 
by dividing waist by hip circumference and expressed as a percentage.  Percentage of total body 
fat, truncal fat, and leg body fat (mean, right and left leg) was determined by dual-energy X-ray 
absorptiometry (DEXA; model QDR-2000 X-ray bone densitometers; Hologic, Waltham, MA).
Coronary heart disease, diabetes and plasma lipoproteins
Prevalence of CHD was defined as ECG abnormalities from a  12-lead resting electrocardiogram 
(Minnesota  codes  1.1-1.2  (large  Q  and  QS  waves),  1.3  (small  Q  and  QS),  4.1-4.4  (ST-T
93depression), 5.1-5.3 (flattened or inverted T waves) or 7.1.1  (complete left bundle branch block)), 
(293;302) a positive Rose questionnaire for angina or prolonged chest pain, (292) hospitalization 
for coronary  revascularization  procedures  or reported  myocardial  infarction.  Rose  angina  was 
defined according to standard criteria as chest pain or discomfort that was brought on by exertion 
(walking  on  flat  ground  or uphill),  was  situated in the  central  or left  anterior chest,  forced  the 
participant to slow down or stop and was relieved within 10 minutes if she did so.
A  75-g oral  glucose tolerance test  was  performed in the morning  after a minimum  8 hour fast; 
blood samples were obtained by venipuncture after 0 and 2 hours.  Plasma glucose was measured 
by  a  glucose-oxidase  method  and  insulin  was  determined  by  radioimmunoassay  in  a  diabetes 
research laboratory.  Diabetes was defined according to 1999 WHO criteria. (290)  A person was 
regarded as having diabetes if the fasting plasma glucose was > 7 mmol/1 (126 mg/dl) or the 2-h 
glucose after the oral glucose tolerance test was >  11.1 mmol/1  (200 mg/dl),  or if he  or she was 
using diabetes medication (oral or insulin).
Fasting  plasma  lipids  and  lipoproteins  were  measured  in  a  Lipid  Research  Clinic  Centre  for 
Disease  Control  (CDC)-certified  research  laboratory,  as  previously  described.  (299)  LDL 
cholesterol  was  calculated  using  the  Friedewald  formula.  Dyslipidaemia  was  defined  as  LDL 
cholesterol >160 mg/dl, HDL cholesterol < 50 mg/dl or statin use.
Childhood and adult social conditions
Information on economic position in child and adulthood was obtained from questionnaires using 
pre-coded  categories.  Childhood  financial  circumstances  (0-2)  distinguished  those  who  were 
“very poor”,  “average” and “well off’.  A total of 20 pre-coded categories of adult income were 
collapsed to form three equally sized groups (0-2) in ascending order (< 15k;  15-44.9k; > 45k US 
dollars).  A  score  of lifetime  economic  position  (0-4)  was  calculated  by  adding  up  childhood 
financial circumstances to adult income, leading to a “social mobility” score with values between 
0 (lowest group in both child and adulthood) up to 4 (highest category at both time points).  For
94sensitivity  analyses,  an  alternative  score  (0-4)  was  calculated  by  adding  childhood  financial 
circumstances to attained education (<12,13-15 and >16 completed years).
World War II Birth Cohort
Food  shortages  and malnutrition  were pervasive during the Japanese  occupation  (1941-45),  and 
infant  mortality  rates  were  reportedly  the  highest  in  the  world.  (303)  To  assess  the  potential 
influence of wartime fetal and infant (up to age 2) malnutrition, participants were  stratified into 
birth  cohorts:  bom  a)  before  1938,  b)  2  years  prior  to  the  Japanese  occupation  (1938-40),  c) 
during up to two years after the occupation (1941-47) or d) more than 2 years post occupation (> 
1947).
Sta tistic a l a n alyses
Analyses were restricted to women with complete information on components of height,  weight, 
socioeconomic variables, diabetes and CHD.  Means or proportions of population characteristics 
and their confidence intervals were calculated.  Means of the anthropometric measures according 
to levels of the socioeconomic indicators were calculated and t-tests for trend performed.  Logistic 
regression analysis was used to calculate age and multiple adjusted odds ratios for having diabetes 
or CHD  across  groups  of all  socioeconomic  indicators  and anthropometric  measures,  using the 
most disadvantaged  or shortest  group  as  the reference category;  p-values  are based  on tests  for 
trend across ordered categorical exposures.
Multiple  adjusted  models  were  constructed  to  additionally  include  BMI,  waist  circumference, 
family history of diabetes,  smoking,  exercise, employment status and household size for models 
with diabetes  as the outcome.  Corresponding models with CHD as the outcome included BMI, 
waist,  family history  of heart  disease,  menopausal  status,  hormone  replacement  therapy  (HRT) 
use,  hypertension,  dyslipidaemia,  smoking  and  exercise.  The  odds  of diabetes  from  multiple 
adjusted  models  were  plotted  according  to  the  score  of  economic  position  in  childhood  and
95adulthood  for  graphic  display.  Correspondingly,  multiple  adjusted  odds  of CHD  were  plotted 
according  to  groups  of leg  length.  Final  models  were  performed  simultaneously  including  all 
socioeconomic variables for diabetes models and leg length for CHD models plus all risk factors 
that  were  either  significant  at alpha <  0.20 in  multiple  adjusted  earlier models  or pre-specified 
covariates  (biological  age  and  age  at  immigration  in  all  models  and  employment  status  and 
household size in diabetes models).
R esu lts
A total 389 women fulfilled the inclusion criteria, representing 85.7% of the total sample.  Mean 
height,  leg  and  trunk length  were  153.2  cm,  70.7  cm  and  82.4  cm;  the  average BMI  was  25.3 
kg/m2.  Approximately a third of women (31.4%) had diabetes, 22.4% had coronary heart disease, 
including 9% of women having both.
[Table 20]
Almost all  (99%) were Philippine bom,  84.6%  were postmenopausal and  16.3%  were currently 
taking oestrogen replacement therapy.  Alcohol consumption  was uncommon  (1%)  and  84%  of 
women had never smoked.  Half (51.6%) of the sample had been educated for 16 years or longer; 
however,  a  third  were  educated  < 1 2   years;  20.7%  reported  growing  up  in  poor  childhood 
circumstances and around a third reported a current total family income of less or equal to 15,000 
US dollar.  One-third was either bom or a toddler during and up to two years post World War II 
(births in  1938-47).  A positive family history of type 2 diabetes was present in 36% and 23.5% 
had a parent with heart disease.  With regard to life-course social mobility, a total of 7.1% (n=22) 
of  women  were  poor  in  childhood  and  were  in  the  lowest  income  group  in  older  adult  life, 
compared to 5.9% being in the most advantaged group at both time points.  The alternative score 
using  education  instead  of  adult  income  yielded  corresponding  figures  of  11%  and  6%, 
respectively (data not shown).
96In age adjusted analyses, total body height, leg and trunk length differed according to education, 
childhood and adult income, life-course socioeconomic position and birth year category, with the 
most advantaged women and those bom before the occupation being the tallest (tTable 21).  For 
example, women who grew up in poor childhood economic circumstances in childhood were on 
average  1.52 meters tall,  compared to  1.53 in those with average income or  1.55  in the well-off 
group  (p-value=0.008).  All differences were statistically significant except for leg length by birth 
year or education.
In  contrast,  education was the  only measure that was  strongly and significantly associated with 
BMI  and  waist  circumference  (p-value  <  0.008  and  0.0004,  respectively),  with  less  educated 
women having a greater BMI and larger waist (tTable 21).  Similar results were obtained using 
other measures of body size, including total percent body fat measured by bioelectric impedance 
and percent trunk fat measured by DEXA (data not shown).
[Table 21]
97Diabetes
The odds of diabetes did not differ significantly according to height, leg or trunk length in age or 
multiple adjusted analyses, but were lower in women with better childhood financial conditions 
(ptrend=0.007),  greater education  (ptrend=0.01)  and higher adult income (ptrend=0.0002) in  age  and 
multiple  adjusted  analyses  including  BMI,  waist  circumference,  family  history  of  diabetes, 
smoking, exercise, employment status and household size (tTable 22).
[Table 22]
Further, diabetes was significantly less common the higher the social mobility score; compared to 
Filipinas who were poor in childhood and remained in the lowest income group in older adult life, 
respective odds ratios (95% Cl) for diabetes were 0.55 (0.18;  1.68), 0.19 (0.06; 0.62), 0.11  (0.03; 
0.42)  down  to  0.07  (0.01;  0.51)  in  those  who  were  most  advantaged  in  childhood  and  in  the 
highest income  group  in  adult  life,  after adjustment  for all  variables  mentioned  above  (ptrend  < 
0.0001).  Similar results were obtained using the alternative score (data not shown).
98Figure 9 Multiple adjusted odds ratios for diabetes according to
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The odds of diabetes were also associated with birth year category; however, this association was 
of  borderline  significance  (ptrend=006)  and  reduced  further  in  multiple  adjusted  models
(Ptrend=0.18).
In final models simultaneously including all socioeconomic variables and other risk factors, lower 
adult household income, a positive family history of diabetes and waist circumference were each 
significantly  and  independently  associated  with  increased  odds  of diabetes  (p-value  <  0.001  in 
each  case),  while  associations  of  childhood  family  income  with  diabetes  did  not  remain 
statistically significant.
99Coronary Heart Disease
CHD prevalence was not significantly associated with any of the socioeconomic indicators,  and 
although the odds of CHD were lower the greater the social mobility score, with odds ratios (95% 
Cl) ranging from 0.55 (0.20;  1.53), 0.46 (0.15;  1.37), 0.39 (0.12;  1.30) down to 0.19 (0.03;  1.15) 
in  the  most  advantaged  women,  these  differences  were  not  statistically  significant  in  age 
(ptrend=0.07) and multiple adjusted analyses (ptrend=013).
[Table 23]
In  contrast,  the  odds  of CHD differed  significantly  across  quarters  of leg,  but not trunk length. 
Compared to those with the shortest legs, odds ratios for CHD were 0.60 (0.31;  1.19), 0.53 (0.26; 
1.05) and 0.44 (0.22; 0.91) in the tallest group, in age (ptrend=0.02) and multiple adjusted models 
(ptrend=0.01).  Total body height showed a comparable, but weaker association (ptrend=010).
100Figure 10 Multiple adjusted odds ratios for coronary heart disease according to
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Final  models  showed  similar  results,  with  shorter  leg  length  (ptrend=0.006),  greater  waist 
circumference  (ptrend=0 01),  hypertension  (p-value=0.01)  and  exercise  (p-value=0.01)  being 
important  predictors  of  CHD  (Table  24).  However,  it  should  be  noted  that  the  estimate  for 
exercise  indicated  a  harmful,  rather  than  a  beneficial  effect,  potentially  reflecting  reverse 
causality, i.e. high risk women engaging in preventive behaviors.
[Table 24]
Adjusting for body size by including either BMI, total percent body fat,  waist-hip ratio or waist 
circumference instead of weight,  or excluding the 4  women  not bom  in the Philippines  did not 
materially  change  the  results  regarding diabetes  or CHD  (data not  shown).  Likewise,  findings
101remained unchanged in  sensitivity analyses  excluding  10  women  with triglyceride  levels  > 400 
(and  thus  potentially  unreliable  estimation  of LDL  cholesterol  by  the  Friedewald  formula)  or 
adjusting  for continuous  measures  of total  cholesterol,  HDL,  LDL  or  triglycerides  alone  or in 
combination  instead  of  dyslipidaemia.  Sensitivity  analyses  excluding  less  specific  ECG 
Minnesota codes (1.3, 4.1-4.3, 5.1-5.3) showed that despite a lower prevalence of CHD leading to 
small  numbers  in  some  of  the  cells,  results  remained  unchanged,  with  leg  length  (multiple 
adjusted p=0.01) showing the strongest association.
C o nclu sio n s
Childhood  and  adult  socioeconomic  factors  contribute  to  the  high  prevalence  of  diabetes  in 
Filipina-American women, a comparatively short and non-obese population by Western standards. 
Results  from  this  study  support  the  hypothesis  that  factors  limiting  early  growth  of  the  legs 
increase the risk of CHD, but not diabetes; socioeconomic factors considered here do not seem to 
underlie this association, despite their strong associations with adult measures of growth.
102Ch a pter 9: Sixth O bjective
O bjective
To investigate whether associations between poor growth of the legs  and higher levels of blood 
pressure and pulse pressure may originate early in life.
Stud y d esig n o f Pr o jec t V iv a
Participants
Study subjects  are Project Viva participants,  a prospective cohort study of pregnant women and 
their offspring.  Research assistants recruited women attending their initial prenatal visit at one of 
eight  urban  and  suburban  offices  of  a  multispecialty  group  practice  in  eastern  Massachusetts. 
(304)  Exclusion  criteria  include  multiple  gestation  (twins,  triplets,  etc),  inability  to  answer 
questions  in  English,  plan  to  move  out  of the  area  before  delivery,  and  gestational  age  >  22 
completed weeks at initial prenatal clinical appointment.  A total of 2670 pregnant women (64% 
of  those  eligible)  were  enrolled  between  April  22,  1999,  and  July  31,  2002,  of  whom  329 
subsequently became ineligible because of multiple gestation (n=19), transferring obstetric care to 
a  non-study  site  (n=115),  or  because  they  were  no  longer  pregnant  (n=195).  Of  the  2341 
remaining participants,  195  (8%) withdrew,  and  18 (<  1%) were lost to follow-up, leaving 2128 
who delivered a live infant.  Of these,  1579 participants were eligible for 3-year follow-up at the 
time  of  analysis.  Participants  who  refused  3-year  follow-up  (n=92),  those  who  had  not  yet 
completed  the  3-year  assessment  (n=118)  or  completed  it by  mail  or phone  but  not  in  person 
(n=106),  those  with  missing  data  on  blood  pressure  (n=92)  or  anthropometry  (n=21),  and  17 
infants  whose gestational  age  at birth was  less  than  34  weeks  were excluded,  resulting in  1133
103mother-infant pairs  for analysis  (appendix  3).  Participants  included in  this  study  were  slightly 
more likely to be white (73 versus 66%) and college educated (35 versus 28%), but did not differ 
in terms of mean household income, maternal pre-pregnancy BMI or birthweight compared to all 
2083 participants who delivered a non-premature child.
All  mothers  gave  informed  consent  and  institutional  review  boards  of participating  institutions 
approved the study.  All procedures were in accordance with the ethical standards established by 
the Declaration of Helsinki. (305)
Measurements
Details of examinations before age 3 years have previously been reported in detail. (304;306)  In 
brief,  information  about  maternal  ethnicity,  age,  education,  parity,  and  household  income  was 
obtained using a combination  of questionnaires  and interviews.  Information  on maternal blood 
pressure,  glucose  tolerance  test  results,  serial  pregnancy  weights,  and  infant  birthweight  and 
delivery date were collected from prenatal medical records.  Mothers reported their pre-pregnancy 
weight and height and paternal weight and height.  Gestational weight gain was calculated as the 
difference between pre-pregnancy weight and the last clinically recorded weight before delivery; 
gestational age was derived from the last menstrual period or from the second trimester ultrasound 
if the two estimates differed by more than  10 days.  Sex-specific birthweight for gestational age 
percentile and z-value based on U.S. national natality data was determined. (307)  On the 6-month 
and  1-year questionnaires,  mothers reported  on infant diet including breast and formula feeding 
and complementary food intake.
Age 3 examinations were carried out in 2003-06 and anthropometry and blood pressure measured 
as described below.
Anthropometry (3 years)
104Children’s heights and weights were measured using a calibrated stadiometer (Shorr Productions, 
Olney,  MD)  and  scale  (Seca  model  881;  Seca Corp.,  Hanover,  MD)  and  age-  and  sex-specific 
height,  weight  and  BMI  percentiles  and  z-scores  calculated  using  U.S.  national  reference  data 
(National  Center  for  Health  Statistics  2004,  CDC  Growth  Charts,  United  States: 
http://www.cdc.gov/growthchartsl.  The Shorr board was placed on top of a hard, flat seat against 
a  flat  door  or  wall  to  assess  sitting  height,  a  measure  of trunk  length.  Children  were  seated 
upright,  as  tall  as  possible,  with  their back  against  the  board,  the  head  in  the  Frankfort  plane, 
knees directed straight ahead and feet hanging freely.  Leg length was calculated as the difference 
between standing and sitting heights.  Research assistants followed standardized techniques, (308) 
and participated in biannual in-service  training to ensure  measurement validity  (U  Shorr;  Shorr 
Productions).  Inter-  and intra-rater measurement errors  were within published reference ranges 
for all measurements. (309)  The percentage of height contributed by leg length and the difference 
in  sex-specific  internally  derived  leg  and  trunk  z-scores  were  calculated  as  measures  of 
disproportion. (115 ;310)
Blood and pulse pressure (3 years)
Using  biannually  calibrated  Dinamap  Pro-100  oscillometric  automated  monitors  (GE  Medical 
Services, Tampa, FL), trained research assistants recorded child blood pressure up to five times at 
1-minute intervals.  Measurement  conditions  including  order of readings,  cuff size,  limb,  body 
position  (sitting,  semi-reclining,  reclining,  standing),  and  state  (sleeping,  quiet  awake,  active 
awake, crying) were recorded.  Pulse pressure was calculated as the difference between averaged 
systolic and diastolic blood pressure measurements.  Mean arterial pressure (MAP) was calculated 
as ((2*DBP) + SBP)/ 3 from averaged systolic and diastolic blood pressure measurements.
105Sta tistic a l a n a ly ses
Means or proportions and standard deviations  of maternal, family and child characteristics were 
calculated separately for girls and boys included in this study.  Differences were compared using 
t-tests  and  chi-squared  tests  for  continuous  and  categorical  variables,  respectively.  Linear 
regression  analysis  was  used  to  investigate  associations  of  maternal,  family  and  child 
characteristics with leg length, trunk length, percent leg length and the difference in leg and trunk 
z-scores,  adjusting  for  age,  sex  and  ethnic  group.  To  investigate  associations  between  the 
anthropometric measures and blood pressure, mixed effects regression models that incorporate up 
to  5  blood  pressure  measurements  from  each  infant  were  used  as  repeated  outcome  measures 
(proc mixed,  SAS  version  8.02  (SAS  Institute)).  Simple models were adjusted for age,  sex and 
measurement  conditions  (child’s  state,  arm,  cuff  size,  body  position,  and  indicator  for  the 
measurement  sequence  number  (1st  through  5th).  Current  height  and  weight  were  then 
successively  added  to  this  model,  as  appropriate.  Fully  adjusted  models  were  performed 
additionally including ethnic group and birthweight.
Sensitivity  analyses  were  performed  replacing  measures  of  leg  and  trunk  length  with  the 
proportion of height contributed by leg length and the differences in leg and trunk length z-scores.
Resu lts
A total of 1133 children attending the age 3  year examination were bom at > 34 weeks gestation 
and also had complete measures  of anthropometry and blood pressure at age 3  years,  reflecting 
90% of all children attending this examination, 58% of children eligible for follow-up at birth and 
54% of all live, non-premature births.
Average systolic, diastolic, pulse and mean arterial pressures (mean (SD)) were 92.1  (11.6), 58.1 
(8.4), 34.0 (7.8), and 69.4 (8.9) mmHg in girls and 92.4 (9.6), 58.3 (7.8), 34.1 (7.3), and 69.7 (7.7) 
mmHg in boys, respectively.  Maternal gestational weight gain, children’s birthweight and length,
106height, weight, BMI, leg and trunk length were all significantly greater in boys, compared to girls 
(p-value < 0.003 in each case); however, the proportion of height contributed by leg length did not 
differ between the sexes.
[T a b l e 25]
Leg length (mean (SD) 41.6 (2.5) cm in girls and 42.0 (2.8) cm in boys) and trunk length (55.2 
(2.6) cm in girls and 56.1  (2.6) cm in boys) were both significantly greater in children who were 
heavier or longer at birth and at age 3  years  and whose mothers or fathers were taller,  adjusting 
for  age,  sex  and  ethnic  group.  Maternal  pre-pregnancy  BMI  was  positively  and  duration  of 
breastfeeding was negatively associated with trunk, but not leg length.  Leg length contributed a 
significantly  greater  proportion  to  body  height  in  children  with  taller  mothers  and  those  with 
greater length at birth and age 3  years,  while maternal age,  children’s weight, BMI and BMI z- 
score  showed inverse associations  with both,  the proportion  of height contributed by leg length 
and the differences in leg and trunk length z-scores.  Despite the greater proportion of leg length 
contributed to the overall height of children who were taller at age 3 years, these showed smaller 
differences in leg and trunk length z-scores.
[T a b l e 26]
In  analyses  adjusting  for  age,  sex  and  measurement  conditions,  height,  weight,  leg  and  trunk 
length were each positively and significantly associated with systolic, diastolic and pulse pressure 
(p-value < 0.05 in each case), except for the association between leg length and DBP, which did 
not reach statistical significance.
[T a b l e 27]
In models including both height and weight,  only weight, but not height,  remained significantly 
and strongly associated with all measures of blood pressure.
107After accounting for differences in height, children with greater leg length had significantly lower 
SBP and PP (regression coefficient (95% Cl) SBP -0.61  mmHg (-0.98;  -0.24), PP -0.45 (-0.73;  - 
0.17) for each centimeter increase in leg length.  Analysis of the proportion of height contributed 
by leg length or the difference in leg and trunk z-scores yielded similar results and adjustment for 
weight did not explain these  associations.  Further adjustment for ethnic  group and birthweight 
attenuated estimates of associations between leg length, leg length percent or difference in leg and 
trunk  z-scores  with  systolic  blood  pressure  only  slightly,  but  associations  were  of borderline 
significance  in  these  models  (p-value  <  0.08  in  each  case).  In  contrast  to  the  results  for  leg 
length,  trunk length was positively  associated with all blood pressure measures before and after 
adjustments.
C o nclu sio n s
Relatively shorter length of the lower body is  associated  with higher blood pressure in the first 
years of life.  Other studies have shown that childhood blood pressure predicts adult hypertension. 
Therefore, factors limiting early growth of the long bones may contribute to an individual’s blood 
pressure trajectory.  Future studies may help identifying underlying growth limiting factors
108Ch a pter 10: S ev enth O bjective
O bjec tiv e
To investigate how  associations between growth and mortality from coronary heart disease  and 
stroke may be influenced by later socioeconomic position and to assess whether associations may 
differ according to prevalent CHD at baseline and duration of follow-up.
Stud y d esig n o f th e O r ig in a l W h iteh a ll Stu d y 
Participants
A  total  of  19019 civil  servants  aged 40-69  years  attended the initial  screening  of the Whitehall 
study between September 1967 and January 1970, representing 74% of those invited.  Participants 
completed  a  standard  questionnaire,  including  age,  self  reported  smoking  habit,  civil  service 
employment grade, medical treatment and health status. (311-314)
Measurements
Anthropometry
Height was measured with the subject wearing shoes and standing with their back to a measuring 
rod;  readings  were taken to the nearest Vi inch  (12.7  mm) below.  (311)  Body mass index  was 
calculated by dividing weight by height squared (kg/m2).
109Cardiovascular risk factors
With the participant seated,  a single reading  of blood pressure  was recorded on the left arm by 
specially  trained  observers  using  the  London  School  of  Hygiene  random  zero 
sphygmomanometer.  Plasma  cholesterol,  two  hour  post-load  glucose,  weight,  and  forced 
expiratory  volume in  one  second  (FEV1),  were determined in  standardized fashion  at baseline. 
(311)  A regression analysis of FEV1  against height was used to adjust FEV1  measurements to a 
uniform height of 175 cm. (312)
Smoking
Smoking status was categorized into four levels as “never”, “ex-“, “current pipe or cigar only” or 
“current”  cigarette  smokers,  with  an  additional  variable to  control for the number of cigarettes 
smoked per day.
Employment grade
The civil  service grade of employment,  an indicator of socioeconomic position,  was coded into 
three  categories:  administrative  and  professional/ executive  grades  (high),  clerical  (middle)  and 
other  grades  (low).  Previous  analyses  have  shown  inverse  associations  between  employment 
grade  and mortality from a variety  of causes,  including CHD,  independent of conventional risk 
factors. (313;314)
Assessment of existing coronary disease
Electrocardiography was undertaken with a Mingograph 3 IB, using “multipoint” electrodes.  Five 
technically adequate complexes were recorded for each of the six limb leads and the middle three 
complexes  were  later  analysed  according  to  the  Minnesota  code.  The  six  limb  lead 
electrocardiography (ECG) removed the need for participants to undress.  Coding was carried out 
independently in duplicate by trained and tested technicians.
110Q  (Minnesota  codes  1:1-1:3),  ST  (4:1-4:4),  T  (5:1-5:3)  and  LBBB  (7:1)  abnormalities  were 
chosen for defining  CHD,  since  these  are  the  strongest independent predictors  of CHD  events. 
(295)
Participants were defined as symptomatic if they reported angina, prolonged chest pain (“pain of 
possible  myocardial  infarction”),  previous  admission  to  hospital  for  CHD  or  being  “under the 
general practitioner with heart disease or blood pressure”.  Prevalent CHD was defined by specific 
ECG abnormalities, or symptoms, or both. (315)
Ascertainment of mortality
Participants  were  flagged  at  the  National  Health  Service  Central  Registry,  which  notified  all 
deaths to the end of 2002.  Causes were classified according to the International Classification of 
Disease, eighth revision (ICD-8), including mortality from CHD (ICD 410-414), stroke (ICD 430- 
438)  and cardiovascular disease  (ICD  390-458).  Eight percent  of deaths  were coded using the 
corresponding codes of ICD 9 and 10.
Statistical a n a ly ses
Of the  19016  participants  with  known  height  and  age,  167  men  were  excluded  in  the  present 
analysis who were lost to follow-up, 44 for whom the cause of death was unknown, 863 men from 
the  diplomatic  service  and  the  British  Council  for  whom  employment  grading  was  not 
comparable, and a further 806 with missing information on any of the covariates.
In  analyses  of  baseline  characteristics  according  to  three  equally  sized  groups  of  height,  the 
prevalence  of  these  characteristics  were  adjusted  for  age  (5  year  age  groups)  by  the  direct 
standardization method.  Trends in these proportions were tested for statistical significance using 
the  Mantel-Haenszel test.  For baseline characteristics  expressed  as  continuous  variables,  least- 
squares  means  were  used  to  present  the  age  adjusted  means,  and  tests  for  trend  across  height 
groups were computed by fitting a linear trend term.
IllAssociation between height and CVD mortality
Linear associations between height and the mortality outcomes  were examined by fitting Cox’s 
proportional hazards models.  These models allowed hazard ratios and 95% confidence intervals 
associated with an increase in height of 15cm to be calculated.  Separate models were fitted for 
participants  with  and  without  CHD  at  baseline.  Models  were  initially  adjusted  for  age  and 
employment grade only and then, additionally, for potential confounding factors.  Variables in the 
fully adjusted models included age,  employment grade, smoking status, cholesterol,  systolic and 
diastolic  blood  pressure,  body  mass  index,  height-adjusted  forced  expiratory  volume  in  one 
second,  glucose intolerance  and diabetes.  These were fitted as continuous variables,  except for 
employment grade (3  levels),  smoking status  (4 levels  with additional adjustment for number of 
cigarettes  smoked  per  day  for  current  smokers),  glucose  intolerance  (2  levels)  and  diabetes  (2 
levels), which were fitted as categorical variables.
To investigate whether the effect of height on CVD, CHD or stroke mortality differed according 
to employment grade, separate height effects were fitted by grade and formal tests for interaction 
carried out by comparing the model fits, with and without the interaction terms, using likelihood 
ratio tests.
Additionally, to compare the magnitude of the association over different periods of follow-up and 
to test the proportional hazards assumption, the follow-up time was split into three intervals (0-9, 
10-19, 20-29, 30+ years) and age adjusted hazard ratios for each interval computed.  Differences 
in the effect of height on mortality between follow-up periods were tested formally by assessing 
the statistical significance of a height by time period interaction term in the models.
Resu lts
In age adjusted analyses, men of shorter stature were more likely to be in low grade employment, 
without a partner, have prevalent CHD at study entry, be a current smoker, glucose intolerant or 
suffer from diabetes, in comparison with taller men.  Height was also significantly associated with
112age, body mass index, total cholesterol, and forced expiratory volume in one second, such that the 
most favourable levels were seen in taller men.  Diastolic blood pressure was positively associated 
with height, although differences between groups were only small.
[Table 28]
Height and cardiovascular outcomes
The 17139 men were followed up for at least 33 years and contributed a total of 5411 deaths from 
cardiovascular disease, including 3530 deaths from CHD and 952 deaths from stroke.
Associations between height and mortality from CVD, CHD and stroke in men who were free of 
coronary heart disease at study entry are presented first.
[Table 29]
In  age  and  grade  adjusted  analyses,  height  was  inversely  related  to  mortality  from  total 
cardiovascular disease (HR associated with each  15  cm increase in height (95%  Cl) 0.89  (0.83; 
0.95); p-value=0.001).  This effect was stronger for CHD mortality (0.81  (0.74; 0.88); p-value < 
0.001),  than for stroke  (0.91  (0.78;  1.08);  p-value=0.28).  When the association between height 
and mortality was investigated separately for each employment grade, it became apparent that the 
beneficial effect of tall  stature on  subsequent  CVD,  CHD  and  stroke mortality was  strongest in 
participants  in  high  employment  grades,  but  weaker  and  non-significant  for  middle  and  low 
grades.
The test for interaction was significant for mortality from CVD (p-value=0.02), but not CHD (p- 
value=0.09)  or  stroke  (p-value=0.13).  Further  adjustments  had  only  a  small  effect  on  these 
results.
Men with CHD at study entry
The pattern  of results was  similar in men  with existing CHD,  but none  of the associations with 
stroke mortality reached conventional levels of statistical significance.
113[Table 30]
Effect of duration of  follow-up
In  combined  analysis  of  men  with  and  without  prevalent  CHD  at  baseline,  height  was 
significantly and inversely associated with mortality from CHD, CHD and stroke, before and after 
adjustments.  Associations  between  height  and  mortality  did  not  differ  significantly  between 
periods  of follow-up,  suggesting that  any  observed  differences  between  follow-up periods  may 
have occurred by chance alone (all tests for interaction p-value > 0.22).
[Table 31]
Co nclu sio n s
Strong, inverse associations between height and CHD mortality in men with and without prevalent 
CHD indicate that short height is not only an important influence on the development of CHD in 
an  asymptomatic  healthy  population,  but  also  affects  the  prognosis  in  men  with  evident  CHD. 
Differences  in these  associations  between  employment  grades  show  the  importance  of bringing 
together  studies  of the  influence  of poor  growth  and  socioeconomic  position  to  consider  their 
interactive effects.  Associations between height and mortality do not differ according to duration 
of follow-up.
114Ch a pter 11: D isc u ssio n
Su m m a r y o f fin d in g s
This body of research brings together evidence from 5 epidemiological studies,  spanning an age 
range  from  childhood  to  late  adult  life.  Each  study  was  selected  to  address  a  specific  aim 
designed to answer part of the underlying hypothesis concerning the relationships between poor 
growth,  social  inequalities  and  cardiovascular  risk.  The  use  of data  from  prospective  cohort 
studies enabled me to investigate associations between markers of growth and long term changes 
in  blood  and  pulse  pressure,  associations  with  future  subclinical  vascular  disease,  as  well  as 
incident  events.  Investigating  different  populations  allowed  replication  and  validation  of 
associations in several data sets; including extrapolation to a comparatively short and non-obese 
population  of Filipino-American  women  and  to  children  as  young  as  3  years  participating  in 
Project Viva, a contemporary US birth cohort study.
In summary, results from these different studies showed the following:
First,  findings  from  the  oldest  currently  ongoing  birth  cohort  study  worldwide,  the  National 
Survey  of Health  and  Development  (NSHD  -  1946  Birth  Cohort  Study),  suggested  that  adult 
height  and  leg  length,  but  not  trunk  length,  are  important  determinants  of  pulse  pressure,  a 
measure of arterial stiffness, in adult men and women.  Similar, but weaker associations were seen 
with systolic, but not diastolic blood pressure.
Second,  longitudinal  analyses  of  the  same  cohort  showed  strong  evidence  that  the  inverse 
associations between both height and leg length,  and pulse pressure and systolic blood pressure 
are amplified with age, independently of a number of potential confounders  and mediators from 
early and adult life that were considered.
115Third, in the Whitehall II Study,  ah occupational cohort,  associations between shorter leg length 
and  greater  pulse  and  blood  pressure  were  replicated  in  both  men  and  women;  as  in  earlier 
analyses,  prenatal  growth,  indicated  by  weight  at  birth,  contributed  little  to  these  associations. 
Although  birthweight  was  recalled  in  adult  life  in  this  cohort,  correlations  with  leg  and  trunk 
length were  similar to those  observed in  the NSHD,  where weight was  recorded  at the time of 
birth.  Results from the Whitehall II Study also showed associations of both components of height 
with  several  other  cardiovascular  risk  factors,  indicating  that  associations  are  not  restricted  to 
blood pressure measures and not specific to leg length.
Fourth,  using specific  measures  of subclinical atherosclerosis in participants  of the Whitehall II 
Study,  men  with  greater height,  leg  and trunk length  showed  significantly  greater distensibility 
and significantly lower stiffness of the carotid arteries in age and multiple adjusted analyses; this 
was not observed for intima media thickness or for any vascular outcome in women.  Birthweight 
was  not associated with  adverse  levels  of vascular structure or function,  and despite  significant 
associations  between  several  socioeconomic  markers  and  arterial  distensibility  and  stiffness  in 
men,  adjustment  for  these  variables  contributed  little  to  associations  between  markers  of poor 
growth and the vascular outcomes.
Fifth,  in  a cross-sectional examination  of Filipino-American  women,  a comparatively short and 
non-obese  population  by  Western  Standards,  who  has  a  high  prevalence  of  diabetes  and 
cardiovascular disease, height,  leg and trunk length were significantly and substantially lower in 
women  who  were  socioeconomically  disadvantaged  in  childhood  and  adulthood.  Diabetes 
prevalence  was  not associated  with measures  of growth,  but was  significantly lower in  women 
with greater education, childhood and adult income or life time economic score.  In contrast, CHD 
prevalence was most strongly associated with leg length, but not trunk length, in age and multiple 
adjusted models.
Sixth,  in Project Viva,  a US  observational cohort study of pregnant women  and their offspring, 
children  with  shorter  leg  length,  relative  to  total  body  height,  showed  higher  levels  of  blood
116pressure  at  age  3  years,  providing  some  evidence  that  associations  between  poor  lower  body 
growth and high blood pressure may originate in childhood.
Lastly,  results  from  the  first  Whitehall  Study  with  a  follow-up  of  over  33  years  and  3893 
cardiovascular  deaths  showed  that  short  stature  is  not  only  an  important  influence  on  the 
development  of CHD  in  an  asymptomatic  healthy population,  but  also  affects  the prognosis  in 
men  with  prevalent  CHD.  No  evidence  was  found  that  the  adverse  effect  of  short  height  is 
restricted to participants  with differential  shrinkage before  study entry.  Notably,  the beneficial 
effect of tall stature on subsequent risk of cardiovascular mortality was strongest in participants in 
high employment grades, with significant inverse associations seen in this group, but weaker and 
non-significant associations in middle and lower grades.
The  contributions  of prenatal  growth  and  socioeconomic  circumstances  were  considered  in  all 
studies  where  birthweight  and  social  position  in  childhood  and/  or  adulthood  were  available. 
While the influence of birthweight to the associations of interest was generally found to be only 
small, the role of social inequalities for growth and later cardiovascular risk appeared to be more 
complex.  Social differences in height and its components were either observed or have previously 
been reported in all studies of adults that were included in this thesis.  Yet, the different indicators 
of social  position  that  were  explored  did  not  account  for  associations  between  components  of 
height  and  cardiovascular  risk,  except  for  results  obtained  in  the  first  Whitehall  study.  These 
suggested  differential  associations  between  growth  and  cardiovascular  mortality  according  to 
adult  socioeconomic  position,  with  effects  being  strongest in  the  most privileged  groups.  The 
joint  and  separate  contributions  of  components  of  height  and  the  different  socioeconomic 
indicators are discussed in more detailed in the context of each objective below.
I n t e r p r e t a t io n  a n d  c o n t e x t
117First objective
Several factors may contribute to the associations  observed between short height and leg length 
and greater blood pressure and arterial stiffness.
Prenatal growth
Impaired fetal development, reflected by low birthweight, might influence early growth and later 
disease  simultaneously,  but it  seems  to influence both components  of height equally.  (115;264) 
Consequently similar associations of trunk and leg length with blood pressure measures would be 
expected if birthweight was a joint underlying factor.  In the 1946 Study, leg length, but not trunk 
length, was strongly associated with pulse pressure and systolic blood pressure and adjustment for 
birthweight did not alter these results.
Socioeconomic influences on growth and cardiovascular risk
Children  who  grow  up  under  disadvantageous  socioeconomic  conditions  have  comparatively 
shorter height and legs in child and adulthood; similarly they have a higher risk of coronary heart 
disease and associated risk factors. (137; 138; 141 ;316;317)
In  the  NSHD,  adjustment  for  childhood  social  class  and  potential  confounding  factors  in 
adulthood,  which  are  also  more  frequent  among the  lower social classes,  such  as  smoking and 
obesity, did not change the observed associations between short leg length and pulse pressure or 
systolic blood pressure in either men and women.  This indicates that early influences on growth 
that are important for development of arterial stiffness in later life may not (or only weakly) be 
socially distributed or not adequately be  captured by the indicators  of childhood  social position 
used in this study.
118Influences on early pre-pubertal growth
Leg  growth  is  particularly  marked  during  the  growth  hormone  dependent  childhood  phase  of 
growth in the first years of life,  (153) and early endocrine control (hormonal levels and receptor 
expression) may simultaneously influence growth spurts of the long bones of the leg and arterial 
growth  during  these  specific  hormonally  controlled phases  of development before  puberty.  In 
contrast,  many  bones  contribute  to  trunk  length;  their  growth  differs  in  timing  and  magnitude 
from that of the long bones. (318)  Consequently, if hormonal factors affect leg length and arterial 
structure and function through arterial growth, attained leg length, rather than trunk length, may 
be more closely associated with adult pulse pressure.
In line with this,  adult leg length has been  suggested and used as a marker of early prepubertal 
childhood  growth,  and  one  previous  study  has  found  that  rather  than  height  per  se,  shorter 
prepubertal  stature  (at  ages  5-8  years)  relative  to  adult  height,  interpreted  as  poor  childhood 
growth, is an important determinant of systolic blood pressure and pulse pressure, but not diastolic 
blood  pressure.  (214)  A  significant  effect  of  adult  height,  after  accounting  for  differences  in 
earlier prepubertal height, would be expected, but was not observed, if changes in height between 
ages 5-8 years until adult life, i.e.  largely pubertal growth, was the more important influence on 
adult blood pressure.  However, these results may not be generalizable and/ or be biased, as this 
study selected 300 survivors (< 50 % response rate) from the Boyd Orr cohort, which originally 
included  children  from  1352  families.  Participants  were  not  representative  in  terms  of  social 
class,  and  due  to  small  numbers,  men  and  women  could  not be  analysed  separately;  however, 
results from this study provide some evidence that childhood stature, rather than later growth rate, 
contributes to adult blood pressure  and arterial stiffness,  and thus corroborate findings from the 
1946 Study.
119Arterial wave reflection
Associations of height and leg length with dynamic properties of the arterial tree may contribute 
to the observed link between short stature and greater pressure.  Pulse pressure is determined by 
arterial  compliance  and  wave  reflection  and  reflected  waves  in  those  of shorter height may be 
more likely to arrive early and during systole, due to their greater levels of arterial stiffness andI 
or shorter transmission path length, resulting in increased central pressure augmentation and pulse 
pressure. (32;205)
In  the  1946  Study,  adult  leg  length,  but  not  trunk  length,  was  strongly  associated  with  pulse 
pressure and systolic blood pressure.  The functionally effective reflection site has been described 
as the “resultant or average” of all individual reflecting sites downstream of the ascending aorta. 
(32)  While the influence of components of height on arterial haemodynamic remains unknown, 
one  previous  report  has  shown  that  correlations  of  aortic  length  with  measures  of  arterial 
haemodynamics were equal or less than those observed with total height. (205)  This suggests the 
importance  of  arterial  path  length  beyond  the  aorta,  and  thus  beyond  sitting  height,  for 
haemodynamic properties such as early wave reflection.  Arterial compliance and wave reflection 
may thus be mechanisms that contribute to some degree to the associations of short height and leg 
length with greater pulse pressure.
Strength and limitations
There  are  limitations  in  extrapolating  results  from  the  1946  Birth  Cohort  Study  to  later 
generations.  Levels  of mean height as well as  overweight and obesity have increased since the 
post war period, and the decline of coronary heart disease mortality rates  over the past 30 years 
has  been  accompanied  by  decreases  in  systolic  blood  pressure,  largely  due  to  advances  in 
treatment and changes  in  risk factor levels.  (319-321)  The observed gradient of pulse pressure
120across  groups  of height and  leg  length  may differ in  younger  generations  with  increased  mean 
height, greater weight and altered burden of cardiovascular risk.
Avoidable loss to follow-up through participants’  refusal or inability to trace was more common 
in those with adverse socioeconomic circumstances in childhood or those of shorter height at age 
4  years.  (280;322)  However,  after  53  years  of  follow-up,  the  sample  was  still  reasonably 
representative of the national population of the same or similar age, taking account of the fact that 
immigration trends after the selection of the sampling frame and exclusion of multiple births and 
those bom outside wedlock prohibit it from being completely representative. (280)  Also, if loss to 
follow-up  was  non-differential  with  regard  to  blood  pressure  outcomes,  i.e.  participants  lost to 
follow-up did not differ in terms  of pulse pressure or blood pressure from those from a manual 
origin or shorter height who were examined at age 53 years, the influence on the results may only 
be small.
Adult leg and trunk length were used as markers of growth at different phases, rather than height 
measured  during  childhood,  for  two  reasons.  First,  this  approach  is  comparable  with  recent 
studies  suggesting  that  leg  length,  as  opposed  to  trunk  length,  is  the  component  of  height 
reflecting the childhood phase of growth and is most closely linked to cardiovascular risk in adult 
life.  Second,  the  comparison  of  leg  to  trunk  length  distinguishes  the  growth  of  long  bones 
occurring under the influence  of growth hormone  during the childhood  phase  of growth,  (153) 
from the  slower and later growth  of the trunk.  (154)  Adult leg and trunk length were used,  as 
components of height in childhood were not available in this cohort.
Using  adult  indicators  of  childhood  growth  has  some  disadvantages.  Although  leg  length  is 
regarded as  a marker of environmental influences  on childhood growth during the first years  of 
life,  later  growth  as  well  as  genetic  factors  will  also  influence  attained  leg  length,  and  their 
contribution to the observed associations cannot be excluded.
Shrinkage  may  introduce  error  in  measures  of adult  height.  However,  previous  studies  have 
shown that loss of stature at these early ages  (before 53  years) is only small.  (162)  In addition,
121analysis of adult leg length avoids measurement bias introduced by age related shrinkage,  which 
reduces  total  height  mainly  as  a  result  of  decreases  in  trunk  length  through  the  osteoporotic 
collapse of vertebrae.  In this  study,  only total and  sitting height (trunk length)  were measured, 
and leg length calculated  from them,  resulting in  greater measurement error in leg length  (non­
differential misclassification), which may bias results towards the null.  Nevertheless, associations 
with  blood  pressure  were  observed  for  leg  length,  not  trunk  length,  and  the  strength  of  the 
association may therefore be even greater if leg length was measured more accurately.
Se c o n d  o b je c t iv e
Longitudinal  analyses  of the  1946  Study  showed  that  leg  length  was  the  component  of height 
associated with larger than average increases in pulse pressure and systolic blood pressure up to 
middle  age.  Early  influences  on  changes  in  the  structure  and  function  of  the  developing 
vasculature may alter the susceptibility for arterial stiffness and hypertension in later life. (220)
Systolic  blood  pressure,  pulse  pressure  and  arterial  stiffness  increase  with  age;  if  poor  early 
growth  contributed  to  the  tracking  of  these  measures,  its  detrimental  influence  on  vascular 
structure and function in the first years of life may amplify the vulnerability of those with shorter 
legs to the effects of ageing on the arterial tree.  Our evidence supports this hypothesis by showing 
an  amplification  of the effect of leg length,  as  a marker of early  growth,  on pulse pressure and 
systolic blood pressure between 36 and 53 years.
Interestingly,  as  mentioned  earlier,  the  one  previous  study  suggesting  that  shorter  prepubertal 
stature  relative  to  adult height  is  an  important  determinant  of adult blood  pressure,  also  found 
associations  with  systolic  blood  pressure  and  pulse  pressure,  but  not  diastolic  blood  pressure. 
(214)  In industrialized countries, systolic blood pressure increases progressively throughout adult 
life, while diastolic blood pressure increases less steeply and ceases to rise or even falls around 55 
years, (27) resulting in a rise in pulse pressure throughout adult life.  Accordingly, in this study of
122blood  pressure  in  the  middle  years  of life,  pulse  pressure  and  systolic  blood  pressure  show  a 
greater rise with age, compared to diastolic blood pressure.  If growth limiting factors influence 
the  age-blood  pressure  relationship,  then  stronger  associations  may  therefore  be  expected  with 
those measures of blood pressure whose increase is more closely linked with ageing, as mentioned 
above.
The  majority  of  cardiovascular  risk  associated  with  hypertension  is  due  to  blood  pressure 
gradually increasing with  age.  The  age  specific  rise,  and  therefore  hypertension,  is  essentially 
absent  in  certain  rural  communities,  and  studies  have  shown  that  this  protection  is  partly  lost 
through migration to industrialized communities.  (27)  This suggests that a continuous influence 
of protective  factors is  necessary for maintaining low pressures  into later life,  and  supports  the 
hypothesis that environmental influences, some of which may operate through an effect on growth 
(e.g. nutrition or stress), can modify the age-blood pressure relationship.
It  remains  unclear,  which  influences  on  growth  may  contribute  to  the  association  with  blood 
pressure and its age related rise, and it is likely that several pathways are involved, some of which 
have previously been discussed.
The quality of early nutrition, rather than  simply energy intake, is a critical influence on growth 
(154) and may affect the individual age-blood pressure relationship.  While dietary interventions 
have  the  potential  to  impact  on  the  population  burden  of  hypertension  and  associated 
cardiovascular  disease,  (323)  evidence  regarding  associations  between  early  life  factors 
influencing  growth,  such  as  breastfeeding  for  example,  and  adult  cardiovascular  risk has  been 
mixed.  Systematically  collected  evidence  suggested  that  selective  publication  of small  studies 
with  positive  findings  may  have  exaggerated  claims  that  breastfeeding  reduces  systolic  blood 
pressure in later life. (324)  Heterogeneity of studies, with smaller and non-significant differences 
of  systolic  blood  pressure  in  larger  studies,  was  also  reported  in  a  more  recent  review.  (325) 
Publication  bias  may  therefore  also  apply  to  individual  studies  reporting  associations  between 
specific nutritional exposures and adult atherosclerosis. (325)
123Growth limiting factors such as impaired fetal development and disadvantageous  socioeconomic 
conditions  have  been  associated  with  high  blood  pressure  and  cardiovascular  risk  and  were 
considered  as  potential  underlying  or  contributing  factors  here  and  in  previous  investigations. 
(326)  Similar to earlier cross-sectional  analyses,  longitudinal  associations  remained unchanged 
after  adjustment  for birthweight.  However,  birthweight  is  only  a  crude  marker  of growth  and 
development  before  birth,  and  this  does  not  preclude  the  possibility  of  prenatal  factors 
simultaneously  influencing  growth  and  later  blood  pressure.  Adjustment  for  childhood  social 
class,  educational  attainment,  adult  social  class  and potential  confounding  factors  in  adulthood 
(obesity,  smoking,  lack  of  exercise)  slightly  reduced  the  estimates  for  the  age  related  rise 
associated with  shorter height and leg  length,  but did not alter levels  of significance.  Some  of 
these  factors,  particularly  obesity,  showed  independent  effects  on  blood  pressure,  and  their 
importance  for  the  development  of  cardiovascular  disease  should  not  be  understated. 
Furthermore, a great variety of influences on growth are socially distributed, and these contribute 
to the shorter height, and particularly leg length, of children growing up in disadvantageous social 
conditions.  (106; 112; 114; 115)  These influences  include prenatal development,  premature birth, 
maternal health, behaviour and care for the child, early nutrition, living conditions, infections and 
age at puberty. (109-113).  Adjustment for childhood social conditions is unlikely to fully account 
for the diverse influences of these factors on early and later blood pressure and the importance of 
early socially patterned exposures underlying the observed associations cannot be excluded.
Earlier  results  from  the  1946  Birth  Cohort  Study  showed  that  birthweight,  despite  being 
negatively  associated  with  systolic  blood  pressure  at  ages  36,  43  and  53  years,  showed  no 
significant influence on the age related rise of blood pressure.  (281)  In contrast,  the association 
between lower childhood social class and systolic blood pressure was shown to increase with age, 
by  1.0  mm  Hg  (95%  confidence  interval:  0.1;  2.0;  p=0 03)  per  decade,  (281)  highlighting  the 
importance of childhood social class for changes in adult blood pressure.  This effect was found to 
largely be mediated by body mass index, which was an increasingly strong determinant of blood
124pressure,  as also observed in the present analysis.  In contrast, estimates for leg length remained 
strong and significant in fully adjusted analyses; however, the largest attenuation of the effect of 
leg  length  was  also  observed  in  models  adjusting  for body  mass  index.  Leg  length may  be  a 
marker of early growth patterns during the childhood phase that influence body weight trajectories 
from  childhood  to  adulthood  and  thus  adult  blood  pressure,  and  early  weight  gain  and  age  at 
puberty may contribute to this. (268)
Short height and blood pressure regulation might be jointly genetically determined;  however,  as 
discussed  earlier,  the  evidence  of  a  genetically  determined  association  between  height  and 
cardiovascular risk factors to date is weak. (278)  Findings from a study with anthropometric data 
on  two  generations  suggested  that  genetic  factors  contribute  little  to  associations  between 
components of height and cardiovascular risk factors, including blood pressure, as adjustment for 
parental height had only a small effect on these associations.  (225)  In addition, recent evidence 
from  a  study  of 35,000  twin  pairs  also  concluded  that  the  association  is  due  to  environmental 
factors directly affecting growth and CHD. (189)
Strength and limitations
The 1946 Birth Cohort is the oldest ongoing birth cohort internationally, and no other birth cohort 
study is available with earlier measures of blood pressure and a follow-up till middle age.
Survivor bias is unlikely to have a great impact on our results, as only 4.8% of the whole cohort 
died  in  adulthood.  (327)  Potentially  avoidable  loss  of  participants  in  this  cohort  has  been 
discussed earlier; an important advantage of repeated measures analyses is that sample size.can be 
maximized  as  multilevel  models  allow  for  incomplete  outcome  data  as  long  as  a  missing  at 
random process can be assumed. (283;285;286)
Strength  and  limitations  of using  adult  components  of height  as  markers  of growth  have  been 
discussed in more detail in the context of the first objective.  In addition, for longitudinal analyses,
125leg  and  trunk  length  were  only  available  at  43  and  53  years  and  were  therefore  not  used  in 
conjunction  with  the  three  blood  pressure  measurements  in  the  longitudinal  multilevel  models. 
This means that participants who attended the screening at age 36 years had to attend one of the 
next two examinations in order to have a valid measure of components of height to be included in 
this analysis, possibly resulting in selection bias.  Previous studies have shown that loss of stature 
at these early ages (before 53 years), although present, is only small. (162)  In addition, repeating 
the  cross-sectional  analyses  using  firstly  measures  of total  height  corresponding  to  the  age  of 
blood pressure measurement and secondly components  of height at age 43,  instead of 53  years, 
did not alter the results  (not  shown).  This indicates  a)  that any potential  loss  of stature  and b) 
selection bias at age 36 years were of little importance for the present analysis.
This  study is  restricted to  an investigation  of changes in blood pressure measured  at three time 
points  during  the  middle  years  of life.  It  may  be  that  the  observed  associations  will  become 
stronger as  the  cohort  ages  and  arterial  stiffness  and blood pressure increase  further due  to the 
continuing  effects  of  ageing  on  the  arterial  tree.  This  could  be  investigated  at  future  data 
collections.  The availability of just three measures of blood pressure taken at fairly distant time 
points allows for only relatively simplistic modelling of changes in blood pressure, which may be 
unable to account for short term changes or more complex variations of blood pressure over time.
The  increase  in  mean  levels  of  blood  pressure  between  43  and  53  years  may  be  influenced 
systematically  by  differences  in  sphygmomanometers  used.  However,  readings  between 
instruments are not likely to vary systematically by components of height.  The variation in blood 
pressure reading might also vary between instruments or increase with age, as observed for pulse 
pressure and systolic blood pressure in this study.  Using a standardized outcome measure, which 
accounts for the increase in the variation in blood pressure with age, a significant increase in the 
effect  of  height  and  leg  length  with  age  was  observed  for  pulse  pressure  and  systolic  blood 
pressure, suggesting that the amplification of the effects of height and leg length were not simply 
due to increasing variance with age or change in measurement instrument.
126Third objective
Assessment of a range  of cardiovascular risk factors in the Whitehall II Study allowed detailed 
investigation  of  the  specificity  of  cross-sectional  associations  with  markers  of  growth.  The 
inverse  associations  between  height  and  CHD  risk  factors  observed  in  men  and  women  of the 
Whitehall II Study have previously been demonstrated in several other studies. (222;223;225;226) 
Findings  of strong associations between leg length and CHD risk factors replicate earlier results 
from the  1946 birth cohort with regard to pulse and blood pressure and confirm results from the 
Caerphilly,  Midspan,  and British  Women’s  Heart  and  Health cohorts,  which  suggested that leg 
length is the component of height more strongly and consistently associated with CHD risk factors 
in  middle-aged  and older men  and women.  (222;224;225)  However,  leg and trunk length both 
showed  significant  relationships  with  a  number  of  cardiovascular  risk  factors,  indicating  that 
associations with arterial stiffness observed earlier may partly reflect adverse levels of risk factors 
for atherosclerosis other than blood pressure.
Associations  between  trunk  length  and  cardiovascular  risk  factors  question  the  specificity  of 
factors limiting the growth of the long bones of the leg being solely responsible for the increased 
risk  of  cardiovascular  disease;  several  aspects  may  explain  or  contribute  to  this.  Even  if 
influences during the growth hormone dependent childhood phase of growth largely underlie the 
link between poor growth and cardiovascular risk,  associations with trunk length,  albeit weaker, 
may  still be  expected.  Although leg length is predominantly responsible  for changes  in height 
during this  period,  both  components  of height  increase in  length  and  may  thus  be  restricted in 
their growth during this phase.
Associations with leg and trunk length may reflect more  general influences  on  growth,  and not 
necessarily one  specific period,  the childhood phase only.  The degree to which  socioeconomic 
and environmental influences on growth are reflected by shorter leg and trunk length are likely to
127depend  on which factors  operate during  sensitive periods  of growth  and differ according to the 
cohort or population under investigation.
Correlation between anthropometric measures
Previous work has shown that birthweight is similarly correlated with leg length and trunk length; 
(264) this has been interpreted as evidence that prenatal growth is unlikely to underlie differential 
associations  of components  of height with adult disease.  Findings  from other studies  show the 
correlation  between  self-reported  and  recorded  birthweight  to  be  relatively  good  in  younger 
people, but only moderate in elderly respondents.  (328;329)  Self-reported birthweights were not 
validated  in  the  Whitehall  II  Study,  and  correlations  between  components  of  height  and 
birthweight recorded at the time of birth (NSHD) versus recalled in adult life (Whitehall II Study) 
were therefore compared.  These were found to be similar for leg and trunk length, as previously 
suggested, (264) for both studies alike.
While leg and trunk length were positively and moderately correlated in Whitehall II participants, 
they  showed  weak  inverse correlations  in  the  NSHD  cohort.  The reasons  for this  are  unclear; 
however,  despite  age  adjustment,  the  different  age  structure  of  the  two  studies,  with  all 
participants being the same age in the  1946 Birth Cohort (NSHD), may have contributed through 
differences  in  the  degree  of  homogeneity  of  early  life  conditions  between  the  two  study 
populations.
Like  analyses  performed  in  the  1946  and  Whitehall  II  cohorts,  other  recent  investigations  of 
associations between components of height and cardiovascular risk have also attempted to directly 
control  for  the  effects  of  prenatal  growth  by  means  of  adjustment.  (223;225)  Self-reported 
birthweights  were  available for less than  a third  of Midspan participants  and adjustment in this 
subset slightly weakened inverse associations with blood pressure. (225)
128Strength and limitations
Strength  and limitations  of the Whitehall  II  Study are also discussed in detail in relation to the 
findings  of  the  following  fourth  objective,  investigating  associations  between  components  of 
height and  vascular structure  and function  in the Whitehall II cohort.  In  addition,  some issues 
specific to the present analysis are discussed below.
129Selection bias
Participants with missing information on components of height were excluded from the analyses 
and this may introduce selection bias, particularly as these data were missing for a large number 
of participants.  Additional age  adjusted analyses  of associations between height and CHD risk 
factors were therefore performed using the maximum number of observations.  Results were little 
different  to  those  obtained  for  height  using  the  restricted  dataset.  In  addition,  analyses  were 
performed  before  and  after  excluding  participants  with  missing  information  on  covariates  and 
estimates of associations were found to be broadly similar between the two samples.
Shrinkage and components of height
Although some shrinkage may commence around the age of 40 years, the degree of height loss is 
generally only small before middle age, but increases with advancing age.  Because loss of height 
can be associated with pathological processes that influence the risk of cardiovascular disease, it 
has  the  potential to bias the  observed  associations.  Leg  length  and trunk length are differently 
affected by shrinkage, as it predominantly affects the vertebral column, i.e. the trunk, and not the 
long bones of the leg.  In line with this, results from the Whitehall II study showed that trunk, but 
not  leg  length,  was  negatively  associated  with  age,  particularly  so  in  women.  Although 
adjustment for age was performed in all analyses,  residual confounding and reverse causality of 
associations with trunk length may play a role, due to metabolic disease processes underlying the 
risk for osteoporosis and cardiovascular disease that occur more commonly at older ages.
Age  related  differences  in  height  or components  of height  may  also  be  due  to  a  cohort  effect. 
Participants bom from  1941  onwards, unlike those bom before  1941, were recipients of war-time 
food  supplements  for expectant and nursing mothers,  and  young children.  Mean differences in 
height at phase  1  and phase 5 was therefore compared between those bom before and after 1941. 
While  those  bom  before  1941  were  slightly  shorter  compared  to  those  bom  after  1941,  age 
adjusted  differences  were  small  and  not  statistically  significant  for height at  phase  1,  height  at 
phase 5, or its components.  Of those measures, the greatest difference between those bom before
130and  after  1941  was  observed for trunk  length  in  women,  with respective  values  of 85.4  versus 
86.2 cm (p-value=0.06).
F o u r t h  o b je c t iv e
Findings of associations between adult markers of poor growth and distensibility and stiffness in 
men  of the  Whitehall  II  Study  are  in  line  with  the  earlier  observed  relationships  between  leg 
length and pulse pressure,  a crude marker of arterial stiffness, and its age related rise.  Estimates 
were greatest for total body height,  largely owing to strong associations observed for both of its 
components, leg and trunk length.  While inverse associations of height and leg length with intima 
media  thickness  were  also  observed  in  analyses  adjusting  for  body  weight,  associations  were 
significant in men only and reduced after accounting for differences in cardiovascular risk factors.
Considering  the  evidence  presented  so  far,  findings  indicate  that  factors  limiting  growth 
predispose  to  atherosclerotic  vascular  changes  before  the  development  of  symptomatic 
cardiovascular  disease.  Associations  with  distensibility  and  compliance,  but  not  intima  media 
thickness,  were  independent  of  cardiovascular  risk  factors  and  this  may  imply  that  functional 
impairment  and  absolute  levels  of  arterial  thickening  are  potentially  affected  via  different 
mechanisms.
Associations between height, leg and trunk length and the arterial measures differed between the 
sexes and the reasons for this remain unclear, particularly as associations of leg length with blood 
and pulse pressure were  shown to be similar in earlier analyses.  The number of women in the 
Whitehall  II  study  is  substantially  lower  than  that  of  men,  reflecting  the  nature  of  this 
occupational  cohort  of  civil  servants.  Also,  men  and  women  differed  in  the  majority  of 
characteristics  that  were  compared;  for example,  women  were  less  likely  to  report  their ethnic 
origin as white European or to be in high employment grades and were more likely to have less 
personal income, household income and wealth, and a lower social class in childhood.  While it is
131unclear how these differences may have contributed to the lack of associations in women, the fact 
that  women  have  lower  levels  of  atherosclerosis  for  a  given  age,  may  have  also  contributed. 
Earlier reports have shown that a large proportion of women show no evidence of any calcified 
atherosclerotic lesions,  as measured by electron beam computed tomography, before around age 
60  years,  (330;331)  and  women  of  the  Whitehall  Study  may  have  been  too  young  to  detect 
differences according to stature.
One previous  study using data from the ARIC  cohort,  found evidence of an inverse association 
between leg length and carotid artery intima media thickness in  12254 middle aged participants; 
measures of arterial function such as distensibility or stiffness were not available. (332)  Estimates 
in  the  ARIC  study  were  small  in  general,  and  differences  in  the  magnitude  and  direction  of 
associations between leg length and intima media thickness between ethnic groups and sexes were 
reported,  being  strongest  and  inverse  in  black  men  but  positive  and  non-significant  in  black 
women.  In  univariate  analyses,  trunk  length  was  also  inversely  associated  with  intima  media 
thickness  in  black  and  white  men  and  women;  however,  after  adjustment  for  leg  length,  field 
centre  and  age,  significant  positive  associations  emerged  in  white  men  and  women,  while 
estimates  were  attenuated  to  non-significance  in  black  men  and  women.  Because  adjustments 
were performed in groups, it is not possible to know which of the adjustment factors has lead to 
the reverse of associations for trunk length;  however,  as leg and trunk length are correlated and 
represent  components  of  the  same  entity,  adjustment  for  leg  length  is  most  likely  to  be 
responsible.  It  should  be  kept  in  mind  that  in  models  including  both  components  of  height 
simultaneously, effects sizes have to be interpreted as differences in leg length for a given trunk 
length and vice versa.
Contrary to results from the  1946 Study, associations with the arterial outcomes were observed in 
men only in the Whitehall II Study, and for both leg and trunk length.  As mentioned above, trunk 
length showed weak inverse associations with intima media thickness in univariate analyses of the 
ARIC cohort; these did not withstand -  or reversed -  upon adjustments.  In the Caerphilly study,
132the inverse association between adult height and CHD was shown to be specific to leg length, and 
not  seen  for  trunk  length.  Likewise,  in  the  Boyd  Orr  study,  leg  length  measured  directly  in 
childhood  was  found  to  be  inversely  associated  with  cardiovascular  disease  mortality  over  52 
years of follow-up,  whereas there was no association between trunk length measured directly in 
childhood and cardiovascular disease mortality in later life. (213)
Results from the previous chapter have shown significant relationships between trunk length and 
several  cardiovascular  risk  factors,  questioning  the  specificity  of leg  length  as  an  indicator  of 
factors  operating  during  the  growth  hormone  dependent  childhood  phase  of  growth  and 
influencing the risk of cardiovascular disease.
The  growth  hormone  -   insulin-like  growth  factor  (IGF)  axis  plays  a  central  role  for the  rapid 
period of postnatal childhood growth and levels of IGF  1  are strongly associated with childhood 
height.  (333;334)  Levels  of IGF  1  and IGF-binding protein  1  in adulthood increase the risk of 
coronary heart disease, potentially through their effects on the endothelium and vascular smooth 
muscle  cells.  (146)  Furthermore,  recent  studies  have  linked  the  IGF  axis,  particularly  raised 
levels of IGF  1  and/ or reduced levels of its main binding protein (IGFBP3) with several cancers. 
(335-338)
While greater stature is associated with a reduced risk of cardiovascular disease, taller people and 
those  with  longer  legs  have  an  increased  risk  of  developing  cancer.  (339-342)  Because  the 
directions of associations  of height and leg length with cardiovascular disease,  contrary to those 
with  cancer,  mirror those  of the  IGF  axis,  it has  been  speculated  that  IGF  1  may underlie  leg 
length-disease associations.  (343)  However, recent results from the Avon Longitudinal Study of 
Parents  and  Children  showed  that  although  IGF  1  was  strongly  associated  with  subsequent 
growth,  there was no evidence to support the hypothesis that leg length is a better biomarker of 
childhood IGF 1 levels than trunk length. (344)
Likewise, in the Whitehall II Study, associations between socioeconomic factors and components 
of stature were observed for both leg and trunk length.  In summary, while these results question
133the  specificity  of leg  length  as  a  marker  of early  influences  on  growth,  they  suggest  that both 
components of height may be useful as markers of early social andJ or hormonal influences that 
potentially influence the risk of cardiovascular disease and cancer.
Strength and limitations
Strengths  of this  study  include  the  standardized  assessment  of  several  vascular  outcomes,  the 
relatively large cohort size, and the wealth of data on potential confounding and mediating factors. 
Information on early life factors, such as birthweight and childhood social class, was reported in 
adulthood, and non-differential measurement error of recalled information and the smaller sample 
size  due  to  missing  data  may  weaken  associations  or  result  in  residual  confounding  when 
controlling for the effect of birthweight or childhood social class.  No validation of self-reported 
birthweights  has  been  carried  out  in  the  Whitehall  II  study,  as  discussed  in  more  detail  in  the 
previous chapter.
Earlier  work  using  data  from  the  Whitehall  II  Study  has  shown  that  height  is  more  strongly 
associated with adult employment grade,  compared to father’s  social class,  (138) an observation 
that  is  generally  not  made  in  studies  using  prospective  measures  of  early  life  social  factors. 
(115;345)  Although  this  is  most  likely  due  to  greater  measurement  error  of early  life  factors 
recalled  in  middle  age,  other  explanations  are  possible.  These  include  a  narrower  range  of 
father’s  social  classes  in  civil  servants,  upward  social  mobility  (i.e.  selection  into  employment 
grades) by height or factors associated with stature, and grade related shrinkage.
Vascular outcome measures
While  vascular outcomes  differed  significantly by presence  or absence  of a range  of traditional 
cardiovascular risk factors, differences according to presence or absence of coronary heart disease 
were weak and inconsistent and this may reflect treatment bias or reverse causality, for example 
smoking cessation in those with symptomatic disease or after treatment.
134The same absolute degree of atherosclerosis may result in clinical disease earlier or present with 
more  severe  symptoms  in  shorter  people  with  relatively  smaller  vessel  diameters.  Although 
information  on  vessel  size  is  not  commonly  available,  studies  using  ultrasound  measures  of 
vascular function have found associations after accounting for vessel size.  (6)  In this study, beta 
stiffness  index  and  distensibility  coefficient  were  used  as  measures  of vascular  function;  these 
account  for  differences  in  baseline  vessel  diameter  by  estimating  relative  change  and  are 
expressed per unit change of blood pressure, i.e. are independent of blood pressure.
135Sensitivity analysis
To test the influence of CHD history and ethnic group on the relationships between anthropometry 
and the vascular outcomes, sensitivity analyses were performed restricted to white Europeans and 
also  stratified  by  presence  or  absence  of CHD.  These  analyses  yielded  similar results  and  no 
evidence for significant effect modification was found.
Selection and survival bias
Survival  and  selection  bias  may have  influenced  our results,  as  components  of height were not 
assessed before phase 5 and a total of 605 (400 men, 205 women) participants (5.9%) died before 
the end of phase 7  (107 deaths due to CHD;  86 men, 21  women), when vascular outcomes were 
measured.  An inverse association between height and fatal and non-fatal CHD events, including 
all  participants  with  data  on  height  measured  at phase  1  (n=10298)  was  observed  in  men  (HR 
(95% Cl) 0.83 (0.75; 0.91)) and women (0.88 (0.72;  1.08)).  However, when the same association 
was investigated using height measured at phase 5, effectively restricting the analysis to those not 
dead or lost to follow-up at that phase (4027 men,  1693 women), and thus eligible for assessment 
of components of height, this estimate was weakened in men (0.89 (0.78;  1.01)), but strengthened 
in  women  (0.59  (0.45;  0.78)).  The  observed  differences  were due to selective  survival/ loss  to 
follow-up, but not shrinkage between phase 1 and 5, as results restricted to phase 5 attendees were 
virtually identical when height at phase  1  was used instead of phase 5  (HR 0.90 in men, 0.59 in 
women.  This  suggests  that  any  associations  between  height  or its  components  as  measured  at 
phase 5 and subsequent cardiovascular risk may be biased, potentially differentially with regard to 
sex.  If the degree  of under-  or overestimation  differentially affected  associations  with the two 
components of height, this may also bias their comparison.
136Shrinkage and components of height
Limitations of leg and trunk length due to measurement error and also as markers of early growth 
have been discussed in detail earlier.  It has been suggested that differential shrinkage of ill people 
before  study  entry  may  lead  to  artificial  associations  between  shortness  and  increased  future 
cardiovascular risk, particularly in the early years of follow-up, (272) and objective 7 will address 
this question in more detail.  Evidence presented above has shown that shrinkage is unlikely to be 
a  major  problem  in  this  study,  particularly  in  comparison  to  the  greater  bias  that  may  be 
introduced  by  selective  mortality.  Differential  shrinkage  of  components  of  height  has  been 
discussed in detail in the previous and earlier chapters.
F if t h  o b je c t iv e
Little  is  known  about  associations  between  components  of  height  and  metabolic  and 
cardiovascular risk in populations of comparatively short height.
Cross-sectional examination of Filipino-American women  showed that the overall prevalence of 
diabetes in this, by Western Standards,  comparatively short and non-obese population is  greatly 
increased,  (298)  similar  to  other  immigrant  populations.  (346)  Unlike  cohorts  where  diabetes 
prevalence is  higher in  migrant than  native  populations,  the  diabetes  prevalence  was  similar to 
that  of women  in  the  Philippines,  and  longer  term  migrants  and  US  bom  Filipinas  in  Hawaii. 
(347;348)  Selective survival of undemutrition or starvation by those with efficient energy storage 
and greater body size may lead to increased susceptibility to diabetes when followed by a Western 
diet with an abundance of food.  (349)  Contrary to this  “thrifty genotype” hypothesis  stands the 
idea of a “thrifty phenotype”, where early undemutrition may lead to impaired development of the 
endocrine pancreas and increased susceptibility to diabetes in later life. (350)  Filipino women are 
less  obese,  compared  to  Caucasian  American  women,  and  earlier  reports  from  the  same 
population  have  shown  that  although  Filipino  women  have  more  visceral  adipose  tissue  (by
137computed tomography) for a given level of body size, this does not explain their high prevalence 
of diabetes.  (348)  Adult body  size is  thus  unlikely to underlie the  observed  associations;  also, 
while education only was the only socioeconomic measure significantly associated with BMI and 
waist, income was most strongly associated with diabetes.  These cross-sectional analyses cannot 
rule  out  the  potential  importance  of weight  trajectories  from  early  to  adult  life  contributing  to 
associations  with  diabetes.  However,  the  observed  results  suggest  that  factors  associated  with 
socioeconomic disadvantage during women’s childhood that persist after migration to the US and 
into adult life may be important for the development of diabetes.  In this context, the quality of the 
diet may be more important than absolute caloric intake or body size for the risk of diabetes in this 
non-obese population,  i.e.  the quality rather than quantity of fat and carbohydrate consumption. 
(351)
Although  components  of  adult  height  differed  significantly  according  to  socioeconomic 
circumstances,  no  evidence  was  found  for  their  association  with  diabetes  or  HOMA-IR  (not 
shown).  This  is  in  contrast  with  two  earlier  studies  of British  men,  (222)  and  women,  (224) 
suggesting that those with poor growth of the long bones of the leg show a higher prevalence of 
insulin resistance and non-insulin dependent diabetes, as well as other cardiovascular risk factors. 
(225;352)  Likewise,  the  most  recently  published  study  using  NHANES  III  data  reported 
significant associations between leg length and leg length to height ratio with adiposity (women 
only),  insulin  resistance  and type  2  diabetes;  diabetes  associations remained  significant in  fully 
adjusted  models.  Ethnic  differences  were  reported,  but  not  shown,  with  associations  being 
observed in Non-Hispanic Whites and Mexican Americans, but not non-Hispanic Blacks. (226)
Socioeconomic indicators available in this sample of Filipino-American women did not appear to 
be the main factors underlying the inverse associations between leg length and CHD observed in 
this  and  previous  studies.  (222;223)  However,  it  should  be  noted  that  indicators  such  as 
childhood  family income  may  be poor measures  of early malnutrition  not  only during times  of
138war and  occupation in  the  Philippines,  but  also considering that access  to food may have been 
easier for families with low income but living or working on farms, for example.
Strength and limitations
An  important  advantage  of  the  investigation  of  Filipina  women  is  that  potential  residual 
confounding  of health behaviours  is  unlikely  to  play  a major role,  as  few  Filipinas  engaged in 
unhealthy behaviours, such as excess alcohol consumption, smoking or sedentary lifestyle.  Some 
limitations  of  the  present  study  should  be  noted.  This  is  a  cross-sectional  study  which  used 
opportunistic sampling to recruit.  Reverse causation and selection bias may have influenced our 
results, and prospective studies are warranted to validate these cross-sectional findings.  Although 
the sample size was  small,  a significant association between leg length and CHD was  observed. 
However, CHD was not significantly associated with any of the socioeconomic indicators, despite 
directions  and  magnitudes  of  associations  with  childhood  and  adult  income  and  life-course 
socioeconomic position being similar compared to diabetes.  The smaller number of CHD cases 
and thus low power may have contributed to the lack of statistical significance.
Childhood  and  adult  income  and  education  were  self  reported  and  may  not  reflect  sustained 
income,  particularly  when  migration  occurred  in  mid-life.  Adult  income  referred  to  current 
income,  and many women (48%) reported to not currently be employed.  Although 52% had  16 
years  of education  or  more,  and  as  such,  were  presumably  college  graduates,  the  lower  adult 
income might reflect underemployment if their Philippine college degrees were not transferable to 
the US,  or they elected not to join the labour force due to concerns  about adjusting to a foreign 
culture and language at an older age (half migrated to the US after age 45 years).  Previous studies 
have shown that immigrants who previously held professional occupations, particularly those who 
migrate in middle age, lose status.  (353)  A total of 67% of our cohort with  16 years or more of 
education held jobs  as  professionals,  managers  etc.  when residing in the Philippines.  Of these, 
half (55%)  held  similar positions  in  the US,  the  remainder  were housewives  (10%),  worked in
139skilled  manual  (12%),  semi-skilled  (6%)  or  unskilled  occupations  (17%)  in  the  US.  As  a 
consequence, the potential misclassification of the socioeconomic variables may have lead to an 
attenuation of associations if it was non-differential with regard to diabetes and CHD.  However, 
underestimation as well as exaggerated effects may have occurred if participants with diabetes or 
CHD  were  selectively  overrepresented  in  the higher  or lower economic  or  educational  groups, 
respectively.
Generalizability of the sample
Census data did not report Asian nationalities  separately in  1995; population-based  sampling of 
all  Filipinos  in  San  Diego  County  was  therefore  not possible.  Because  the  sampling  frame  is 
unknown, it was not possible to calculate response rates and discuss the representativeness of the 
study population in detail.  However,  comparisons with 2000 United States  Census data suggest 
that this cohort is representative of all Filipino-Americans with regard to education (where 43.8% 
of all Filipino-Americans >25 years of age are college graduates compared to 52% in this cohort). 
Median  household  income  in  this  cohort  ($25,000-29,999)  is  lower  than  national  statistics 
($65,189)  for  all  Filipino-Americans;  (24)  this  discrepancy  likely  reflects  underemployment  or 
retired status in this older cohort.
S ix t h  o b je c t iv e
In 3  year old children of Project Viva,  a prospective U.S. birth cohort study of pregnant women 
and their offspring, poor linear growth of the lower body, i.e.  shorter leg length, relative to total 
body height, was associated with higher blood pressure.
Leg  length  was  positively  associated  with blood pressure in  analyses  adjusted for age,  sex  and 
measurement conditions, but inverse associations emerged after additional inclusion of height in 
the  model.  While  such  reversal  of  associations  may  occur  as  a  statistical  artefact  due  to 
multicollinearity (between height and leg length),  this is unlikely to be the case here for several
140reasons.  Correlations between height and leg length versus trunk length are generally both high 
(0.85 in both cases in this study) and it thus seems unlikely that collinearity differentially affects 
models including leg, but not trunk length.  Also, analyses of leg percent or difference in leg and 
trunk z-scores, which are not subject to this problem, yielded similar results.
The inverse association between  leg length and blood pressure in Project Viva replicates earlier 
findings in adults and  suggests that the association between poor growth of the lower body and 
high blood pressure may have its origins early in life and develop during the childhood phase of 
growth.
Associations were observed for all four blood pressure outcomes, but were slightly stronger and 
remained significant in fully adjusted analyses for pulse pressure and systolic blood pressure,  as 
observed  in  the  1946  Study.  Although  not  the  case  for  adults,  greater  measurement  error  of 
diastolic blood pressure may contribute to differential associations in childhood. (354)  In studies 
investigating the role of prenatal growth, as indicated by birthweight, an effect on diastolic blood 
pressure has  also less frequently been reported,  potentially due to a lack of significant findings. 
(281)  The reasons for this remain  unclear;  however,  as hypothesized in chapter 5,  associations 
between  growth  limiting  factors  and  blood  pressure  may  be  strongest  for  those  measures  that 
show a greater rise with age, i.e. systolic blood pressure and pulse pressure.
Of all childhood predictors  of adult blood pressure, blood pressure levels in childhood are most 
important.  (354;355)  Evidence  comes  from  longitudinal  studies  showing  that  blood  pressure 
tracks from childhood to adulthood.  Blood pressure rises with age, particularly in childhood, but 
while children with initially high levels of blood pressure are more likely to become adults with 
high blood pressure, not all children maintain their ranks. (356)  Factors that influence the level at 
which  blood  pressure  tracks  during  childhood  include  growth,  obesity  and  the  degree  of 
maturation acquired. (357)  Height and weight are each positively associated with blood pressure 
during childhood, and this was seen in children of Project Viva, too.  In analyses including height
141and  weight  simultaneously,  weight emerged  as  the  more important  (or stronger)  influence,  and 
this has previously been reported. (358)
Although  no  previous  studies  are  available  investigating  associations  between  components  of 
height and blood pressure in childhood, one earlier report has shown an association between fetal 
femur length and systolic blood pressure at age 6 years, adjusting for current height. (228)  In that 
study, the authors obtained similar results  after adjustment for current weight or BMI instead of 
height, and this was also observed in Project Viva (not shown).
Results  from  the  Muscatine  Study  examining  children  aged  5  to  18  years  showed  that  while 
having  high  levels  of  blood  pressure  for  age  was  associated  with  excessive  body  weight  or 
precocious height, having high blood pressure for height but not for age was associated with being 
short for age.  (359)  This pattern suggests that the positive association between height and blood 
pressure reflects  greater weight and  obesity,  also  supported by results from adjusted analyses in 
this study, where weight emerged as the stronger predictor, as mentioned above.
Positive  associations between trunk length  and blood pressure mirror those  observed for height 
and the notion that these reflect the effects of greater weight and obesity are supported by the fact 
that weight and BMI showed stronger correlations with trunk length (correlation coefficients 0.71 
and 0.23, respectively),  compared to leg length (0.56 and 0.01,  respectively) in these 3  year old 
children.
Shorter leg length,  for a given height,  may indicate that growth potential has not been  achieved 
during the childhood phase.  Relatively shorter childhood leg length may as such be a measure of 
being short for age, and thus be associated with lower levels of blood pressure in accordance with 
results from The Muscatine Study.
Predictors of components of height
142Of all predictors that were considered, only few showed significant associations that differentially 
affected components of height; these consisted largely of parental and children’s anthropometry. 
Leg  length  contributed  a  significantly  greater proportion  to  body height  in  children  with  taller 
mothers and those with greater length, but not weight, at birth and at age 3 years; while maternal 
age,  children’s weight and BMI showed inverse associations with both, the proportion of height 
contributed by leg length and the differences in leg and trunk length z-scores.
In  contrast to  results  from  Project  Viva,  data  from  NSHD  showed  that  diet in  early  childhood 
(breastfeeding  and  greater  energy  intake  at  age  4  years)  was  associated  with  greater  adult  leg 
length.  (115)  Data from  the  Boyd-Orr  cohort  showed  similar results,  with breastfeeding,  high 
energy  diets  at  age  2  years,  and  advantaged  childhood  social  circumstances  each  being 
specifically associated with longer leg length in childhood.  (106;360)  Results of this study were 
also  indicative  of the  association  between  breastfeeding  and  leg  length  being  stronger  at  older 
ages,  and  this  may  suggests  that  associations  may emerge  in  Project  Viva  as  its  children  grow 
older.  However, differences between this and previous studies may also be explained by changes 
in  early  life  conditions  of children  of the  earlier  cohorts  bom  1918-39  and  1946,  respectively, 
compared to contemporary and  socially relatively homogenous children  of Project Viva.  These 
secular changes in early life conditions may also underlie the overall lack of associations observed 
between markers  of socioeconomic position and components of height in this study,  which is in 
contrast with the notion of leg length being a sensitive marker of early environmental influences 
on growth. (310)
Strength and limitations
Important  strength  of the  Project  Viva  Study  include  prospectively  collected  longitudinal  data 
beginning in early pregnancy, detailed assessment of demographic, socioeconomic and biological 
family  and  child  characteristics,  availability  of  components  of  height,  in  addition  to  multiple 
standardized recordings of blood pressure at the 3 year examination.
143Within  person  variability  of  blood  pressure  is  particularly  high  in  childhood,  (361)  and  the 
importance of measuring blood pressure multiple times in epidemiological studies of children has 
previously been highlighted.  (354)  In  Project Viva,  to reduce biases  resulting from equipment, 
subject,  environment,  and  technique,  blood pressure  was  measured  according to  a  standardized 
protocol by trained research assistants using calibrated Dinamap Pro-100 oscillometric automated 
monitors,  which  recorded  blood  pressure  up  to  five  times  at  1-minute  intervals.  Measurement 
conditions  were  recorded  and  controlled  for in  all  analyses.  Previous  research  has  shown  that 
multiple  measurements  are  vital  in  estimating  childhood  blood  pressure,  (354)  and  multilevel 
analyses including up to five measures for each child were performed, accounting for within and 
between  person  variations,  and  allowing  a  more  precise  estimation  of  blood  pressure  and  its 
predictors.  (358)  However, it has been suggested that obtaining data from several visits, days or 
weeks apart, may be more important than increasing the number of measurements per visit; (354) 
however, this is difficult to achieve in the context of a large,  long term prospective birth cohort 
study.
Mothers included in the study were relatively well educated and older, and all resided in eastern 
Massachusetts,  potentially  limiting  generalizability.  Also,  only  53%  of all  originally  included 
mother child  pairs  were  accounted  for in  the  present  analysis,  potentially introducing  selection 
bias  and  limiting  the  generalizability/  external  validity  of  findings.  Compared  to  the  whole 
cohort,  mothers  who  were  included  were  indeed  slightly  more  likely  to  be  white  and  better 
educated,  but  no  differences  existed  for  household  income,  maternal  pre-pregnancy  BMI  or 
children’s birthweight, compared to all 2083 participants who delivered a non-premature child.
Inverse associations between leg length and blood pressure emerged after adjustment for height, 
and as leg and trunk length are the two only components of height, it is not possible to determine 
whether relatively shorter legs  or longer trunks are underlying the observed associations.  It has 
previously been suggested that rather than height per se, the distance from the heart to the vertex 
of the head is more important for the positive relationship between height and blood pressure that
144exists  during the  growing  years.  (362)  Total  sitting height includes  the length  of the neck and 
head  and  it  is  therefore  possible  that  longer trunks  rather than  shorter legs  drive  the  observed 
associations, lending some support to this hypothesis.
While the availability of a range of prospectively collected potential confounding and mediating 
factors are a strength of this study, children who grow poorly are likely to differ from those who 
do not with regard to many unmeasured factors, in addition to those controlled for in the present 
analysis.  In the context of an  observational study,  it is not possible to account for all unknown 
factors that may influence both  growth and blood pressure  simultaneously.  However,  any such 
factors need to differentially be associated with components of height in order to account for the 
observed  associations.  Of the  variables  considered,  surprisingly few  fulfilled this  criterion  and 
these did not account for the observed link between short leg length and high blood pressure.
Se v e n t h  o b je c t iv e
While  increased  levels  of CHD  morbidity  and  mortality  in  those  of  shorter  height  have  been 
demonstrated  in  many  studies,  some  questions  remain  unanswered.  The  first Whitehall  Study, 
with an adequate number of people with and without evidence of CHD at baseline, a large number 
of deaths due to CHD and stroke, a long duration of follow-up, and sufficient power to investigate 
effect modification, provides the opportunity to address some of these questions.
Symptomatic participants
Not many studies have explored the role of short height in participants with prevalent CHD, and 
these  yielded  conflicting  results  for  the  prognosis  after  myocardial  infarction.  (201-204)  Age 
adjusted  mortality  rates  from  coronary  heart  disease  in  the  first  Whitehall  Study  were,  as 
expected,  more  than  twice  as  high in participants  with  CHD  at  study entry,  compared to those 
without, representing their worse prognosis.  The strong, inverse associations between height and 
CHD mortality observed in this high risk group indicate that short height is not only an important
145influence on the development of CHD in an asymptomatic healthy population, but also affects the 
prognosis in men with evident CHD.
Interaction of early and later life effects
Previous  investigations  of  the  association  between  height  and  mortality  have  commonly 
performed  adjustments  to  account  for  socioeconomic  confounding.  Findings  from  the  first 
Whitehall  Study  now  provide  evidence  that  influences  on  growth  may  interact  with  adult 
socioeconomic  position  in  their  effects  on  cardiovascular  mortality,  rather  than  representing  a 
joint  underlying  mechanism,  and  this  may  explain  some  of  the  discrepant  findings  of  earlier 
studies.  A study of Finnish men has  previously suggested that those with poor prenatal growth 
are  more vulnerable to the effects  of low  socioeconomic  status  on CHD.  (124)  In contrast, the 
present study shows that the positive effect of growth in height (or adverse effect of short height) 
on  cardiovascular  mortality  is  particularly  apparent  in  those  of  higher  employment  grades. 
Several  circumstances  may  contribute  to  these  discrepant  findings.  First,  in  the  Finnish  study 
almost half of the 285  fatal and non-fatal CHD events occurred in labourers.  Differences in the 
effect of birthweight on CHD between social classes were of borderline significance and restricted 
to labourers.  This group is not represented in our analysis, which is based on nearly 4000 deaths 
in an occupational cohort of British civil servants,  all office workers.  The comparability of the 
two populations is therefore questionable.  Second, while Barker et al. suggested that the effect of 
prenatal growth on CHD is more evident in those of low adult social class, this study showed that 
the association between  short height and CHD is  strongest in high employment grades.  Size at 
birth  and  height,  although  weakly  correlated,  are  markers  of  growth  phases  with  different 
determinants  and  duration,  and  these  may  represent  separate influences  on  cardiovascular risk. 
(172;264)
Research from the  1958 British birth cohort has shown that the shorter height of low birthweight 
infants  was  overcome  in  children  from  the  highest,  but  not  other  social  classes.  (363)  This 
differential  ‘catch  up’  growth  in  height  has  been  attributed  to  their  better  social  conditions,
146including  nutrition,  education  and  health  care.  These  inequalities  in  the  realization  of growth 
potential suggest that variation in height within social classes of origin, and particularly for those 
from  most  privileged  backgrounds,  has  a  larger  genetic  component  than  variations  in  height 
overall.  When investigating differences between employment grades in adulthood,  the opposite 
may be the case.  The  civil  service has provided  an  opportunity for upward social mobility for 
children of manual workers, mainly with regard to the clerical grades, and to a lesser degree for 
the  higher  grades.  (364)  Downward  social  mobility  of those  from  privileged  backgrounds  to 
lower employment grades has been much less common.  This means that people in higher grades 
represent the widest spectrum of childhood  backgrounds,  ranging from those who maintained a 
privileged position throughout their life,  to those  who moved up to the greatest extent from the 
lowest childhood conditions.  People moving to a higher class are on average taller than the class 
they  leave  and  shorter  than  the  class  they join,  and  this  has  also  been  observed  for  the  civil 
service. (365)  Upward social mobility therefore results in a decrease in mean height in the higher 
grades,  narrowing  height  inequalities  between  grades  in  adulthood.  (345)  Within  high  grades, 
shorter  participants  thus  represent  the  upwardly  mobile,  and  their  childhood  environment  and 
cardiovascular  risk  differs  from  the  taller  participants  of  continuously  high  social  position. 
Absolute mortality rates reflect this social mobility, being lowest in the tallest group in the highest 
employment  grade  and  similar  when  comparing  the  shortest  group  in  the  highest  grade  to  the 
tallest group in the grade below (results not shown).
In  addition,  the relative contribution  of early disadvantage for adult cardiovascular risk may be 
smaller  in  men  in  lower  employment  grades  with  increased  risk  factors  and  higher  absolute 
mortality.  Thus  the  strongest  relationship  between  short height  and  CVD  may  be  expected  in 
lower risk participants in the higher grades.
Length of  follow up
The  inverse  association  between  height  and  mortality  was  not  confined  to  the  first  period  of 
follow-up, contrary to a suggestion based on earlier follow-up of this study,  (272) and providing
147no evidence that associations may be restricted to participants whose short height was a result of 
existing disease in childhood or shrinkage in adulthood.  The issue of reverse causality has been 
examined in  long term follow-ups  of young adults in  Scotland  and the US.  (165; 183)  In these 
studies, participants’  height was assessed at University entry, minimizing any potential influence 
of  shrinkage  owing  to  concomitant  disease.  In  both  studies  greater  stature  offered  protection 
against CHD.
Strength and limitations
Strengths  of the  present  study  include  its  almost  complete  follow-up  for mortality,  minimising 
potential  selection  bias;  the  availability  of  information  on  a  range  of  potential  covariates, 
including  socioeconomic  position,  smoking  and  obesity;  and  extended  follow-up  with  a  large 
number of deaths, so facilitating examination of reverse causality.  Despite these advantages, the 
study invariably has some weaknesses.  In having only a single baseline assessment of the cohort, 
there will have been  some measurement misclassification,  albeit non-differential with respect to 
the  exposure  of interest.  The  generalizability  of findings  from  an  occupational  cohort  of male 
civil-servants is limited.  The study of participants of socioeconomic status higher than the general 
population  average,  and  thus  of taller  stature  and  with  lower  mortality  rates,  may  result  in  an 
underestimation of the association between height and CHD.  Contrary to this notion, our results 
suggest  that  this  association  may  be  particularly  marked  in  socially  homogenous  cohorts. 
(151; 165; 173; 183)  Given  their  related  aetiologies,  the  association  between  height  and  CHD 
would  be  expected  to  be  similar  to  that  with  ischemic,  but  not  hemorrhagic  stroke.  (200) 
However,  information  on  stroke  sub-types  was  not  sufficiently  well  characterized  to  allow 
separate investigation.
148Conclusions and Im plications
Many studies have demonstrated an inverse association between height and cardiovascular risk in 
adult life.  This, together with recent evidence of long term influences of childhood conditions on 
adult  cardiovascular  risk,  has  led  to  speculations  about  early  life  influences  as  origins  of 
atherosclerosis  and  symptomatic  cardiovascular disease.  Leg length,  one  component  of height, 
was proposed to be useful as  a sensitive marker of early environmental factors that are  socially 
distributed  and  may  link  poor  growth,  atherosclerosis  and  cardiovascular  risk,  and  this  has 
provided the background of this thesis.
In  line  with  this,  findings  of pulse  pressure,  a  marker  of arterial  stiffness,  and  systolic  blood 
pressure being significantly greater in men and women  of shorter height and leg length, but not 
trunk length, have supported a role of factors limiting early linear growth for the development of 
high blood pressure in later life.  Importantly,  these associations were shown to be significantly 
amplified with age, and this may be regarded as evidence for the hypothesis that people with poor 
growth are more susceptible to the effects of ageing on the arterial tree.  Findings from the NSHD 
were validated in participants  of the Whitehall II cohort,  who also provided evidence of inverse 
associations  between  poor  growth  and  specific  measures  of  vascular  function,  arterial 
distensibility and stiffness, in adult men.
The  prevalence  of isolated  systolic  hypertension,  arteriosclerosis  and  other  diseases  associated 
with aging continue to rise as the elderly population grows and future studies may show whether 
associations  are  even  more  marked  in  older populations.  Nutritional  factors  influence  the  age 
related  rise  of  blood  pressure,  largely  responsible  for  the  high  prevalence  of hypertension  in 
industrialized countries, and populations with low salt intake, for example, have been shown to be 
relatively  free  from hypertension.  (366)  If nutritional  factors  limiting  growth  contribute  to  the 
tracking of cardiovascular risk throughout life, preventive measures aimed at reducing the rise of
149blood  pressure  and  arterial  stiffness  during  midlife  will  need  to  be  implemented  early  in  life. 
Findings of associations between relatively shorter leg length and higher blood pressure observed 
in 3 year old children of Project Viva are in support of this.
As  outlined  above,  leg  length  is  generally  regarded  a  marker  of  early  influences  during  the 
childhood phase of growth and potentially underlying causal factors were discussed.  Stature is to 
some degree genetically determined, (367) but there is little evidence that genetic factors underlie 
the link between poor growth  and  cardiovascular risk.  (189;225;278)  Importantly, poor growth 
and  shorter  height  are  more  common  in  men  and  women  growing  up  and  living  in  adverse 
socioeconomic circumstances, and stature thus reflects socioeconomic disadvantage over the life- 
course.  Accordingly,  socioeconomic differences in height and its components were observed or 
have previously been reported for all studies of adults included in this report.  (115;138;151;152) 
Large  differences  in height  and  its  components  according to  socioeconomic  position  were  also 
found  in  a  sample  of Filipino-American  women,  a  comparatively  short  population.  While  the 
high risk of diabetes in these women differed significantly by childhood and adult socioeconomic 
factors, leg length, but not trunk length, was shown to be the factor most strongly associated with 
the risk of CHD.
Because  of the  social distribution  of growth  and  stature,  and the  well documented influence  of 
social  disadvantage  on  cardiovascular  risk,  it  is  likely  that  factors  linking  poor  growth  and 
cardiovascular  risk  are  socially  distributed.  In  all  studies,  adjustments  were  performed  to 
investigate the  role  of prenatal  growth,  socioeconomic  factors  or  other potentially  confounding 
and  mediating  factors.  While  the  role  of  prenatal  growth  was  shown  to  be  limited  for  the 
associations  that  were  investigated,  the  influence  of  socioeconomic  factors  appeared  more 
complex.  While adjustments for indicators of social position in childhood and adulthood did not 
account  for  the  observed  associations,  issues  of residual  confounding  and  effect  modification 
arose.
150Differences  in  results  of  randomized  trials  and  observational  studies  investigating  socially 
distributed exposures,  such as vitamin intake or hormone replacement therapy, have highlighted 
that even careful adjustments do not preclude residual influences, due to the measurement error, 
biases  and the complexity of associations  and confounding structure.  (271)  Indicators  of social 
position that are available in long term prospective studies are unlikely to adequately capture the 
different pathways through which early disadvantage or deprivation may limit growth and affect 
atherosclerosis  and  cardiovascular  disease.  Importantly,  adjustment  for  socioeconomic  factors 
that  are  hypothesized  to  contribute  to  or  underlie  the  relationships  between  growth  and 
cardiovascular  risk  will  represent  overadjustment  if  not  interpreted  in  the  context  of  the 
underlying causal model.
Further,  adjustments  for  socioeconomic  factors  may  be  inappropriate  if  effect  modification  is 
present.  The differential associations between short height and cardiovascular mortality between 
employment  grades  that  were  observed  in  men  with  and  without  prevalent  CHD  in  the  first 
Whitehall study have provided some evidence for the complex interactions between poor growth 
and socioeconomic position that are present.
Taking  together evidence  of a)  early  fife  exposures  specifically  affecting leg,  rather than  trunk 
length, b) the notion that up until puberty, and particularly during the childhood phase of growth, 
a much greater proportion of increases in height is due to leg growth, making it more vulnerable 
to  environmental  exposures,  c)  secular  increases  in  height,  attributed  to  improved  childhood 
conditions, largely affecting leg length, and d) inverse associations with markers of cardiovascular 
risk being observed for leg length, rather than trunk length, it may not be surprising that factors 
limiting the growth of the long bones of the legs have been suggested to contribute to the origins 
of atherosclerosis and cardiovascular risk.
While findings of this thesis lend some support to this hypothesis and have shown that shorter leg 
length is associated with increased arterial stiffness, subclinical atherosclerosis and cardiovascular
151risk,  potentially  from  an  early  age  on  and  with  effects  being  amplified  with  age,  they  also 
highlight that some of these claims should be treated with caution.
In particular, they question the specificity of leg length as a marker of early influences operating 
during the childhood phase  of growth that  are  responsible for the increased cardiovascular risk 
associated  with  shorter  height.  Factors  simultaneously  influencing  growth  and  arterial 
development, stiffness and atherosclerosis are likely to act over prolonged periods of time and be 
influenced by a complex set of socioeconomic factors at different ages.
Future and ongoing longitudinal studies may shed light on the role of tempo of growth and timing 
of puberty for associations between growth and cardiovascular risk and this may help to identify 
children  with  growth  patterns  that  would  benefit  from  early  monitoring  and  management  of 
cardiovascular risk.
152Ta blesTable 1 Characteristics of men and women of the NSHD at age 53 years
N MEN WOMEN
MEN/WOMEN
MEANS (SE) P-VALUE*
BIRTHWEIGHT (G) 1724/ 1695 3461.8(12.5) 3320.8(11.7) < 0.001
WEIGHT (KG) 1451/1501 83.7 (0.36) 71.6 (0.37) <0.001
BMI (KG/M2) 1452/ 1496 27.4 (0.11) 27.4 (0.14) 0.82
WAIST-HIP RATIO (%) 1452/ 1504 93.6 (0.16) 80.7 (0.17) <0.001
HEIGHT (M) 1729/1700 174.7 (0.16) 161.6 (0.15) <0.001
LEG LENGTH (M) 1724/ 1698 82.7 (0.12) 74.8 (0.12) <0.001
TRUNK LENGTH (M) 1724/ 1698 92.0(0.10) 86.8(0.10) <0.001
SYSTOLIC BLOOD PRESSURE 1441/ 1464 140.0 (0.52) 132.2 (0.51) <0.001
DIASTOLIC BLOOD PRESSURE 1441/1464 87.3 (0.32) 81.6 (0.30) <0.001
PULSE PRESSURE 1441/1464 52.7 (0.35) 50.6 (0.36) <0.001
PROPORTIONS P-VALUE*
FATHER IN A NON-MANUAL CLASS 1644/ 1604 41.2 41.7 0.79
EDUCATION AT A-LEVEL OR MORE 1626/1599 41.5 27.5 < 0.001
NON-MANUAL SOCIAL CLASS 1690/1608 60.4 71.7 <0.001
ANTIHYPERTENSIVE DRUG USE 1461/1517 13.8 15.5 0.20
CURRENT CIGARETTE SMOKER 1461/1517 23.9 22.7 0.46
REGULAR EXERCISE 1460/ 1517 52.1 49.2 0.13
* t-test for differences in means and chi-squared test for differences in proportions
154Table 2 Mean (95% Cl) pulse pressure in each of the four height and leg length groups
AND DIFFERENCES IN Z-SCORES COMPARING EACH WITH THE SHORTEST GROUP
PULSE PRESSURE MEANS DIFFERENCES IN Z-SCORES
MODEL A* MODEL B**  MODEL C***
MEN [1363]
HEIGHT
1 (< 170.2 CM) 54.6 (53.2; 56.0) 0 0 0
2 (> 170.2 CM-174.8 CM) 52.9 (51.5; 54.3) -0.14 (-0.28; 0.01) -0.13 (-0.28; 0.01) -0.13 (-0.28; 0.02)
3 (>174.8 CM-178.9 CM) 52.8 (51.3; 54.2) -0.11 (-0.26; 0.04) -0.10 (-0.25; 0.05) -0.09 (-0.24; 0.05)
4 (> 179.9 CM) 51.0 (49.6; 52.4) -0.24 (-0.39;-0.10) -0.23 (-0.37;-0.08) -0.22 (-0.36;-0.07)
P-TREND <0.001 0.003 0.007 0.01
LEG LENGTH
1 (< 79.3 CM) 55.8 (54.4; 57.2) 0 0 0
2 (> 79.3 CM-82.6 CM) 53.9 (52.5; 55.3) -0.14 (-0.28; 0.01) -0.13 (-0.27; 0.02) -0.13 (-0.27; 0.02)
3 (> 82.6 CM -  85.8 CM) 50.8 (49.4; 52.2) -0.35 (-0.49;-0.12) -0.34 (-0.49;-0.19) -0.34 (-0.48;-0.19)
4 (> 85.8 CM) 50.7 (49.3; 52.1) -0.34 (-0.49;-0.19) -0.33 (-0.47;-0.18) -0.32 (-0.47;-0.17)
P-TREND < 0.001 <0.001 <0.001 <0.001
WOMEN [1355]
HEIGHT
1 (<158.0 CM) 52.9 (51.5; 54.3) 0 0 0
2 (>158.0 CM-161.6 CM) 51.6 (50.1; 53.0) -0.09 (-0.24; 0.06) -0.07 (-0.22; 0.08) -0.08 (-0.23; 0.07)
3 (>161.6 CM-165.5 CM) 49.2 (47.7; 50.6) -0.25 (-0.40;-0.11) -0.24 (-0.39;-0.09) -0.24 (-0.39;-0.09)
4 (> 165.5 CM) 48.4 (46.9; 49.8) -0.28 (-0.43;-0.14) -0.27 (-0.42;-0.12) -0.27 (-0.41 ;-0.12)
P-TREND <0.001 <0.001 < 0.001 <0.001
LEG LENGTH
1 (<71.8 CM) 53.3 (51.9; 54.8) 0 0 0
2 (>71.8 CM-74.7 CM) 50.5 (49.1; 52.0) -0.18 (-0.33;-0.03) -0.17 (-0.31;-0.02) -0.17 (-0.32;-0.02)
3 (> 74.7 CM -  77.7 CM) 49.7 (48.3; 51.2) -0.23 (-0.38;-0.08) -0.21 (-0.36;-0.06) -0.22 (-0.37;-0.07)
4 (> 77.7 CM) 48.6 (47.2; 50.1) -0.30 (-0.45;-0.15) -0.29 (-0.44;-0.14) -0.28 (-0.43;-0.13)
P-TREND <0.001 <0.001 <0.001 <0.001
* Model A: Adjustment for use of antihypertensive medication, body mass index, waist-hip ratio and smoking 
** Model B: As model A, with additional adjustment for childhood social class 
*** Model C: As model A, with additional adjustment for birthweight
155Table 3 Mean (95% Cl) systolic blood pressure in each of the four height and leg length
GROUPS AND DIFFERENCES IN Z-SCORES COMPARING EACH WITH THE SHORTEST GROUP
SYSTOLIC PRESSURE MEANS DIFFERENCES IN Z-SCORES
MODEL A* MODEL B** MODEL C***
MEN [1363]
HEIGHT
1 141.7(139.7; 143.8) 0 0 0
2 140.8(138.7; 142.8) -0.06 (-0.20; 0.08) -0.05 (-0.19; 0.09) -0.05 (-0.19; 0.09)
3 140.0(137.9; 142.2) -0.06 (-0.20; 0.09) -0.04 (-0.18; 0.11) -0.03 (-0.18; 0.11)
4 137.6 (135.5; 139.7) -0.17 (-0.32;-0.03) -0.14 (-0.28; 0.00) -0.14 (-0.28; 0.01)
P-TREND 0.006 0.03 0.08 0.09
LEG LENGTH
1 143.1 (141.0; 145.2) 0 0 0
2 142.3 (140.2; 144.3) -0.03 (-0.17; 0.11) -0.01 (-0.16; 0.13) -0.02 (-0.16; 0.12)
3 138.1 (136.0; 140.2) -0.21 (-0.36;-0.07) -0.20 (-0.34;-0.05) -0.20 (-0.35;-0.06)
4 136.5 (134.5; 138.6) -0.25 (-0.40;-0.12) -0.23 (-0.37;-0.08) -0.23 (-0.37;-0.08)
P-TREND <0.001 < 0.001 <0.001 <0.001
WOMEN [1355]
HEIGHT
1 135.2(133.2; 137.2) 0 0 0
2 133.6(131.5; 135.7) -0.06 (-0.20; 0.08) -0.05 (-0.19; 0.10) -0.05 (-0.20; 0.09)
3 131.6 (129.5; 133.7) -0.15 (-0.29;-0.01) -0.15 (-0.29;-0.00) -0.14 (-0.28; 0.00)
4 128.1 (125.9; 130.2) -0.28 (-0.42;-0.13) -0.27 (-0.42;-0.12) -0.27 (-0.41 ;-0.12)
P-TREND <0.001 < 0.001 <0.001 <0.001
LEG LENGTH
1 135.6(133.5; 137.7) 0 0 0
2 132.6(130.6; 134.7) -0.10 (-0.25; 0.05) -0.09 (-0.23; 0.06) -0.09 (-0.24; 0.05)
3 131.2(129.1; 133.3) -0.16 (-0.30;-0.01) -0.14 (-0.29; 0.01) -0.15 (-0.29; 0.00)
4 129.5(127.4; 131.5) -0.23 (-0.38;-0.08) -0.22 (-0.37;-0.08) -0.22 (-0.37;-0.07)
P-TREND <0.001 0.002 0.003 0.003
* Model A:  Adjustment for use of antihypertensive medication, body mass index, waist-hip ratio and smoking 
** Model B: As model A, with additional adjustment for childhood social class 
*** Model C: As model A, with additional adjustment for birthweight
156Table 4 Mean  (95%  Cl)  diastolic  blood  pressure in  each  of  the  four  height  and  leg
LENGTH GROUPS AND DIFFERENCES IN Z-SCORES COMPARING EACH WITH THE SHORTEST GROUP
DIASTOLIC PRESSURE MEAN DIFFERENCES IN Z-SCORES
MODEL A* MODEL B** MODEL C***
MEN [1363]
HEIGHT
1 87.1 (85.8; 88.4) 0 0 0
2 87.9 (86.6; 89.2) 0.05 (-0.09; 0.20) 0.06 (-0.08; 0.21) 0.06 (-0.08; 0.20)
3 87.2 (85.9; 88.6) 0.03 (-0.11;0.18) 0.05 (-0.09; 0.20) 0.05 (-0.09; 0.20)
4 86.7 (85.4; 88.0) -0.01 (-0.16; 0.13) 0.02 (-0.13;0.16) 0.01 (-0.13; 0.16)
P-TREND 0.5 0.8 0.8 0.9
LEG LENGTH
1 87.3 (86.0; 88.6) 0 0 0
2 88.4 (87.1;89.7) 0.10 (-0.04; 0.25) 0.12 (-0.03; 0.26) 0.11 (-0.03:0.25)
3 87.3 (86.0; 88.6) 0.04 (-0.11; 0.18) 0.05 (-0.09; 0.20) 0.04 (-0.10; 0.19)
4 85.9 (84.6; 87.2) -0.04 (-0.19; 0.11) -0.01 (-0.16; 0.14) -0.02 (-0.17; 0.13)
P-TREND 0.07 0.4 0.7 0.6
WOMEN [1355]
HEIGHT
1 82.3 (81.1; 83.5) 0 0 0
2 82.1 (80.8; 83.3) 0.01 (-0.14;0.15) 0.01 (-0.14;0.15) 0.01 (-0.14; 0.15)
3 82.4 (81.2; 83.7) 0.05 (-0.10; 0.19) 0.04 (-0.11; 0.19) 0.05 (-0.10; 0.19)
4 79.7 (78.4; 81.0) -0.13 (-0.28; 0.01) -0.14 (-0.29; 0.01) -0.14 (-0.29; 0.01)
P-TREND 0.009 0.2 0.1 0.2
LEG LENGTH
1 82.2(81.0; 83.5) 0 0 0
2 82.1 (80.9; 83.3) 0.04 (-0.11; 0.19) 0.05 (-0.10; 0.20) 0.04 (-0.11; 0.19)
3 81.5 (80.2; 82.7) 0.01 (-0.14; 0.16) 0.01 (-0.14;0.16) 0.01 (-0.14; 0.16)
4 80.8 (79.6; 82.1) -0.04 (-0.19; 0.11) -0.04 (-0.19; 0.12) -0.04 (-0.19; 0.12)
P-TREND 0.08 0.5 0.5 0.6
* Model A: Adjustment for use of antihypertensive medication, body mass index, waist-hip ratio and smoking 
** Model B: As model A, with additional adjustment for childhood social class 
*** Model C: As model A, with additional adjustment for birthweight
157Ta b le 5 C h ara cter istics o f th e sa m ple in relation to h eig h t, leg a n d  tr u n k leng th
risk factors jq** HEIGHT
1 2 3
SHORTEST TALLEST
GROUP GROUP
MEANS P-VALUE*
birthweight (G) 3419 3271 3375 3535 < 0.001
BMI AT 36 YEARS (KG/M2) 3048 24.2 23.9 23.7 <0.001
BMI AT 43 YEARS (KG/M2) 3228 25.6 25.2 24.8 <0.001
BMI AT 53 YEARS (KG/M2) 2948 27.9 27.3 27.1 < 0.001
WAIST-HIP RATIO AT 53 YEARS (%) 2956 87.4 86.8 86.9 0.20
PROPORTIONS P-VALUE*
MATE SEX 3429 50.7 50.4 50.2 0.79
father in a no n-m anual CLASS 3248 31.3 42.5 51.1 < 0.001
EDUCATION AT A-LEVEL OR MORE 3225 26.7 36.6 40.6 < 0.001
non-m anual SOCIAL CLASS 3298 57.4 68.9 71.5 <0.001
ANTIHYPERTENSIVE DRUGS AGE 36 3079 2.6 0.9 0.9 < 0.001
ANTIHYPERTENSIVE DRUGS AGE 43 3251 4.6 3.3 1.9 < 0.001
ANTIHYPERTENSIVE DRUGS AGE 53 2978 16.4 16.1 11.5 0.002
CURRENT CIGARETTE SMOKER 2978 25.5 23.9 20.4 0.007
REGULAR EXERCISE 2977 43.8 53.0 55.3 < 0.001
* Chi-squared test for linear trend across categories
** Numbers are based on the model including height and may vary slightly in analysis of leg or trunk length
158Table 5 Continued
RISK FACTORS LEG LENGTH
1 2 3
SHORTEST TALLEST
GROUP GROUP
MEANS P-VALUE*
BIRTHWEIGHT (G) 3296 3375 3505 <0.001
BMI AT 36 YEARS (KG/M2) 24.3 23.8 23.6 <0.001
BMI AT 43 YEARS (KG/M2) 25.8 25.0 24.8 <0.001
BMI AT 53 YEARS (KG/M2) 28.1 27.4 26.7 < 0.001
WAIST-HIP RATIO AT 53 YEARS (%) 87.0 86.9 ’  87.2 0.56
PROPORTIONS P-VALUE*
MALE SEX 50.7 50.0 50.5 0.91
FATHER IN A NON-MANUAL CLASS 33.0 42.5 48.8 <0.001
EDUCATION AT A-LEVEL OR MORE 29.3 35.5 38.8 < 0.001
NON-MANUAL SOCIAL CLASS 61.0 68.1 68.8 < 0.001
ANTIHYPERTENSIVE DRUGS AGE 36 1.8 1.1 1.5 0.50
ANTIHYPERTENSIVE DRUGS AGE 43 4.8 2.4 2.8 0.009
ANTIHYPERTENSIVE DRUGS AGE 53 16.7 14.3 12.9 0.02
CURRENT CIGARETTE SMOKER 24.0 23.4 22.5 0.44
REGULAR EXERCISE 47.7 51.6 52.8 0.02
* Chi-squared test for linear trend across categories
159Table 5 Continued
RISK FACTORS TRUNK LENGTH
1 2 3
SHORTEST TALLEST
GROUP GROUP
MEANS P-VALUE*
BIRTHWEIGHT (G) 3313 3380 3487 <0.001
BMI AT 36 YEARS (KG/M2) 23.8 24.0 23.9 0.41
BMI AT 43 YEARS (KG/M2) 25.1 25.4 25.2 0.57
BMI AT 53 YEARS (KG/M2) 27.2 27.6 27.4 0.28
WAIST-HIP RATIO AT 53 YEARS (%) 87.9 86.7 86.5 <0.001
PROPORTIONS P-VALUE*
MALE SEX 50.3 49.7 51.1 0.70
FATHER IN A NON-MANUAL CLASS 33.7 41.9 49.4 <0.001
EDUCATION AT A-LEVEL OR MORE 28.1 34.9 41.0 <0.001
NON-MANUAL SOCIAL CLASS 58.5 66.8 72.8 <0.001
ANTIHYPERTENSIVE DRUGS AGE 36 2.2 1.2 1.0 0.02
ANTIHYPERTENSIVE DRUGS AGE 43 3.9 3.1 2.9 0.21
ANTIHYPERTENSIVE DRUGS AGE 53 15.5 14.5 14.1 0.38
CURRENT CIGARETTE SMOKER 26.4 22.4 21.1 0.005
REGULAR EXERCISE 45.2 50.8 56.1 <0.001
* Chi-squared test for linear trend across categories
160T a b le   6  C r o s s -s e c tio n a l  a s s o c ia tio n s   b e tw e e n   co m p o n e n ts  o f   h e ig h t  a n d   b lo o d   p r e ssu r e  m e a su r e s  a t   e a c h   a g e   (r e g r e s sio n  
COEFFICIENTS AND 95 PERCENT CONFIDENCE INTERVALS)
PULSE PRESSURE SYSTOLIC PRESSURE DIASTOLIC PRESSURE
36 YEARS
Nt COEFFICIENT 95% Cl COEFFICIENT 95% Cl COEFFICIENT 95% Cl
HEIGHT OVERALL* 3034 -0.029 -0.093,0.035 -0.12 -0.20, -0.034 -0.089 -0.16, -0.020
MEN 1516 0.013 -0.077,0.10 -0.038 -0.15,0.076 -0.051 -0.15,0.046
WOMEN 1518 -0.078 -0.17,0.012 -0.21 -0.34, -0.088 -0.13 -0.23, -0.034
INTERACTIONS P=0.16 P=0.044 P=0.24
LEG LENGTH OVERALL* 3030 -0.0085 -0.088,0.072 -0.10 -0.21,0.0041 -0.93 -0.18,-0.0056
MEN 1514 -0.014 -0.13,0.10 -0.067 -0.21,0.080 -0.052 -0.18,0.071
WOMEN 1516 -0.0021 -0.11,0.11 -0.14 -0.29,0.013 -0.14 -0.26, -0.014
INTERACTIONS P=0.88 P=0.50 P=0.34
TRUNK LENGTH OVERALL* 3032 -0.048 -0.14,0.047 -0.11 -0.24,0.013 -0.065 -0.17,0.039
MEN 1514 0.058 -0.080,0.20 0.014 -0.16,0.19 -0.044 -0.19,0.10
WOMEN 1518 -0.16 -0.29, -0.030 -0.25 -0.43, -0.067 -0.087 -0.23,0.059
INTERACTIONS P=0.024 P=0.042 P=0.69
* Adjusted for sex
t Numbers are based on the model including pulse pressure and may vary slightly in analysis of systolic or diastolic blood pressure 
S Test for interaction is for sex by component of height in a model including both men and women
161Table 6 Continued
PULSE PRESSURE SYSTOLIC PRESSURE DIASTOLIC PRESSURE
43 YEARS
N* COEFFICIENT 95% Cl COEFFICIENT 95% Cl COEFFICIENT 95% Cl
HEIGHT OVERALL* 3154 -0.065 -0.13, -0.00048 -0.15 -0.23, -0.057 -0.080 -0.15, -0.013
MEN 1586 -0.071 -0.16,0.015 -0.092 -0.21,0.025 -0.021 -0.11,0.070
WOMEN 1568 -0.057 -0.15,0.039 -0.21 -0.34, -0.076 -0.15 -0.25, -0.05
INTERACTION* P=0.83 P=0.20 P=0.059
LEG LENGTH OVERALL* 3153 -0.095 -0.18, -0.013 -0.19 -0.30, -0.078 -0.096 -0.18, -0.0098
MEN 1585 -0.10 -0.22,0.0087 -0.15 -0.30,0.0051 -0.044 -0.16,0.075
WOMEN 1568 -0.085 -0.21,0.035 -0.24 -0.40, -0.072 -0.15 -0.28, -0.028
INTERACTION* P=0.82 P=0.43 P=0.21
OVERALL* 3155 -0.016 -0.11,0.082 -0.069 -0.20,0.065 -0.054 -0.16,0.049
TRUNK MEN 1585 -0.027 -0.16,0.11 -0.017 -0.20,0.17 0.0097 -0.13,0.15
LENGTH WOMEN 1570 -0.0043 -0.15,0.14 -0.12 -0.32,0.072 -0.12 -0.27,0.029
INTERACTION* P=0.82 P=0.44 P=0.22
* Adjusted for sex
t Numbers are based on the model including pulse pressure and may vary slightly in analysis of systolic or diastolic blood pressure. 
$ Test for interaction is for sex by component of height in a model including both men and women.
162Table 6 Continued
PULSE PRESSURE SYSTOLIC PRESSURE DIASTOLIC PRESSURE
53 YEARS
Nt COEFFICIENT 95% Cl COEFFICIENT 95% Cl COEFFICIENT 95% Cl
HEIGHT OVERALL* 2905 -0.25 -0.33, -0.17 -0.36 -0.47, -0.25 -0.11 -0.18, -0.04
MEN 1441 -0.23 -0.33, -0.12 -0.31 -0.46,-0.15 -0.08 -0.18,0.017
WOMEN 1464 -0.28 -0.40,-0.16 -0.42 -0.59, -0.26 -0.14 -0.24, -0.045
INTERACTION* P=0.51 P=0.32 P=0.37
LEG LENGTH OVERALL* 2903 -0.36 -0.46, -0.26 -0.48 -0.62, -0.34 -0.12 -0.21,-0.03
MEN 1440 -0.38 -0.51,-0.25 -0.50 -0.70, -0.31 -0.12 -0.24,0.0017
WOMEN 1463 -0.34 -0.48, -0.19 -0.45 -0.66, -0.25 -0.12 -0.24,0.0043
INTERACTION* P=0.65 P=0.74 P=0.96
TRUNK LENGTH OVERALL* 2904 -0.057 -0.17,0.059 -0.13 -0.30,0.041 -0.071 -0.17,0.032
MEN 1440 -0.01 -0.17,0.15 -0.016 -0.25,0.22 -0.0039 -0.15,0.14
WOMEN 1464 -0.11 -0.28,0.06 -0.25 -0.49, -0.0071 -0.14 -0.29, -0.0003
INTERACTION* P=0.43 P=0.18 P=0.18
* Adjusted for sex
t Numbers are based on the model including pulse pressure and may vary slightly in analysis of systolic or diastolic blood pressure
* Test for interaction is for sex by component of height in a model including both men and women
163T a b l e 7 T he effects o f h eig h t,  leg a n d t r u n k leng th o n p u l se p r e ssu r e,  sy sto lic a n d d ia sto lic  bl o o d pr e ssu r e be tw een 36 a n d  
53 y e a r s.  R eg r e ssio n co efficients a n d  95 percent c o n fid en c e in ter v a ls fo r th e effect o n b l o o d pr e ssu r e at 36 y e a r s (interc ept) 
AND ON THE LINEAR CHANGE (SLOPE) BETWEEN 36 AND 53 YEARS FROM A MULTILEVEL MODEL INCLUDING 908 6  OBSERVATIONS
INTERCEPT (MMHG) SLOPE (MMHG/YEAR)
PULSE PRESSURE COEFFICIENT 95% Cl P-VALUE* COEFFICIENT 95% Cl P-VALUE*
HEIGHT -0.005 -0.064,0.054 0.87 -0.014 -0.020, -0.0081 <0.001
LEG LENGTH 0.010 -0.063,0.083 0.79 -0.020 -0.026, -0.014 <0.001
TRUNK LENGTH -0.040 -0.13,0.046 0.36 -0.001 -0.0088,0.067 0.80
SYSTOLIC BLOOD PRESSURE COEFFICIENT 95% Cl P-VALUE* COEFFICIENT 95% Cl P-VALUE*
HEIGHT -0.091 -0.17, -0.013 0.023 -0.013 -0.021,-0.0052 <0.001
LEG LENGTH -0.086 -0.18,0.012 0.085 -0.021 -0.029, -0.013 <0.001
TRUNK LENGTH -0.095 -0.21,0.021 0.11 -0.0001 -0.0098,0.0098 0.99
DIASTOLIC BLOOD PRESSURE! COEFFICIENT 95% Cl P-VALUE* COEFFICIENT 95% Cl P-VALUE*
HEIGHT -0.083 -0.15,-0.020 0.010 -0.001 -0.0049,0.0029 0.62
LEG LENGTH -0.088 -0.17,-0.0076 0.032 -0.002 -0.0079,0.0039 0.51
TRUNK LENGTH -0.053 -0.15,0.041 0.27 -0.001 -0.0088,0.0068 0.80
* Chi-squared test for linear trend
t Model for diastolic blood pressure differs slightly from others, as it does not include a quadratic term for age
164T a b l e 8 T he effect o f h eig h t, leg a n d tr u n k leng th o n pu l se pr e ssu r e, sy sto lic a n d d ia sto lic b l o o d pr essu r e be tw e en 36 a n d 53 
y e a r s.  R eg r e ssio n  coefficients  a n d  95  percent  c o n fid en c e  in t er v a l s  for  th e  effect  o n  th e  lin ea r  c h a n g e  o f  bl o o d  pr essu r e 
(slo pe) BETWEEN 36 AND 53 YEARS from m u l tile v el m o d els in c lu d in g 7110 OBSERVATIONS befo r e a n d after a d ju stm en ts
pulse pressure
HEIGHT LEG LENGTH
COEFFICIENT 95% Cl P-VALUE* COEFFICIENT 95% Cl P-VALUE*
UNADJUSTED -0.013 -0.019, -0.0071 <0.001 -0.021 -0.029,-0.013 <0.001
ADJUSTMENT FOR ANTIHYPERTENSIVE DRUGS -0.012 -0.018, -0.0061 <0.001 -0.020 -0.028,-0.012 <0.001
ADJUSTMENT FOR BODY MASS INDEX* -0.012 -0.018, -0.0061 <0.001 -0.019 -0.027,-0.011 <0.001
ADJUSTMENT FOR ADULT FACTORS* -0.013 -0.019,-0.0071 <0.001 -0.021 -0.029,-0.013 <0.001
ADJUSTMENT FOR EARLY LIFE FACTORS§ -0.014 -0.020, -0.0081 <0.001 -0.021 -0.029, -0.013 <0.001
ADJUSTMENT FOR ALL VARIABLES ABOVE -0.011 -0.017,-0.0051 <0.001 -0.018 -0.026, -0.010 <0.001
SYSTOLIC BLOOD PRESSURE
HEIGHT LEG LENGTH
COEFFICIENT 95% Cl P-VALUE* COEFFICIENT 95% Cl P-VALUE*
UNADJUSTED -0.015 -0.023, -0.0072 <0.001 -0.022 -0.032, -0.012 <0.001
ADJUSTMENT FOR ANTIHYPERTENSIVE DRUGS -0.013 -0.021, -0.0052 <0.001 -0.021 -0.031,-0.011 <0.001
ADJUSTMENT FOR BODY MASS INDEX* -0.012 -0.020, -0.0042 0.003 -0.015 -0.025, -0.0052 0.003
ADJUSTMENT FOR ADULT FACTORS* -0.014 -0.022, -0.0062 <0.001 -0.022 -0.032, -0.012 <0.001
ADJUSTMENT FOR EARLY LIFE FACTORS§ -0.014 -0.022, -0.0062 <0.001 -0.022 -0.032, -0.012 <0.001
ADJUSTMENT FOR ALL VARIABLES ABOVE
* m,:  —i*__ c_i:  „   “
-0.010 -0.018, -0.0022 0.012 -0.015 -0.025, -0.0052 0.003
t Adjustment includes body mass index as a time varying covariate and an interaction term for BMI and age 
* Adjustment for adult life factors: educational attainment, smoking, exercise and adult social class 
§ Adjustment for early life factors: birthweight and childhood social class
165Table 9 A ge adjusted characteristics of men and women participating in the W hitehall 
II Study visit 1997-99
variables N MEANS (SD)/ PROPORTIONS
MEN/ WOMEN MEN WOMEN P-VALUE
AGE (YEARS) 3457/1534 55.5 (6.0) 56.1 (6.0) 0.0007
HEIGHT AT PHASE 1 (M) 3457/1534 176.5 (6.7) 162.9 (6.4) <0.0001
HEIGHT AT PHASE 5 (M) 3457/ 1534 176.2 (6.7) 162.3 (6.4) <0.0001
LEG LENGTH (M) 3457/1534 83.8 (4.4) 76.4 (4.3) <0.0001
TRUNK LENGTH (M) 3457/1534 92.4 (3.7) 85.9 (3.8) <0.0001
BIRTHWEIGHT (LBS) 2287/1084 7.6 (1.3) 7.2 (1.4) < 0.0001
PULSE PRESSURE (MMHG) 3449/1531 44.5(11.0) 46.5 (12.8) < 0.0001
SBP (MMHG) 3449/1531 122.6 (15.9) 121.4(17.6) < 0.0001
DBP (MMHG) 3449/ 1531 78.2 (10.5) 75.0 (10.0) < 0.0001
CHOLESTEROL (MMOL/L) 3425/ 1509 5.9 (1.04) 6.0(1.08) < 0.0001
HDL CHOLESTEROL (MMOL/L) 3020/1337 1.38 (0.35) 1.66 (0.43) <0.0001
TRIGLYCERIDE (MMOL/L)* 3425/1509 1.23 (0.92) 1.01 (0.64) <0.0001
WAIST-HIP RATIO (%) 3354/1498 92.5 (6.3) 79.8 (6.9) < 0.0001
BODY MASS INDEX (KG/M2) 3423/1527 26.0 (3.4) 26.5 (5.0) 0.0002
FASTING GLUCOSE (G/L)t 3245/1426 5.1 (0.50) 4.9 (0.52) <0.0001
2HR GLUCOSE (G/L)f 2952/1277 5.9 (1.6) 6.1 (1.5) 0.0003
ANTIHYPERTENSIVE TREATMENT 3441/1526 12.4 15.9 0.0006
DIABETES (%) 3457/1534 5.1 5.3 0.75
CHILDHOOD SOCIAL CLASS I/II 3253/1368 45.2 43.3 0.19
LOW ADULT GRADE (%) 3457/1534 6.8 41.5 < 0.0001
CURRENT SMOKER (%) 3450/1525 9.4 12.7 0.0005
HIGH ALCOHOL INTAKE (%) 3441/1526 12.4 15.9 0.0006
* Geometric mean
t Excludes participants with diabetes
166T a b l e 10 A g e a d ju st e d c o r r e l a t io n c o effic ien ts fo r h e ig h t, le g l e n g t h , t r u n k  le n g t h
AND BIRTHWEIGHT IN THE NSHD AND WHITEHALL II STUDY
MEASURE HEIGHT TRUNK LENGTH  LEG LENGTH BIRTHWEIGHT
NSHD: 1495 WOMEN (COEFFICIENTS SHOWN IN THE UPPER RIGHT CORNER OF THE TABLE) AND 1444 MEN
HEIGHT - 0.60 (P< 0.001)  0.73 (P < 0.001) 0.22 (P < 0.001)
TRUNK LENGTH 0.62 (P< 0.001) -0.11 (P< 0.001) 0.13 (P< 0.001)
LEG LENGTH 0.76 (P < 0J)01) -0.05 (P=0.08) 0.16 (P< 0.001)
BIRTHWEIGHT 0.27 (P < 0.001) 0.17 (P< 0.001)  0.20 (P< 0.001)
_
WHITEHALL STUDY: 1084 WOMEN (COEFFICIENTS SHOWN IN THE UPPER RIGHT CORNER) AND 2287 MEN
HEIGHT - 0.76 (P< 0.001) 0.83 (P< 0.001) 0.19 (P< 0.001)
TRUNK LENGTH 0.78 (P < 0.001) - 0.27 (P < 0.001) 0.17 (P< 0.001)
LEG LENGTH 0.87 (P < 0.001) 0.38 (P< 0.001) - 0.15 (P< 0.001)
BIRTHWEIGHT 0.22 (P < 0.001) 0.17 (P< 0.001) 0.19 (P< 0.001) -
167Table 11 A ge adjusted differences in levels of cardiovascular risk factors per standard deviation increase in height
COEFFICIENT (95% CONFIDENCE INTERVAL)
FULL SAMPLE RESTRICTED SAMPLE
ADJUSTMENT N AGE ADJUSTED N AGE ADJUSTED FULLY ADJUSTED!
WOMEN
AGE (PHASE 5) 1534 -1.06 (-1.36; -0.75)$ 994 -0.90 (-1.28; -0.52)$ -0.59 (-0.98; -0.21)$
PULSE PRESSURE (MMHG) 1531 -1.26 (-1.88; -0.64)$ 985 -1.13 (-1.89; -0.37)$ -1.01 (-1.79; -0.23)$
SYSTOLIC PRESSURE (MMHG) 1531 -2.22 (-3.09;-1.36)$ 985 -2.10 (-3.16;-1.03)$ -1.76 (-2.83;-0.68)$
DIASTOLIC PRESSURE (MMHG) 1531 -0.96 (-1.48; -0.45)$ 985 -0.96 (-1.60;-0.33)$  . -0.75 (-1.39;-0.11)#
CHOLESTEROL (MMOL/L) 1509 -0.03 (-0.08; 0.03) 886 -0.06 (-0.12; 0.01) -0.05 (-0.12; 0.02)
HDL CHOLESTEROL (MMOL/L) 1337 0.02 (-0.0009; 0.05) 867 0.02 (-0.008; 0.05) 0.008 (-0.02; 0.04)
TOTAL/HDL CHOLESTEROL* 1337 -0.01 (-0.03; 0.001) 867 -0.02 (-0.04; -0.001)# -0.01 (-0.03; 0.006)
TRIGLYCERIDES (MMOL/L)* 1509 -0.05 (-0.08; -0.03)$ 986 -0.04 (-0.06; -0.006)# -0.03 (-0.06; 0.004)
FASTING GLUCOSE (G/L) 1426 -0.007 (-0.04; 0.02) 944 0.01 (-0.02; 0.05) 0.02 (-0.01; 0.05)
2 HR GLUCOSE (G/L) 1277 -0.18 (-0.26; -0.09)$ 852 -0.12 (-0.22; -0.01)# -0.10 (-0.21; 0.007)
WAIST-HIP RATIO (%) 1498 -0.80 (-1.15;-0.45)$ 976 -0.90 (-1.32; -0.48)$ -0.77 (-1.21;-0.34)$
MEN
AGE (PHASE 5) 3457 -0.74 (-0.94; -0.54)$ 2165 -0.41 (-0.66; -0.17)$ -0.54 (-0.79; -0.29)$
PULSE PRESSURE (MMHG) 3449 -0.40 (-0.75; -0.03)# 2151 -0.49 (-0.94; -0.03)# -0.42 (-0.90; 0.05)
SYSTOLIC PRESSURE (MMHG) 3449 -0.41 (-0.93; 0.11) 2151 -0.41 (-1.07; 0.25) -0.20 (-0.87; 0.47)
DIASTOLIC PRESSURE (MMHG) 3449 -0.02 (-0.37; 0.34) 2151 0.08 (-0.38; 0.54) 0.22 (-0.24; 0.68)
CHOLESTEROL (MMOL/L) 3425 -0.07 (-0.10; -0.03)$ 2150 -0.11 (-0.15; -0.06)$ -0.11 (-0.16;-0.06)$
HDL CHOLESTEROL (MMOIVL) 3020 0.00006 (-0.01; 0.01) 1889 -0.002 (-0.02; 0.01) -0.005 (-0.02; 0.01)
TOTAL/HDL CHOLESTEROL* 3020 -0.01 (-0.02; -0.002)# 1889 -0.02 (-0.03; -0.003)# -0.02 (-0.03; -0.002)#
TRIGLYCERIDES (MMOL/L)* 3425 -0.03 (-0.05; -0.01)$ 2150 -0.03 (-0.05; -0.007)$ -0.03 (-0.05; -0.0006)#
FASTING GLUCOSE (G/L) 3245 0.02 (-0.002; 0.004) 2055 0.02 (-0.005; 0.04) 0.02 (-0.006; 0.04)
2 HR GLUCOSE (G/L) 2952 -0.17 (-0.22;-0.11)$ 1880 -0.15 (-0.21;-0.08)$ -0.14 (-0.21;-0.06)$
WAIST-HIP RATIO (%) 3354 -0.77 (-0.98; -0.56)$ 2115 -0.62 (-0.89; -0.35)$ -0.61 (-0.90; -0.33)$
* Based on log transformed values; # p-value < 0.05; $ p < 0.01; $ p < 0.001
§ Includes adjustment for birthweight, childhood social class, adult grade, and antihypertensive treatment (blood pressure outcomes)
168T a b l e  12 A g e a d ju s t e d d iffe r e n c e s in l e v e l s o f c a r d io v a sc u l a r r isk f a c t o r s per st a n d a r d  d e v ia t io n in c r e a se in leg l e n g t h
COEFFICIENT (95% CONFIDENCE INTERVAL)
FULL SAMPLE RESTRICTED SAMPLE
ADJUSTMENT N AGE ADJUSTED N AGE ADJUSTED FULLY ADJUSTED!
WOMEN
AGE (PHASE 5) 1534 -0.23 (-0.54; 0.07) 994 -0.19 (-0.57; 0.19) -0.10 (-0.47; 0.27)
PULSE PRESSURE (MMHG) 1531 -0.87 (-1.48; -0.27)t 985 -0.90 (-1.65;-0.16)# -0.80 (-1.55;-0.05)#
SYSTOLIC PRESSURE (MMHG) 1531 -1.72 (-2.56; -0.87)$ 985 -1.88 (-2.92;-0.83)$ -1.72 (-2.75; -0.70)$
DIASTOLIC PRESSURE (MMHG) 1531 -0.84 (-1.34; -0.35)$ 985 -0.98 (-1.60;-0.35)t -0.92 (-1.53; -0.31)$
CHOLESTEROL (MMOL/L) 1509 -0.05 (-0.10; 0.008) 886 -0.06 (-0.13; 0.002) -0.06 (-0.12; 0.01)
HDL CHOLESTEROL (MMOL/L) 1337 0.02 (-0.008; 0.04) 867 0.02 (-0.007; 0.05) 0.02 (-0.01; 0.05)
TOTAL/HDL CHOLESTEROL* 1337 -0.01 (-0.03; 0.0003) 867 -0.02 (-0.04; -0.005)$ -0.02 (-0.04; -0.002)#
TRIGLYCERIDES (MMOL/L)* 1509 -0.05 (-0.08; -0.03)$ 986 -0.05 (-0.08; -0.02)$ -0.04 (-0.07; -0.01)$
FASTING GLUCOSE (G/L) 1426 -0.02 (-0.04; 0.01) 944 0.007 (-0.03; 0.04) 0.01 (-0.02; 0.05)
2 HR GLUCOSE (G/L) 1277 -0.14 (-0.23;-0.06)$ 852 -0.11 (-0.21;-0.0004)# -0.09 (-0.20; 0.02)
WAIST-HIP RATIO (%) 1498 -0.09 (-0.44; 0.26) 976 -0.40 (-0.82; 0.03) -0.32 (-0.75; 0.12)
MEN
AGE (PHASE 5) 3457 -0.21 (-0.41;-0.01)# 2165 -0.03 (-0.28; 0.21) -0.08 (-0.32; 0.16)
PULSE PRESSURE (MMHG) 3449 -0.37 (-0.72; -0.01)# 2151 -0.66 (-1.11; -0.22)$ -0.61 (-1.07;-0.15)$
SYSTOLIC PRESSURE (MMHG) 3449 -0.58 (-1.10;-0.06)# 2151 -0.93 (-1.58; -0.28)$ -0.79 (-1.44; -0.15)#
DIASTOLIC PRESSURE (MMHG) 3449 -0.21 (-0.57; 0.14) 2151 -0.27 (-0.72; 0.18) -0.18 (-0.62; 0.27)
CHOLESTEROL (MMOL/L) 3425 -0.08 (-0.11;-0.04)$ 2150 -0.11 (-0.16; -0.07)$ -0.12 (-0.16; -0.07)$
HDL CHOLESTEROL (MMOL/L) 3020 0.006 (-0.007; 0.02) 1889 0.002 (-0.01; 0.02) 0.0005 (-0.02; 0.02)
TOTAL/HDL CHOLESTEROL* 3020 -0.02 (-0.03; -0.009)$ 1889 -0.02 (-0.04; -0.01)$ -0.02 (-0.04; -0.009)$
TRIGLYCERIDES (MMOL/L)* 3425 -0.04 (-0.06; -0.02)$ 2150 -0.04 (-0.07; -0.02)$ -0.04 (-0.06; -0.02)$
FASTING GLUCOSE (G/L) 3245 0.009 (-0.008; 0.03) 2055 0.006 (-0.02; 0.03) 0.006 (-0.02; 0.03)
2 HR GLUCOSE (G/L) 2952 -0.14 (-0.19; -0.08)$ 1880 -0.11 (-0.18; -0.05)$ -0.10 (-0.17;-0.03)$
WAIST-HIP RATIO (%) 3354 -0.42 (-0.63;-0.21)$ 2115 -0.29 (-0.56; -0.02)# -0.29 (-0.56; -0.01)#
* Based on log transformed values; # p-value < 0.05; t p < 0.01; $ p < 0.001
§ Includes adjustment for birthweight, childhood social class, adult grade, and antihypertensive treatment (blood pressure outcomes)
169Table 13 A ge adjusted differences in levels of cardiovascular risk factors per standard deviation increase in trunk length
COEFFICIENT (95% CONFIDENCE INTERVAL)
FULL SAMPLE RESTRICTED SAMPLE
ADJUSTMENT N AGE ADJUSTED N AGE ADJUSTED FULLY ADJUSTED§
WOMEN
AGE (PHASE 5) 1534 -1.50 (-1.80;-1.21)$ 994 -1.30 (-1.67;-0.93)$ -0.91 (-1.29;-0.53)$
PULSE PRESSURE (MMHG) 1531 -1.13 (-1.76; -0.51)$ 985 -0.89 (-1.65;-0.12)# -0.77 (-1.56; 0.03)
SYSTOLIC PRESSURE (MMHG) 1531 -1.79 (-2.66;-0.92)$ 985 -1.40 (-2.46; -0.33)f -0.92 (-2.02; 0.17)
DIASTOLIC PRESSURE (MMHG) 1531 -0.65 (-1.17; -0.14)$ 985 -0.51 (-1.15;0.13) -0.16 (-0.81; 0.49)
CHOLESTEROL (MMOL/L) 1509 0.01 (-0.04; 0.07) 886 -0.02 (-0.09; 0.05) -0.02 (-0.09; 0.05)
HDL CHOLESTEROL (MMOL/L) 1337 0.02 (-0.003; 0.04) 867 0.01 (-0.02; 0.04) -0.008 (-0.04; 0.02)
TOTAL/HDL CHOLESTEROL* 1337 -0.008 (-0.02; 0.009) 867 -0.007 (-0.03;0.01) 0.002 (-0.02; 0.02)
TRIGLYCERIDES (MMOIVL)* 1509 -0.03 (-0.05; -0.002)# 986 -0.004 (-0.03; 0.03) 0.007 (-0.02; 0.04)
FASTING GLUCOSE (G/L) 1426 0.006 (-0.02; 0.03) 944 0.02 (-0.02; 0.05) 0.02 (-0.01;0.06)
2 HR GLUCOSE (G/L) 1277 -0.15 (-0.24; -0.07)$ 852 -0.09 (-0.20; 0.02) -0.08 (-0.19; 0.03)
WAIST-HIP RATIO (%) 1498 -1.35 (-1.70; -0.99)$ 976 -1.21 (-1.65; -0.78)$ -1.07 (-1.53;-0.62)$
MEN
AGE (PHASE 5) 3457 -1.10 (-1.29;-0.90)$ 2165 -0.76 (-1.01;-0.50)$ -0.92 (-1.17;-0.67)$
PULSE PRESSURE (MMHG) 3449 -0.27 (-0.63; 0.10) 2151 -0.06 (-0.54; 0.41) 0.02 (-0.47; 0.50)
SYSTOLIC PRESSURE (MMHG) 3449 -0.03 (-0.56; 0.50) 2151 0.44 (-0.24; 1.12) 0.68 (-0.006; 1.36)
DIASTOLIC PRESSURE (MMHG) 3449 0.24 (-0.12; 0.60) 2151 0.50 (0.03; 0.98) 0.66 (0.19; 1.13)
CHOLESTEROL (MMOL/L) 3425 -0.03 (-0.06; 0.01) 2150 -0.05 (-0.10; -0..007)# -0.06 (-0.11;-0.008)#
HDL CHOLESTEROL (MMOL/L) 3020 -0.007 (-0.02; 0.006) 1889 -0.008 (-0.02; 0.009) -0.01 (-0.03; 0.007)
TOTAL/HDL CHOLESTEROL* 3020 0.002 (-0.009; 0.01) 1889 -0.001 (-0.02; 0.01) 0.0006 (-0.01; 0.02)
TRIGLYCERIDES (MMOL/L)* 3425 -0.005 (-0.02; 0.01) 2150 -0.002 (-0.03; 0.02) 0.006 (-0.02; 0.03)
FASTING GLUCOSE (G/L) 3245 0.02 (0.005; 0.04) 2055 0.03 (0.003; 0.05) 0.03 (0.002; 0.05)
2 HR GLUCOSE (G/L) 2952 -0.14 (-0.20; -0.08)$ 1880 -0.13 (-0.20; -0.06)$ -0.12 (-0.20; -0.05)$
WAIST-HIP RATIO (%) 3354 -0.90 (-1.12; -0.69)$ 2115 -0.81 (-1.09; -0.53)$ -0.79 (-1.08;-0.51)$
* Based on log transformed values; # p-value < 0.05; $ p < 0.01; $ p < 0.001
§ Includes adjustment for birthweight, childhood social class, adult grade, and antihypertensive treatment (blood pressure outcomes)
170T a b l e 14 A g e a d ju st e d c h a r a c t e r ist ic s o f m e n a n d  w o m e n pa r t ic ipa t in g in th e W h iteh all 
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VARIABLE N MEANS/ PROPORTIONS
MEN/WOMEN MEN WOMEN P-VALUE
AGE (YEARS) 2953/1159 62.3 61.9 0.08
WHITE EUROPEAN (%) 2950/1158 93.5 85.3 0.0001
YEARS OF FOLLOW-UP (PHASE 3-7) 2823/1103 11.3 11.1 0.0001
INTIMA MEDIA THICKNESS (MM)# 2952/1158 0.780 0.766 0.0001
BETA STIFFNESS INDEX * 2929/1140 10.90 10.31 0.0001
DISTENSIBILITY (10'3 /KPA)# 2929/1140 13.92 15.08 0.0001
SBP (MMHG) 2950/1158 127.4 125.6 0.001
DBP (MMHG) 2950/1158 74.2 72.6 0.0001
PP (MMHG) 2950/1158 53.2 53.0 0.56
MAP (MMHG) 2950/1158 91.9 90.3 0.0001
PREVALENT CHD (%) 2953/1159 16.4 20.5 0.002
PREVALENT CHD EXCL. ANGINA (%) 2953/1159 10.8 9.9 0.40
DIABETES (%) 2953/1159 6.8 6.6 0.88
HYPERTENSION (%) 2953/1159 35.8 38.7 0.07
D  Y  SLIPIDAEMIA (%) 2953/1159 53.0 34.1 0.0001
NEVER SMOKER (%) 2944/1155 52.2 62.7 0.0001
CURRENT SMOKER (%) 2944/1155 6.4 8.3 0.04
HIGH ALCOHOL INTAKE (%) 2922/1138 21.9 12.8 0.0001
HEALTHY DIET (%) 2920/1127 79.0 81.7 0.05
SUFFICIENT PHYSICAL ACTIVITY (%) 2919/1138 59.6 45.1 0.0001
HIGHER EDUCATION (%) 2721/1023 61.7 44.8 0.0001
PERSONAL INCOME > 25K (%) 2897/1110 61.1 30.3 0.0001
PERSONAL INCOME < 15 K (%) 2897/1110 11.2 41.1 0.0001
HOUSEHOLD INCOME > 50K (%) 2868/1074 32.5 18.9 0.0001
HOUSEHOLD INCOME < 20K (%) 2868/1074 15.2 38.6 0.0001
HOUSEHOLD WEALTH < 100K (%) 2880/1067 4.6 14.4 0.0001
ADMINISTRATIVE GRADE (%) 2939/1149 55.3 23.2 0.0001
MANUAL FATHER’S SOCIAL CLASS (%) 2789/1046 37.4 44.0 0.0002
MARRIED/ COHABITING 2940/1150 83.2 57.7 0.0001
HEIGHT (M) 2415/946 176.4 162.5 0.0001
LEG LENGTH (CM) 2172/883 83.9 76.7 0.0001
TRUNK LENGTH (CM) 2174/891 92.5 85.8 0.0001
BIRTHWEIGHT (KG) 1944/831 3.44 3.26 0.0001
WEIGHT (KG)  PHASE 5 2399/960 80.6 69.5 0.0001
WEIGHT (KG)  PHASE 7 2945/1158 81.1 69.4 0.0001
BMI (KG/M2) PHASE 5 2392/942 25.9 26.3 0.006
BMI (KG/M2) PHASE 5 2945/1157 26.4 26.7 0.02
WAIST PHASE 5 2127/884 93.4 84.0 0.0001
WAIST PHASE 7
.  ..........
2948/1157 95.4 87.4 0.0001
171Table 15 A ge adjusted cardiovascular risk factors and socioeconomic characteristics across groups of intima media thickness
MEN N QUARTILES OF INTIMA MEDIA THICKNESS P-VALUEf
(N) (750) (739) (770) (693)
INTIMA MEDIA THICKNESS 2952 <0.683 0.700-0.767 0.780-0.883 > 0.900
WHITE EUROPEAN (%) 2949 94.4 95.1 92.8 90.8 0.008
PREVALENT CHD (%) 2952 18.0 17.3 16.1 15.6 0.32
PREV. CHD EXCL. ROSE ANGINA (%) 2952 11.1 12.3 10.6 9.9 0.39
DIABETES (%) 2952 5.9 6.6 5.8 9.9 0.02
HYPERTENSION (%) 2952 29.4 33.9 36.8 44.5 0.0001
DYSLIPIDAEMIA (%) 2952 50.1 52.7 52.9 60.1 0.0003
NEVER SMOKER (%) 2943 53.9 55.5 54.1 43.9 0.0001
CURRENT SMOKER (%) 2943 5.6 5.6 8.0 7.3 0.05
HIGH ALCOHOL INTAKE (%) 2921 22.1 21.6 21.1 24.5 0.32
HEALTHY DIET (%) 2919 79.1 78.2 79.4 78.5 0.71
SUFFICIENT PHYSICAL ACTIVITY (%) 2918 56.9 58.5 61.8 61.5 0.09
HIGHER EDUCATION (%) 2720 57.8 62.5 62.4 64.7 0.02
PERSONAL INCOME > 25K (%) 2896 59.6 62.5 62.7 59.0 0.86
PERSONAL INCOME < 15 K (%) 2896 12.5 9.5 10.3 12.5 0.98
HOUSEHOLD INCOME > 50K (%) 2867 31.3 33.5 33.4 32.1 0.59
HOUSEHOLD INCOME < 20K (%) 2867 14.6 12.9 14.9 17.9 0.07
HOUSEHOLD WEALTH < 100K (%) 2879 3.5 4.7 4.3 6.6 0.02
ADMINISTRATIVE GRADE (%) 2938 55.2 55.8 54.2 54.6 0.47
MANUAL FATHER’S SOCIAL CLASS (%) 2788 34.7 36.0 39.8 40.6 0.03
MARRIED/ COHABITING (%) 2939 82.4 83.2 83.9 83.3 0.47
t Chi-squared test for trend
172Table 15 Continued
WOMEN N QUARTILES OF INTIMA MEDIA THICKNESS P-VALUEt
(N) (307) (254) (301) (296)
INTIMA MEDIA THICKNESS 1158 <0.683 0.685-0.750 0.767-0.845 > 0.850
WHITE EUROPEAN (%) 1157 89.4 88.6 85.1 78.4 0.0001
PREVALENT CHD (%) 1158 17.1 19.0 20.9 23.1 0.04
PREV. CHD EXCL. ROSE ANGINA (%) 1158 8.4 7.5 10.8 11.7 0.06
DIABETES (%) 1158 7.9 6.0 6.8 6.5 0.62
HYPERTENSION (%) 1158 25.2 37.1 40.3 51.2 0.0001
DYSLJPIDAEMIA (%) 1158 28.4 32.2 38.6 37.0 0.02
NEVER SMOKER (%) 1154 59.6 66.1 61.0 62.1 0.92
CURRENT SMOKER (%) 1154 8.5 9.5 8.7 9.0 0.68
HIGH ALCOHOL INTAKE (%) 1137 15.8 11.3 11.6 12.7 0.34
HEALTHY DIET (%) 1126 81.5 84.6 78.1 81.5 0.54
SUFFICIENT PHYSICAL ACTIVITY (%) 1137 54.2 42.1 42.8 40.1 0.002
HIGHER EDUCATION (%) 1022 43.9 45.5 43.8 46.1 0.77
PERSONAL INCOME > 25K (%) 1109 30.9 29.2 33.1 25.8 0.35
PERSONAL INCOME < 15 K (%) 1109 40.2 42.9 39.7 42.4 0.59
HOUSEHOLD INCOME > 50K (%) 1073 20.7 21.2 16.2 17.7 0.25
HOUSEHOLD INCOME < 20K (%) 1073 34.5 43.0 37.8 41.9 0.25
HOUSEHOLD WEALTH < 100K (%) 1066 16.4 15.6 14.1 14.2 0.54
ADMINISTRATIVE GRADE (%) 1148 26.2 22.0 25.8 17.2 0.05
FATHER’S SOCIAL CLASS MI (%) 1045 44.0 42.7 46.8 42.6 0.99
MARRIED/ COHABITING (%) 1149 53.6 59.8 53.6 61.9 0.09
f Chi-squared test for trend
173Table 16 Age adjusted cardiovascular risk factors and socioeconomic characteristics across groups of the beta stiffness index
MEN N QUARTILES OF BETA STIFFNESS INDEX P-VALUEf
(N) (732) (732) (733) (732)
BETA STIFFNESS INDEX 2929 <8.93 8.93-10.67 10.68-12.96 > 12.93
WHITE EUROPEAN (%) 2926 97.2 94.4 94.5 88.0 0.0001
PREVALENT CHD (%) 2929 16.1 16.1 17.0 16.3 0.64
PREV. CHD EXCL. ROSE ANGINA (%) 2929 11.8 10.2 10.9 10.4 0.59
DIABETES (%) 2929 5.5 6.0 7.1 8.4 0.01
HYPERTENSION (%) 2929 32.1 33.6 38.7 37.7 0.003
DYSLIPIDAEMIA (%) 2929 48.3 50.4 54.3 57.9 0.0001
NEVER SMOKER (%) 2920 54.8 52.9 51.0 50.1 0.18
CURRENT SMOKER (%) 2920 6.1 6.0 4.8 9.3 0.32
HIGH ALCOHOL INTAKE (%) 2898 22.1 24.0 21.3 18.1 0.02
HEALTHY DIET (%) 2896 79.7 79.0 82.3 76.1 0.37
SUFFICIENT PHYSICAL ACTIVITY (%) 2895 60.0 61.7 61.0 55.8 0.11
HIGHER EDUCATION (%) 2698 61.2 62.3 62.3 60.3 0.73
PERSONAL INCOME > 25K (%) 2874 64.7 63.4 61.5 55.7 0.001
PERSONAL INCOME < 15 K (%) 2874 10.3 9.8 9.8 14.3 0.04
HOUSEHOLD INCOME > 50K (%) 2845 33.4 33.5 33.2 29.5 0.27
HOUSEHOLD INCOME < 20K (%) 2845 12.7 13.6 14.3 18.9 0.007
HOUSEHOLD WEALTH < 100K (%) 2857 3.6 3.9 4.5 5.8 0.04
ADMINISTRATIVE GRADE (%) 2915 60.7 55.2 57.0 49.9 0.002
MANUAL FATHER’S SOCIAL CLASS (%) 2766 36.8 39.6 38.1 35.1 0.50
MARRIED/ COHABITING (%) 2916 83.3 84.7 85.4 79.7 0.48
t Chi-squared test for trend
174Table 16 Continued
WOMEN N QUARTILES OF BETA STIFFNESS INDEX P-VALUEf
(N) (285) (285) (285) (285)
BETA STIFFNESS INDEX 1140 <8.31 8.31-10.07 10.08-12.58 > 12.58
WHITE EUROPEAN (%) 1139 86.3 87.1 87.7 79.8 0.03
PREVALENT CHD (%) 1140 22.2 22.2 20.2 19.4 0.49
PREV. CHD EXCL. ROSE ANGINA (%) 1140 9.0 10.1 10.9 9.5 0.68
DIABETES (%) 1140 6.4 4.9 7.4 7.9 0.24
HYPERTENSION (%) 1140 28.5 38.0 42.5 43.2 0.0002
DYSUPIDAEMIA (%) 1140 35.7 36.0 36.4 29.1 0.22
NEVER SMOKER (%) 1136 59.4 64.4 62.7 64.6 0.10
CURRENT SMOKER (%) 1136 11.6 8.7 6.3 7.7 0.04
HIGH ALCOHOL INTAKE (%) 1119 11.0 11.7 14.0 10.9 0.68
HEALTHY DIET (%) 1108 82.4 81.0 85.4 74.0 0.14
SUFFICIENT PHYSICAL ACTIVITY (%) 1120 39.3 49.1 47.2 44.2 0.65
HIGHER EDUCATION (%) 1008 43.2 45.7 41.6 45.8 0.96
PERSONAL INCOME > 25K (%) 1092 30.5 28.9 32.2 26.4 0.74
PERSONAL INCOME < 15 K (%) 1092 40.8 42.0 39.9 43.8 0.75
HOUSEHOLD INCOME > 50K (%) 1056 21.2 18.9 17.6 15.5 0.10
HOUSEHOLD INCOME < 20K (%) 1056 41.4 36.9 37.0 41.6 0.76
HOUSEHOLD WEALTH < 100K (%) 1048 10.3 17.9 12.3 17.6 0.71
ADMINISTRATIVE GRADE (%) 1130 22.6 24.3 ,  24.9 19.0 0.62
FATHER’S SOCIAL CLASS I/II (%) 1027 40.7 41.0 49.0 42.8 0.60
MARRIED/ COHABITING (%) 1131 58.9 63.0 57.9 53.7 0.40
t Chi-squared test for trend
175Table 17 Age adjusted cardiovascular risk factors and socioeconomic characteristics across groups of distensibility
MEN N QUARTILES OF DISTENSIBILITY COEFFICIENT P-VALUEf
(N) (732) (732) (733) (732)
DISTENSIBILITY COEFFICIENT 2929 <11.45 11.45-14.08 14.08-17.20 > 17.21
WHITE EUROPEAN (%) 2926 89.8 93.9 93.7 96.7 0.0001
PREVALENT CHD (%) 2929 16.5 16.7 17.1 15.8 0.76
PREV. CHD EXCL. ROSE ANGINA (%) 2929 11.1 10.3 10.7 11.9 0.69
DIABETES (%) 2929 9.3 7.8 5.9 4.2 0.0001
HYPERTENSION (%) 2929 45.7 41.6 30.9  . 25.3 0.0001
DYSLIPIDAEMIA (%) 2929 58.8 58.3 48.8 47.4 0.0001
NEVER SMOKER (%) 2920 50.8 50.1 53.5 55.5 0.05
CURRENT SMOKER (%) 2920 8.6 6.0 5.7 5.8 0.25
HIGH ALCOHOL INTAKE (%) 2898 19.6 21.9 23.7 20.3 0.60
HEALTHY DIET (%) 2896 74.9 79.8 82.2 79.5 0.14
SUFFICIENT PHYSICAL ACTIVITY (%) 2895 56.8 60.2 60.9 60.4 0.18
HIGHER EDUCATION (%) 2698 61.1 59.8 64.3 61.4 0.27
PERSONAL INCOME > 25K (% ) 2874 54.6 61.6 63.7 64.2 0.0005
PERSONAL INCOME < 15 K (%) 2874 14.8 8.6 11.1 9.9 0.06
HOUSEHOLD INCOME > 50K (%) 2845 27.4 32.6 34.7 33.9 0.02
HOUSEHOLD INCOME < 20K (% ) 2845 19.5 13.0 15.1 12.1 0.008
HOUSEHOLD WEALTH < 100K (%) 2857 6.0 5.6 3.0 3.4 0.004
ADMINISTRATIVE GRADE (% ) 2915 50.2 55.9 .  56.3 60.8 0.0008
MANUAL FATHER’S SOCIAL CLASS (%) 2766 35.5 38.7 37.7 37.2 0.65
MARRIED/ COHABITING (%) 2916 80.6 84.3 85.6 83.6 0.38
f Chi-squared test for trend
176Table 17 Continued
WOMEN N QUARTILES OF DISTENSIBILITY COEFFICIENT P-VALUEf
(N) (285) (285) (285) (285)
DISTENSIBILITY COEFFICIENT 1140 < 12.14 12.15-15.51 15.53-19.23 > 19.24
WHITE EUROPEAN (%) 1139 80.8 84.7 89.0 86.9 0.008
PREVALENT CHD (%) 1140 20.7 21.9 19.0 22.1 0.62
PREV. CHD EXCL. ROSE ANGINA (%) 1140 10.3 11.2 8.9 8.3 0.17
DIABETES (%) 1140 8.1 7.2 4.6 7.0 018
HYPERTENSION (%) 1140 53.3 46.6 31.1 19.2 0.0001
DYSUPIDAEMIA (%) 1140 30.2 38.4 31.1 35.1 0.73
NEVER SMOKER (%) 1136 61.7 68.9 61.7 58.5 0.22
CURRENT SMOKER (%) 1136 9.1 4.8 8.9 11.2 0.12
HIGH ALCOHOL INTAKE (%) 1119 13.9 11.6 14.4 10.2 0.35
HEALTHY DIET (%) 1108 77.5 83.9 82.7 81.5 0.50
SUFFICIENT PHYSICAL ACTIVITY (%) 1120 45.6 41.8 49.8 44.6 0.56
HIGHER EDUCATION (%) 1008 43.7 43.9 45.7 43.7 0.52
PERSONAL INCOME > 25K (%) 1092 28.3 28.4 32.7 30.2 0.37
PERSONAL INCOME < 15 K (%) 1092 41.7 46.0 37.7 39.6 0.19
HOUSEHOLD INCOME > 50K (%) 1056 16.1 17.0 18.3 22.0 0.13
HOUSEHOLD INCOME < 20K (%) 1056 43.5 38.9 33.2 40.4 0.09
HOUSEHOLD WEALTH < 100K (%) 1048 15.7 14.3 15.8 12.4 0.88
ADMINISTRATIVE GRADE (%) 1130 17.6 22.9 •25.7 24.1 0.07
FATHER’S SOCIAL CLASS I/II (%) 1027 44.9 47.6 42.7 37.2 0.22
MARRIED/ COHABITING (%) 1131 54.3 56.8 59.5 62.3 0.38
tChi-squared test for trend
111Table  18  Percent  differences  in  arterial  measures  according  to  standardized
ANTHROPOM ETRIC MEASURES IN THE WHITEHALL II STUDY
N % DIFFERENCE 
(P-VALUE)
%  DIFFERENCE 
(P-VALUE)
%  DIFFERENCE 
(P-VALUE)
MODEL If MODEL 2% MODEL 3§
MEN
INTIMA MEDIA THICKNESS
BIRTHWEIGHT 1932 0.13 (P=0.77) -0.32 (P=0.46) -0.11 (P=0.80)
HEIGHT 2401 0.03 (P=0.94) -1.03 (P=0.01) -0.23 (P=0.60)
LEG LENGTH 2161 -0.35 (P=0.40) -1.09 (P=0.01) -0.69 (P=0.11)
TRUNK LENGTH 2163 0.51 (P=0.22) -0.53 (P=0.24) 0.39 (P=0.42)
BETA STIFFNESS INDEX
BIRTHWEIGHT 1920 0.48 (P=0.48) -0.02 (P=0.97) 0.19 (P=0.78)
HEIGHT 2381 -1.44 (P=0.02) -3.20 (P=0.0001) -2.47 (P=0.0002)
LEG LENGTH 2141 -0.76 (P=0.22) -1.77 (P=0.006) -1.57 (P=0.02)
TRUNK LENGTH 2143 -1.78 (P=0.005) -3.54 (P=0.0001) -2.43 (P=0.0008)
DISTENSIBILITY
BIRTHWEIGHT 1920 0.10 (P=0.88) 1.03 (0.12) 0.52 (P=0.43)
HEIGHT 2381 1.81 (P=0.004) 4.90 (P=0.0001) 3.67 (P=0.0001)
LEG LENGTH 2141 1.18 (P=0.07) 2.99 (P=0.0001) 2.39 (P=0.0004)
TRUNK LENGTH 2143 1.84 (P=0.006) 4.84 (P=0.0001) 3.37 (P=0.0001)
WOMEN
INTIMA MEDIA THICKNESS
BIRTHWEIGHT 824 -0.10 (P=0.86) -0.38 (P=0.51) -0.06 (P=0.92)
HEIGHT 941 0.36 (P=0.51) -0.03 (P=0.96) 0.86 (P=0.14)
LEG LENGTH 878 0.27 (P=0.64) -0.05 (P=0.93) 0.20 (P=0.73)
TRUNK LENGTH 886 0.37 (P=0.51) 0.01 (P=0.99) 1.61 (P=0.01)
BETA STIFFNESS INDEX
BIRTHWEIGHT 811 2.74 (P=0.007) 2.74 (P=0.008) 3.35 (P=0.001)
HEIGHT 926 -0.27 (P=0.78) -0.34 (P=0.73) 0.42 (P=0.69)
LEG LENGTH 864 0.94 (P=0.35) 1.03 (P=0.32) 0.89 (P=0.39)
TRUNK LENGTH 872 -0.99 (P=0.32) -1.06 (P=0.30) 0.64 (P=0.58)
DISTENSIBILITY
BIRTHWEIGHT 811 -2.41 (P=0.03) -2.00 (P=0.08) -3.19 (P=0.004)
HEIGHT 926 1.29 (P=0.23) 2.15 (P=0.06) 0.71 (P=0.53)
LEG LENGTH 864 -0.39 (P=0.73) 0.06 (P=0.96 1.14 (P=0.87)
TRUNK LENGTH 872 2.36 (P=0.04) 3.09 (P=0.008) 0.60 (P=0.64)
t Model 1: Adjusted for age 
t Model 2: Adjusted for age and concurrent weight
§ Model 3: Adjusted for age, weight, ethnic group, prevalent CHD, diabetes, hypertension, dyslipidaemia and smoking
178Table  19  Percent  differences  in  stiffness  and  distensibility  in  men  according  to
STANDARDIZED ANTHROPOM ETRIC MEASURES ADJUSTING FOR SOCIOECONOM IC MEASURES
ANTHROPOMETRY %  DIFFERENCE (P-VALUE)
STIFFNESS DISTENSIBILITY
HEIGHT
MODEL It (AS MODEL 3 IN TABLE 18) -2.47 (P=0.0002) 3.67 (P=0.0001)
MODEL 1 (RESTRICTED SAMPLE*) -2.52 (P=0.0004) 3.54 (P=0.0001)
MODEL 1 + HOUSEHOLD INCOME -2.47 (P=0.0006) 3.46 (P=0.0001)
MODEL 1 + PERSONAL INCOME -2.51 (P=0.0005) 3.51 (P=0.0001)
MODEL 1 + OCCUPATIONAL GRADE -2.56 (P=0.0004) 3.57 (P=0.0001)
MODEL 1 + EDUCATION -2.52 (P=0.0004) 3.54 (P=0.0001)
MODEL 1 + FATHER’S SOCIAL CLASS -2.59 (P=0.0003) 3.59 (P=0.0001)
MODEL 1  + ALL VARIABLES MENTIONED ABOVE -2.57 (P=0.0004) 3.57 (P=0.0001)
LEG LENGTH
MODEL It (AS MODEL 3 IN TABLE 18) -1.57 (P=0.02) 2.39 (P=0.0004)
MODEL 1 (RESTRICTED SAMPLE*) -1.73 (P=0.01) 2.45 (P=0.0008)
MODEL 1 + HOUSEHOLD INCOME -1.70 (P=0.02) 2.41 (P=0.0009)
MODEL 1 + PERSONAL INCOME -1.73 (P=0.01) 2.44 (P=0.0008)
MODEL 1 + OCCUPATIONAL GRADE -1.74 (P=0.01) 2.44 (P=0.0008)
MODEL 1 + EDUCATION -1.73 (P=0.01) 2.44 (P=0.0008)
MODEL 1 + FATHER’S SOCIAL CLASS -1.78 (P=0.01) 2.48 (P=0.0007)
MODEL 1 + ALL VARIABLES MENTIONED ABOVE -1.78 (P=0.01) 2.47 (P=0.0008)
TRUNK LENGTH
MODEL 1* (AS MODEL 3 IN TABLE 17) -2.43 (P=0.0008) 3.37 (P=0.0001)
MODEL 1 (RESTRICTED SAMPLE*) -2.39 (P=0.002) 3.04 (P=0.0002)
MODEL 1  + HOUSEHOLD INCOME -2.30 (P=0.003) 2.94 (P=0.0003)
MODEL 1 + PERSONAL INCOME -2.36 (P=0.002) 3.00 (P=0.0002)
MODEL 1  + OCCUPATIONAL GRADE -2.41 (P=0.002) 3.04 (P=0.0002)
MODEL 1  + EDUCATION -2.36 (P=0.002) 3.03 (P=0.0002)
MODEL 1 + FATHER’S SOCIAL CLASS -2.44 (P=0.002) 3.08 (P=0.0001)
MODEL 1 + ALL VARIABLES MENTIONED ABOVE -2.38 (P=0.002) 3.00 (P=0.0002)
* Includes 2099 men with complete information on all covariates
t Model 1: Adjusted for age, weight, ethnic group, prevalent CHD, diabetes, hypertension, dyslipidaemia and smoking
179Table 20 Characteristics of women in the Filipina Study
N
MEANS/ PROPORTIONS 
(95 % CONFIDENCE INTERVALS)
AGE (YEARS) 389 58.7 (57.8; 59.7)
AGE AT IMMIGRATION >45 YEARS (%) 382 48.4 (43.4; 53.5)
YEARS SINCE IMMIGRATION (YEARS) 382 16.6(15.5; 17.7)
HEIGHT (CM) 389 153.2 (152.6; 153.8)
LEG LENGTH (CM) 389 70.7 (70.4; 71.1)
SITTING HEIGHT (CM) 389 82.4 (82.1; 82.8)
WEIGHT (KG) 389 59.5 (58.5; 60.5)
BODY MASS INDEX (KG/M2) 389 25.3 (24.9; 25.6)
OBESITY (%) 389 9.8 (6.8; 12.7)
WAIST CIRCUMFERENCE (CM) 389 80.8 (79.8; 81.7)
WAIST HIP RATIO 389 0.83 (0.83; 0.84)
DIABETES (%) 389 31.4 (26.7; 36.0)
CORONARY HEART DISEASE (%) 389 22.4 (18.2; 26.5)
ALCOHOL CONSUMPTION >3 TIMES/WEEK (%) 389 1.0 (0.0; 2.0)
PHYSICAL ACTIVITY > 3 TIMES/WEEK (%) 387 65.9 (61.2; 70.6)
CURRENT SMOKER (%) 387 11.4 (8.2; 14.5)
DYSLIPIDAEMIA (%) 389 53.2 (48.3; 58.2)
FAMILY HISTORY OF DIABETES (% ) 389 36.0 (31.2; 40.8)
FAMILY HISTORY OF HEART DISEASE (%) 370 23.5 (19.2; 27.8)
CHILDHOOD FAMILY INCOME 380
POOR 20.7 (16.7; 24.9)
AVERAGE 70.3 (65.7; 74.9)
WELL-OFF 9.0 (6.1; 11.8)
EDUCATION 386
< 12 YEARS 31.1 (26.5; 35.7)
13-15 YEARS 17.4(13.6; 21.1)
> 16 YEARS 51.6 (46.6; 56.5)
ADULT HOUSEHOLD INCOME 330
< 15K 34.2 (28.5; 38.7)
15-44.9K 32.1 (27.1; 37.2)
> 45K 33.6 (29.1; 39.4)
ECONOMIC SCORE 323
0 7.1 (4.3; 9.9)
1 32.8 (27.7; 37.9)
2 29.1 (24.2; 34.1)
3 25.1 (20.4; 29.8)
4 5.9 (3.3; 8.5)
BIRTH YEAR 383
BEFORE 1938 50.1 (45.1; 55.1)
1938-1940 12.3 (9.0; 15.6)
1941-1947 18.8 (14.9; 22.7)
AFTER 1947 18.8 (14.9; 22.7)
180T a b l e 21  A g e a d ju s t e d m e a n s  o f a n t h r o po m e t r ic m e a su r e s  a c c o r d in g   to  so c io ec o n o m ic
POSITION IN CHILD AND ADULTHOOD IN FILIPINO WOMEN
MEANS (95% CONFIDENCE INTERVALS)
HEIGHT (M) LEG LENGTH (CM) TRUNK LENGTH (CM)
BIRTH YEAR (N=382)
BEFORE 1938 1.54(1.53; 1.55) 70.84 (70.01; 71.68) 83.08 (82.39; 83.77)
1938-1940 1.55(1.54; 1.57) 72.12(71.09; 73.15) 83.05 (82.19; 83.90)
1941-1947 1.52(1.51; 1.54) 70.16 (69.17; 71.16) 82.26(81.44; 83.08)
AFTER 1947 1.51 (1.48; 1.53) 70.05 (68.63; 71.48) 80.46 (79.28; 81.64)
P trend 0.02 0.24 0.005
CHILDHOOD INCOME (N=373)
POOR 1.52(1.51; 1.53) 70.25 (69.45; 71.05) 81.60 (80.94; 82.27)
AVERAGE 1.53(1.53; 1.54) 70.73 (70.30; 71.16) 82.65 (82.29; 83.01)
WELL-OFF 1.55(1.53; 1.57) 71.77 (70.55; 72.99) 82.87 (81.86; 83.88)
P trend 0.008 0.05 0.001
EDUCATION (N=380)
< 12 YEARS 1.52(1.51; 1.53) 70.31 (69.63; 70.98) 81.90 (81.34; 82.46)
13-15 YEARS 1.53(1.52; 1.54) 70.67 (79.80; 71.54) 82.30 (81.58; 83.02)
> 16 YEARS 1.54(1.53; 1.55) 71.00 (70.47; 71.50) 82.84 (82.42; 83.27)
P trend 0.02 0.12 0.009
ADULT INCOME (N=324)
< 15K 1.52(1.51; 1.53) 70.17 (69.47; 70.87) 82.04(81.46; 82.63)
15-44.9K 1.54 (1.53; 1.56) 71.29 (70.60;71.98) 83.17 (82.60; 83.74)
> 45K 1.54(1.53; 1.55) 71.28 (70.57;71.99) 82.91 (82.31; 83.50)
P trend 0.02 0.04 0.05
ECONOMIC SCORE (N=317)
0 1.52(1.49; 1.54) 69.76 (68.26;71.26) 82.00 (80.76; 83.23)
1 1.52(1.51; 1.53) 70.26 (69.54; 70.98) 81.97 (81.38; 82.56)
2 1.55 (1.54; 1.56) 71.37 (70.64; 72.11) 83.49 (82.88; 84.09)
3 1.54(1.53; 1.56) 71.38 (70.55; 72.21) 82.87 (82.19; 83.55)
4 1.55(1.53; 1.58) 71.73 (70.09; 73.38) 83.37 (82.01;84.73)
P trend 0.003 0.009 0.02
181Table 21 Continued
MEANS (95% CONFIDENCE INTERVALS)
BMI (KG/M2) WAIST (CM)
BIRTH YEAR (N=382)
BEFORE 1938 25.7 (24.9; 26.6) 81.9 (79.6; 84.1)
1938-1940 25.7 (24.7; 26.7) 83.0 (80.2; 85.7)
1941-1947 24.9 (23.9; 25.9) 79.6 (76.9; 82.2)
AFTER 1947 24.2 (22.8; 25.7) 77.7 (73.9; 81.5)
P trend 0.13 0.10
CHILDHOOD INCOME (N=373)
POOR 25.5 (24.7; 26.3) 81.5 (79.3; 83.6)
AVERAGE 25.3 (24.8; 25.7) 80.5 (79.3; 81.6)
WELL-OFF 25.0 (23.8; 26.2) 81.2 (77.9; 84.4)
P trend 0.48 0.68
EDUCATION (N=380)
< 12 YEARS 26.0 (25.3; 26.6) 83.6 (81.8; 85.4)
13-15 YEARS 25.4 (24.6; 26.3) 79.8 (77.6; 82.1)
> 16 YEARS 24.8 (24.3; 25.3) 79.3 (78.0; 80.7)
P trend 0.008 0.0004
ADULT INCOME (N=324)
< 15K 24.9 (24.2; 25.5) 80.1 (78.3; 81.9)
15-44.9K 25.9 (25.3; 26.6) 82.3 (80.5; 84.0)
> 45K 25.0 (24.3; 25.7) 78.9 (77.0; 80.7)
P trend 0.75 0.39
ECONOMIC SCORE (N=317)
0 24.95 (23.5; 26.4) 81.6 (76.7; 84.5)
1 25.00 (24.3; 25.7) 80.0 (78.2; 81.9)
2 25.69 (25.0; 26.4) 81.6 (79.7; 83.5)
3 25.22 (24.4; 26.0) 79.4 (77.3; 81.6)
4 24.86 (23.3; 26.4) 80.0 (75.7; 84.3)
P trend 0.76 0.73
182Table 22 Odds ratios for diabetes in Filipino women (minimum n=304)
ODDS RATIO (95% CONFIDENCE INTERVALS)
RISK FACTOR AGE ADJUSTEDt FULLY ADJUSTED*
HEIGHT
1 SHORTEST (<148.6 CM) 1 1
2 (148.6-152.4 CM) 1.21 (0.64; 2.27) 1.04 (0.51; 2.12)
3 (152.4-157.5 CM) 1.13 (0.58; 2.20) 0.59 (0.26; 1.30)
4 TALLEST (>157.5 CM) 1.90 (0.99; 3.66) 1.16(0.54; 2.48)
P trend 0.07 0.96
LEG LENGTH
1 SHORTEST (<68.6 CM) 1 1
2 (68.6-70.5 CM) 0.94 (0.49; 1.80) .0.76 (0.37; 1.58)
3 (70.5-73.0 CM) 1.12(0.59; 2.11) 0.77 (0.36; 1.63)
4 TALLEST (>73.0 CM) 1.32 (0.70; 2.49) 0.73 (0.35; 1.55)
P trend 0.32 0.45
TRUNK LENGTH
1 SHORTEST (<80.0 CM) 1 1
2 (80.0-82.6 CM) 0.80 (0.41; 1.54) 0.67 (0.31; 1.45)
3 (82.6-84.5 CM) 1.08 (0.58; 2.00) 0.64 (0.31; 1.33)
4 TALLEST (>84.5 CM) 1.67 (0.86; 3.27) 1.09 (0.50; 2.35)
P trend 0.13 0.94
CHILDHOOD FAMILY INCOME
POOR 1 1
AVERAGE 0.48 (0.28; 0.83) 0.48 (0.25; 0.90)
WELL-OFF 0.34 (0.13; 0.90) 0.26 (0.08; 0.82)
P trend 0.005 0.007
EDUCATION
< 12 YEARS 1 1
13-15 YEARS 0.78 (0.40; 1.51) 0.72 (0.32; 1.63)
> 16 YEARS 0.41 (0.24; 0.72) 0.44 (0.23; 0.84)
P trend 0.001 0.01
ADULT HOUSEHOLD INCOME
< 15K 1 1
15-44.9K 0.58(0.31; 1.08) 0.34 (0.16; 0.70)
> 45K 0.24 (0.11; 0.55) 0.16 (0.06; 0.42)
P trend 0.0008 0.0002
ECONOMIC SCORE
0 1 1
1 0.73 (0.29; 1.85) 0.55 (0.18; 1.68)
2 0.40(0.15; 1.09) 0.19(0.06; 0.62)
3 0.22 (0.07; 0.68) 0.11 (0.03; 0.42)
4 0.14 (0.02; 0.79) 0.07 (0.01; 0.51)
P trend 0.0006 <0.0001
t Adjusted for current age and age at immigration
# Additionally includes BMI, waist, family history of diabetes, smoking, exercise, employment status, household size
183Table 23 Odds ratios for coronary heart disease in Filipino women (minimum n=304)
ODDS RATIO (95% CONFIDENCE INTERVALS)
RISK FACTOR AGE ADJUSTED1 FULLY ADJUSTED**
HEIGHT
1 SHORTEST (<148.6 CM) 1 1
2 (148.6-152.4 CM) 0.89 (0.45; 1.76) 0.77 (0.36; 1.64)
3 (152.4-157.5 CM) 0.91 (0.45; 1.84) 0.82 (0.38; 1.76)
4 TALLEST (>157.5 CM) 0.67 (0.32; 1.40) 0.45 (0.19; 1.07)
P trend 0.33 0.10
LEG LENGTH
1 SHORTEST (<68.6 CM) 1 1
2 (68.6-70.5 CM) 0.60 (0.31; 1.19) 0.52(0.24; 1.12)
3 (70.5-73.0 CM) 0.53(0.26; 1.05) 0.52(0.24; 1.11)
4 TALLEST (>73.0 CM) 0.44 (0.22; 0.91) 0.32 (0.14; 0.74)
P trend 0.02 0.01
TRUNK LENGTH
1 SHORTEST (<80.0 CM) 1 1
2 (80.0-82.6 CM) 0.60 (0.28; 1.29) 0.56 (0.25; 1.27)
3 (82.6-84.5 CM) 1.17 (0.61; 2.24) 0.76 (0.36; 1.62)
4 TALLEST (>84.5 CM) 0.80 (0.38; 1.69) 0.48 (0.20; 1.13)
P trend 0.95 0.16
CHILDHOOD FAMILY INCOME
POOR 1 1
AVERAGE 0.72 (0.40; 1.32) 0.71 (0.37; 1.37)
WELL-OFF 0.47 (0.16; 1.40) 0.45 (0.15; 1.40)
P trend 0.14 0.15
EDUCATION
<12 YEARS 1 1
13-15 YEARS 1.21 (0.55; 2.66) 1.40 (0.58; 3.35)
> 16 YEARS 1.30 (0.69; 2.46) 1.47 (0.71; 3.06)
P trend 0.43 0.32
ADULT HOUSEHOLD INCOME
< 15K 1 1
15-44.9K 0.69 (0.33; 1.43) 0.61 (0.27; 1.38)
> 45K 0.64(0.27; 1.52) 0.78 (0.30; 2.01)
P trend 0.32 0.61
ECONOMIC SCORE
0 1 1
1 0.55 (0.20; 1.53) 0.43 (0.14; 1.38)
2 0.46 (0.15; 1.37) 0.38 (0.11; 1.27)
3 0.39 (0.12; 1.30) 0.41 (0.11; 1.54)
4 0.19(0.03; 1.15) 0.14 (0.02; 0.96)
P trend 0.07 0.13
f Adjusted for current age and age at immigration
## Additionally includes BMI, waist, family history, menopausal status, HRT, hypertension, dyslipidaemia, smoking,exercise
184T a b l e  2 4   O d d s  r a t io s  fo r  d ia b e t e s  a n d   c o r o n a r y  h e a r t  d ise a se  fr o m   m o d e l s  in c l u d in g
ALL RISK FACTORS SIMULTANEOUSLY
ODDS RATIO 
(95% CONFIDENCE INTERVALS)
P-VALUE
DIABETES (N=305)
AGE (YEARS) 1.04(0.99; 1.09) 0.07
AGE AT IMMIGRATION (YEARS) 0.99 (0.96; 1.03) 0.74
WAIST CIRCUMFERENCE (CM) 1.07(1.03; 1.10) <0.0001
CHILDHOOD FAMILY INCOME (PER CATEGORY!) 0.66 (0.36; 1.20) 0.17
EDUCATION (PER CATEGORY!) 0.72 (0.50; 1.04) 0.08
ADULT HOUSEHOLD INCOME (PER CATEGORY!) 0.40 (0.24; 0.66) 0.0003
FAMILY HISTORY OF DIABETES (Y/N) 5.14 (2.72; 9.70) <0.0001
CURRENT EMPLOYMENT STATUS (Y/N) 1.34 (0.72; 2.51) 0.36
NUMBER OF HOUSEHOLD MEMBERS 0.99(0.82; 1.19) 0.91
CORONARY HEART DISEASE (N=380)
AGE (YEARS) 1.02 (0.99; 1.07) 0.22
AGE AT IMMIGRATION (YEARS) 0.98 (0.96; 1.01) 0.17
WAIST CIRCUMFERENCE (CM) 1.03 (1.01; 1.06) 0.01
HYPERTENSION (Y/N) 1.74 (0.98; 3.08) 0.06
DYSLIPIDAEMIA (Y/N) 1.62 (0.51; 5.18) 0.42
REGULAR EXERCISE (Y/N) 1.67 (0.94; 2.97) 0.08
LEG LENGTH (PER CATEGORY!) 0.72 (0.56; 0.91) 0.006
185Table 25 Characteristics of 564 girls and 569 boys participating in Project V iva 03-06
VARIABLE  N  MEANS (SD)/PROPORTIONS  P-VALUE
GIRLS/ BOYS  GIRLS  BOYS
MATERNAL AND FAMILY CHARACTERISTICS 
MATERNAL AGE AT ENROLMENT (YEARS) 
MATERNAL HEIGHT (CM)
PATERNAL HEIGHT (CM)
MATERNAL PRE-PREGNANCY BMI (KG/M2) 
GESTATIONAL WEIGHT GAIN (KG)
SMOKING DURING PREGNANCY (%)
MULTIPARITY (%)
MATERNAL RACE/ ETHNICITY (% WHITE)
MOTHER MARRIED/ COHABITATING (%)
MOTHER’S EDUCATION > COLLEGE GRADUATE (%) 
HOUSEHOLD INCOME > 70,000 DOLLARS (%) 
MATERNAL HYPERTENSION (%)
PREGNANCY INDUCED HYPERTENSION (%)
CHILDHOOD CHARACTERISTICS DURING INFANCY 
GESTATIONAL AGE (WEEKS)
BIRTHWEIGHT (KG)
BIRTHLENGTH (CM)
BIRTHWEIGHT FOR GESTATIONAL AGE (Z-VALUE) 
BREASTFEEDING DURATION AT 1 YEAR (MONTHS)
CHILDHOOD CHARACTERISTICS AGE 3 YEARS 
AGE (MONTHS)
SYSTOLIC BLOOD PRESSURE (MMHG)
DIASTOLIC BLOOD PRESSURE (MMHG)
MEAN ARTERIAL PRESSURE (MMHG)
PULSE PRESSURE (MMHG)
WEIGHT (KG)
BMI (KG/M2)
BMI Z-SCORE 
HEIGHT (CM)
LEG LENGTH (CM)
LEG LENGTH (% OF HEIGHT)
TRUNK LENGTH (CM)
DIFFERENCE IN Z-SCORES (LEG AND TRUNK)
564/ 569 32.8 (4.8) 32.3 (5.2) 0.05
564/569 164.7 (6.9) 165.4 (7.0) 0.13
553/558 179.6 (7.6) 179.1 (7.8) 0.29
562/567 24.5 (5.1) 24.6 (5.1) 0.68
556/ 561 15.2 (5.4) 16.2 (5.3) 0.001
564/569 8.5 12.1 0.05
564/569 53.9 52.7 0.69
564/ 569 73.8 71.9 0.48
563/569 93.1 92.6 0.77
564/ 566 73.9 70.1 0.16
528/517 68.9 65.8 0.27
552/554 1.6 1.4 0.80
552/554 8.7 9.9 0.48
564/ 569 39.7(1.4) 39.6(1.5) 0.41
564/568 3.46 (0.47) 3.58 (0.54) < 0.0001
342/ 328 49.6 (2.0) 50.2 (2.1) <0.0001
564/568 0.23 (0.92) 0.21 (0.98) 0.06
540/ 536 6.55 (4.5) 6.41 (4.6) 0.62
564/569 39.0 (3.5) 39.4 (4.3) 0.09
564/ 569 92.1 (11.6) 92.41 (9.6) 0.64
564/ 569 58.1 (8.4) 58.33 (7.8) 0.64
564/569 69.4 (8.9) 69.69 (7.7) 0.61
564/569 34.0 (7.8) 34.09 (7.3) 0.87
564/569 15.4(2.2) 16.12 (2.2) <0.0001
564/569 16.3(1.5) 16.69(1.5) < 0.0001
564/569 0.41 (0.99) 0.53(1.1) 0.06
564/569 96.86 (4.31) 98.13 (4.6) < 0.0001
564/569 41.57 (2.53) 42.04 (2.8) 0.003
564/569 42.95(1.44) 42.82(1.5) 0.16
564/ 569 55.19(2.57) 56.09 (2.6) < 0.0001
564/569 0(1.1) 0(1.1) 1.00
186T a b l e 26  M ea n d ifferen c e in a n th r o po m etr y  at  a g e 3  y e a r s  a c c o r d in g to e a r l y life fa c t o r s,  a d ju st e d for a g e,  sex  a n d ethnic
GROUP (REGRESSION COEFFICIENTS AND 95%  CONFIDENCE INTERVALS)
VARIABLE LEG LENGTH  (CM) TRUNK LENGTH (CM) % LEG LENGTH DIFFERENCE IN  Z- 
SCORES
MATERNAL AND FAMILY CHARACTERISTICS
MATERNAL AGE AT ENROLMENT (PER YEARS) -0.03 (-0.05; 0.001) 0.01 (-0.02; 0.04) -0.02 (-0.04; -0.003)* -0.01 (-0.03; -0.002)*
SMOKING DURING PREGNANCY 0.27 (-0.15; 0.69) 0.08 (-0.38; 0.55) 0.13 (-0.13; 0.40) 0.08 (-0.12; 0.27)
MATERNAL HEIGHT (PER CM) 0.10(0.08,0.12)$ 0.09 (0.07; 0.11)$ 0.02 (0.006; 0.03)t 0.002 (-0.007; 0.01)
PATERNAL HEIGHT (PER CM) 0.08 (0.06,0.09)1 0.08 (0.06; 0.10)$ 0.009 (-0.002; 0.02) -0.003 (-0.01; 0.005)
PRE-PREGNANCY BMI (PER KG/M2) 0.02 (-0.01; 0.05) 0.03 (0.003; 0.06)* -0.03 (-0.02; 0.01) -0.005 (-0.02; 0.007)
GESTATIONAL WEIGHT GAIN (PER KG) 0.01 (-0.01; 0.03) 0.02 (-0.003; 0.05) -0.003 (-0.02; 0.01) -0.005 (-0.02,0.006)
PRIMIGRAVIDA 0.06 (-0.20; 0.31) 0.21 (-0.07; 0.49) -0.07 (-0.23; 0.10) -0.06 (-0.18; 0.06)
MOTHER NOT MARRIED AND/ OR COHABHATING 0.03 (-0.49; 0.56) -0.25 (-0.83; 0.32) 0.15 (-0.18; 0.48) 0.11 (-0.14; 0.35)
MOTHER’S EDUCATION < COLLEGE GRADUATE 0.02 (-0.28; 0.32) 0.03 (-0.30; 0.36) 0.006 (-0.18; 0.19) -0.005 (-0.14; 0.13)
HOUSEHOLD INCOME < 70K (%) -0.09 (-0.39; 0.21) -0.12 (-0.45; 0.22) 0.003 (-0.19; 0.19) 0.008 (-0.13; 0.15)
NO MATERNAL HYPERTENSION -0.61 (-1.67; 0.44) -0.36 (-1.51; 0.80) -0.25 (-0.91; 0.41) -0.10 (-0.59; 0.39)
NO PREGNANCY INDUCED HYPERTENSION -0.14 (-0.58; 0.31) 0.19 (-0.30; 0.67) -0.17 (-0.45; 0.11) -0.12 (-0.33; 0.09)
CHILDHOOD CHARACTERISTICS DURING INFANCY
GESTATIONAL AGE (PER WEEK) 0.08 (-0.01; 0.17) -0.004 (-0.10; 0.10) 0.05 (-0.004; 0.11) 0.031 (-0.01:0.07)
BIRTHWEIGHT (PER KG) 0.96 (0.71; 1.21)$ 0.98 (0.70; 1.25)$ 0.13 (-0.03; 0.29) -0.017 (-0.14; 0.10)
BIRTHLENGTH (PER CM) 0.35 (0.28; 0.43)$ 0.35 (0.27; 0.44)$ 0.06 (0.005; 0.11)* -0.004 (-0.04; 0.03)
BIRTHWEIGHT FOR GEST. AGE (Z-VALUE) 0.53 (0.40; 0.66)$ 0.62 (0.48; 0.76)$ 0.04 (-0.05;0.12) -0.040 (-0.10; 0.02)
BREASTFEEDING DURATION (PER MONTH) -0.03 (-0.06; 0.001) -0.04 (-0.07; -0.01)* -0.0003 (-0.02; 0.02) 0.004 (-0.01;0.02)
CHILDHOOD CHARACTERISTICS AGE 3 YEARS
WEIGHT (KG) 0.51 (0.45; 0.56)$ 0.79 (0.74; 0.84)$ -0.05 (-0.09; -0.01)$ -0.11 (-0.14; -0.09)$
BMI (KG/M2) 0.02 (-0.07; 0.10) 0.43 (0.34; 0.52)$ -0.18 (-0.23;-0.13)$ -0.16 (-0.20; -0.12)$
HEIGHT (CM)
n .im liia  < ■ '' A  C•  4 *  m  f \  /VI >   4 >   •>   _ _ _ r  A AA1
0.47 (0.45; 0.49)$ 0.53 (0.51; 0.55)$ 0.04 (0.02; 0.06)$ -0.03 (-0.05; -0.02)$
* p-value < 0.5; $ p-value < 0.01; $ p-value < 0.001
187T a b l e 27 Re g r e ssio n coefficients (95% c o n fid en c e in t er v a l s) for asso c ia tio n s  be tw e en a n th r o po m etr y a n d b l o o d pr essu r e at
AGE 3 YEARS FROM SEPARATE MULTIVARIATE RANDOM EFFECTS REGRESSION MODELS (N=l 133)
ANTHROPOMETRY MODEL SBP DBP MAP PP
HEIGHT SIMPLE ADJUSTED MODEL* 
+ADJUSTMENT FOR WEIGHT 
FULLY ADJUSTED§
0.42 (0.28; 0.56)$ 
-0.06 (-0.26; 0.13) 
-0.03 (-0.22; 0.17)
0.16 (0.05; 0.26)$ 
0.01 (-0.14; 0.16) 
0.03 (-0.12; 0.18)
0.25(0.14,0.35)$ 
-0.02 (-0.17, 0.14) 
0.01 (-0.15,0.16)
0.27(0.16; 0.37)$ 
-0.06 (-0.21; 0.09) 
-0.05 (-0.20; 0.10)
WEIGHT SIMPLE ADJUSTED MODEL* 
+ADJUSTMENT FOR HEIGHT 
FULLY ADJUSTED§
1.18(0.92; 1.44)$ 
1.26(0.90; 1.63)$ 
1.32 (0.95; 1.69)$
0.40 (0.20; 0.60)$ 
0.39 (0.11; 0.68)$ 
0.43 (0.15; 0.72)$
0.67 (0.47,0.87) $ 
0.69 (0.40,0.98) $ 
0.74 (0.45,1.03) $
0.79 (0.59; 0.99)$ 
0.87 (0.60; 1.15)$ 
0.89 (0.60; 1.17)$
LEG LENGTH SIMPLE ADJUSTED MODEL* 
+AD  JU STMENT FOR HEIGHT 
+ADJUSTMENT FOR WEIGHT 
FULLY ADJUSTED§
0.32 (0.09; 0.55)$ 
-0.61 (-0.98; -0.24)$ 
-0.39 (-0.77; -0.02)* 
-0.35 (-0.74; 0.04)
0.13 (-0.05; 0.30) 
-0.21 (-0.50; 0.07) 
-0.15 (-0.43; 0.14) 
-0.21 (-0.51; 0.09)
0.19(0.01,0.37)* 
-0.35 (-0.64,0.06)* 
-0.23 (-0.52,0.06) 
-0.26 (-0.56, 0.05)
0.18 (0.01; 0.35)* 
-0.45 (-0.73;-0.17)$ 
-0.30 (-0.59; -0.02)* 
-0.19 (-0.49; -0.10)
TRUNK LENGTH SIMPLE ADJUSTED MODEL*
+ADJUSTMENT FOR HEIGHT 
+ADJUSTMENT FOR WEIGHT 
FULLY ADJUSTED§
0.74 (0.52; 0.96)$ 
0.61 (0.24; 0.98)$ 
0.39 (0.02; 0.77)* 
0.35 (-0.04; 0.74)
0.27 (0.11; 0.44)$ 
0.21 (-0.07; 0.50) 
0.15 (-0.14; 0.43) 
0.21 (-0.09; 0.51)
0.43 (0.26,0.60) $ 
0.35 (0.06, 0.64)* 
0.23 (-0.06,0.52) 
0.26 (-0.05,0.56)
0.50 (0.33; 0.66)$ 
0.45 (0.17; 0.73)$ 
0.30 (0.02; 0.59)* 
0.19 (-0.10; 0.49)
LEG LENGTH (%) SIMPLE ADJUSTED MODEL* 
+ADJUSTMENT FOR WEIGHT 
FULLY ADJUSTED§
-0.44 (-0.80, -0.07)* 
-0.40 (-0.75, -0.05)* 
-0.35 (-0.73,0.03)
-0.16 (-0.43,0.12) 
-0.14 (-0.42,0.13) 
-0.22 (-0.51,0.07)
-0.25 (-0.53,0.03) 
-0.23 (-0.51,0.05) 
-0.26 (-0.56,0.03)
-0.33 (-0.60, -0.05)* 
-0.31 (-0.57, -0.04)* 
-0.19 (-0.48,0.10)
DIFFERENCE IN Z-SCORES SIMPLE ADJUSTED MODEL* 
+ADJUSTMENT FOR WEIGHT 
FULLY ADJUSTED§
-0.90 (-1.40; -0.41)$ 
-0.53 (-1.02; -0.047)* 
-0.46 (-0.98; 0.05)
-0.32 (-0.69; 0.060) 
-0.19 (-0.57; 0.19) 
-0.28 (-0.68; 0.12)
-0.52 (-0.90; -0.13)$ 
-0.31 (-0.69; 0.07) 
-0.34 (-0.74; 0.06)
-0.66 (-1.03; -0.28)$ 
-0.42 (-0.78; -0.05)* 
-0.26 (-0.65; 0.13)
# Adjusted for sex, age, state, arm, cuff size, body position, indicator for the sequence number (1st through 5m )
§ Additionally adjusted for ethnic group and birthweight; * p-value for trend < 0.05; t p-value <0.01; $ p-value < 0.001
188Table 28 Age adjusted means and prevalences of baseline physical characteristics in relation to adult height
HEIGHT P trend
VARIABLE TERTILE 1  
(<  173.0 CM
TERTILE 2 
(173.1 -  178.0 CM
TERTILE 3 
(>178.0 CM
(N) 4939 6490 5742
MEANS (SE)
AGE AT ENTRY (YEARS) 53.6 (0.1) 52.0 (0.1) 50.9 (0.1) <0.001
SYSTOLIC BLOOD PRESSURE (MMHG) 136.4 (0.3) 136.6(0.3) 136.8 (0.3) 0.18
DIASTOLIC BLOOD PRESSURE (MMHG) 84.2 (0.2) 84.6 (0.2) 84.8 (0.2) 0.01
BODY MASS INDEX (KG/M2) 25.0 (0.04) 24.8 (0.04) 24.5 (0.04) <0.001
CHOLESTEROL (MMOL/L) 5.16(0.02) 5.10(0.02) 5.05 (0.02) 0.001
FEVi (L/SEC) 2.81 (0.01) 3.14 (0.01) 3.41 (0.01) <0.001
PROPORTIONS (SE)
LOW WORK GRADE 34.1 (0.7) 23.6 (0.5) 18.6 (0.5) <0.001
NO PARTNER 15.1 (0.5) 11.3 (0.4) 9.7 (0.4) < 0.001
CHD AT BASELINE 20.1 (0.5) 18.1 (0.5) 17.2 (0.5) <0.001
CURRENT CIGARETTE SMOKER 44.3 (0.7) 41.9(0.6) 38.6 (0.7) < 0.001
GLUCOSE INTOLERANCE 6.2 (0.4) 5.9 (0.3) 4.2 (0.3) <0.001
DIABETES 1.8 (0.2) 1.1 (0.1) 1.1 (0.2) 0.001
189Table 29 Hazard ratios (95 percent confidence intervals) for cardiovascular mortality associated with an increase of 15 cm
IN HEIGHT BY EMPLOYMENT GRADE IN MEN WITHOUT CHD AT BASELINE
HEIGHT AGE ADJUSTED+ FULLY ADJUSTED*
OUTCOME EMPLOYMENT GRADE MEAN (SE) N DEATHS HAZARD RATIO (95%CI) P-VALUE HAZARD RATIO (95%CI) P-VALUE
ALL 175.9(0.1) 13885 3975 0.89 (0.83-0.95) 0.001 0.91 (0.85-0.98) 0.009
CVD HIGH
MIDDLE
LOW
TEST FOR INTERACTION
176.6 (0.1) 
174.0 (0.1) 
173.2 (0.2)
10408
2234
1243
2784
763
428
0.84 (0.77-0.91) 
0.96 (0.82-1.13) 
1.05 (0.87-1.26) 
P=0.02
<0.001
0.79
0.52
0.87 (0.80-0.95) 
0.97 (0.83-1.15) 
1.03 (0.85-1.25) 
P=0.05
0.002
0.73
0.75
ALL 175.9(0.1) 13885 2530 0.81 (0.74-0.88) <0.001 0.84 (0.77-0.92) < 0.001
CHD
HIGH
MIDDLE
LOW
TEST FOR INTERACTION
176.6 (0.1) 
174.0 (0.1) 
173.2 (0.2)
10408
2234
1243
1781
478
271
0.77 (0.69-0.85) 
0.84(0.69-1.03) 
0.95 (0.75-1.20) 
P=0.09
<0.001
0.10
0.65
0.81 (0.73-0.90) 
0.87 (0.71-1.07) 
0.94 (0.74-1.19) 
P=0.21
<0.001
0.19
0.59
ALL 175.9(0.1) 13885 738 0.91 (0.78-1.08) 0.28 0.90 (0.76-1.06) 0.21
STROKE
HIGH
MIDDLE
LOW
TEST FOR INTERACTION
176.6(0.1) 
174.0(0.1) 
173.2 (0.2)
10408
2234
1243
517
146
75
0.82 (0.67-1.01) 
1.18(0.82-1.72) 
1.06 (0.68-1.66) 
P=0.13
0.06
0.37
0.80
0.82(0.67-1.00) 
1.17(0.80-1.70) 
1.01 (0.64-1.60) 
P=0.16
0.05
0.42
0.95
+ Analysis of all grades combined is also adjusted for grade
# Multiple adjustment is for age, smoking habit, cholesterol, systolic and diastolic blood pressure, body mass index, forced expiratory volume in one second (adjusted for height), glucose 
intolerance and diabetes
190Table 30 Hazard ratios (95 percent confidence intervals) for cardiovascular mortality associated with an increase of 15 cm
IN HEIGHT BY EMPLOYMENT GRADE IN MEN WITH PREVALENT CHD AT BASELINE
HEIGHT AGE ADJUSTED4 FULLY ADJUSTED*
OUTCOME EMPLOYMENT GRADE MEAN (SE) N DEATHS HAZARD RATIO (95%CI) P-VALUE HAZARD RATIO (95%CI) P-VALUE
ALL 174.9(0.1) 3254 1466 0.78 (0.70-0.87) <0.001 0.80 (0.72-0.90) <0.001
CVD HIGH
MIDDLE
LOW
TEST FOR INTERACTION
175.9(0.1) 
173.3 (0.3) 
171.8 (0.4)
2207
601
446
960
280
226
0.75 (0.65-0.86) 
0.84 (0.65-1.09) 
0.83 (0.64-1.08) 
P=0.41
<0.001
0.19
0.16
0.75 (0.65-0.87) 
0.93 (0.72-1.20) 
0.84(0.65-1.10) 
P=0.27
<0.001
0.58
0.21
ALL 174.9(0.1) 3254 1000 0.74 (0.65-0.85) < 0.001 0.77 (0.67-0.88) <0.001
CHD HIGH
MIDDLE
LOW
TEST FOR INTERACTION
175.9(0.1) 
173.3 (0.3) 
171.8 (0.4)
2207
601
446
644
196
160
0.66 (0.55-0.79) 
0.91 (0.66-1.23) 
0.88 (0.65-1.20) 
P=0.06
< 0.001
0.53
0.42
0.67 (0.56-0.80) 
1.00 (0.74-1.36) 
0.90(0.66-1.24) 
P=0.03
<0.001
0.98
0.52
ALL 174.9(0.1) 3254 214 0.76(0.56-1.02) 0.07 0.76(0.56-1.03) 0.07
STROKE
HIGH
MIDDLE
LOW
TEST FOR INTERACTION
175.9(0.1) 
173.3 (0.3) 
171.8(0.4)
2207
601
446
153
37
24
0.76(0.53-1.09) 
0.74 (0.37-1.49) 
0.80 (0.36-1.79) 
P=0.93
0.13
0.40
0.58
0.74 (0.50-1.07) 
0.80 (0.41-1.53) 
0.81 (0.34-1.91) 
P=0.81
0.10
0.49
0.63
+ Analysis of all grades combined is also adjusted for grade
# Multiple adjustment is for age, smoking habit, cholesterol, systolic and diastolic blood pressure, body mass index, forced expiratory volume in one second (adjusted for height), glucose 
intolerance and diabetes
191Table 31 Hazard ratios (95 percent confidence intervals) for cardiovascular mortality associated with an increase of 15 cm
IN HEIGHT ACCORDING TO LENGTH OF FOLLOW-UP IN ALL MEN
AGE ADJUSTED FULLY ADJUSTED*
OUTCOME FOLLOW-UP PERIOD N DEATHS HAZARD RATIO (95%CI) P-VALUE HAZARD RATIO (95%CI) P-VALUE
ALL 17139 5441 0.82 (0.77-0.87) <0.001 0.87 (0.82-0.93) <0.001
CVD 0-9 YEARS 17139 971 0.71 (0.62-0.81) <0.001 0.78 (0.68-0.90) <0.001
10-19 YEARS 15247 1650 0.87 (0.78-0.97) 0.009 0.93 (0.83-1.04) 0.20
20-29 YEARS 11967 2036 0.80 (0.73-0.89) <0.001 0.85 (0.77-0.94) 0.001
30+ YEARS
TEST FOR INTERACTION
7368 784 0.96 (0.81-1.12) 
P=0.25
0.58 0.99 (0.84-1.17) 
P=0.22
0.88
ALL 17139 3530 0.75 (0.70-0.81) <0.001 0.81 (0.75-0.87) <0.001
CHD
0-9 YEARS 17139 757 0.67 (0.58-0.79) <0.001 0.75 (0.64-0.88) <0.001
10-19 YEARS 15247 1098 0.83 (0.73-0.95) 0.005 0.89 (0.78-1.02) 0.10
20-29 YEARS 11967 1251 0.73 (0.64-0.83) <0.001 0.79 (0.69-0.89) <0.001
30+ YEARS
TEST FOR INTERACTION
7368 424 0.78 (0.62-0.97) 
P=0.41
0.03 0.82(0.66-1.03)
P=0.36
0.09
ALL 17139 952 0.86 (0.75-0.99) 0.04 0.86 (0.74-1.00) 0.04
STROKE
0-9 YEARS 17139 99 0.78 (0.51-1.20) 0.26 0.85 (0.54-1.32) 0.46
10-19 YEARS 15247 262 0.74 (0.57-0.97) 0.03 0.75 (0.57-0.99) 0.04
20-29 YEARS 11967 410 0.79 (0.63-0.98) 0.03 0.79 (0.63-0.98) 0.04
30+ YEARS
TEST FOR INTERACTION
7368 181 1.42(1.02-1.99)
P=0.39
0.04 1.43(1.01-2.01)
P=0.43
0.04
# Full adjustment is for age, employment grade, smoking habit, cholesterol, systolic and diastolic blood pressure, body mass index, forced expiratory volume in one second (adjusted for 
height), glucose intolerance and diabetes
192A ppendixAppendix 1  Contact and response rates of the NSHD at age 53 years.
ORIGINAL COHORT 5362
DEAD BY 53 YEARS -469
LIVING ABROAD AT 53 YEARS -580
ALIVE AND RESIDENT IN ENGLAND, SCOTLAND OR WALES 4313
PREVIOUSLY REFUSED -640
UNTRACED AT 53 YEARS -330
CONTACT ATTEMPTED 3386
NEW TEMPORARY OR PERMANENT REFUSALS -380
CONTACTED AND GAVE INFORMATION 3035
HOME VISIT 2989
POSTAL CONTACT ONLY 46
RESPONSE RATES
OF THE WHOLE COHORT (3035/5362) 56.6%
OF THOSE ALIVE AND RESIDENT IN ENGLAND, SCOTLAND OR WALES 
(3035/4313)
70.4%
OF THOSE CONTACTED AT 53 YEARS (3035/3386) 89.6%
THOSE ALIVE AND RESIDENT AS A % OF THE ORIGINAL COHORT 80.4%
194Appendix 2 Parameters and estimates of the basic multilevel models
In the following equations,  ytj  denotes the blood pressure (pulse pressure, systolic or diastolic blood 
pressure) of subject j (j= 1,  ..., N) on measurement occasion i (i=l,2,3) and  xtj  the age at which that 
measurement was taken (36, 43 and 53 years).  The fixed parameter  J30   represents the mean intercept 
or,  in  this  example,  the  overall  mean  blood  pressure  at  age  36  years.  The  fixed  parameter  fil 
represents the mean slope or equivalently the linear change in blood pressure for each yearly increase 
in age.  p 2  - fi5   denote the fixed effects of the quadratic increase of blood pressure with age, sex,  an 
interaction  term  for  the  linear  change  of  blood  pressure  by  sex  and  an  interaction  term  for  the 
quadratic increase of blood pressure by sex,  respectively.  The basic multilevel model for repeated 
measures of blood pressure at age 36, 43 and 53 years is then written as
Q )
y V = 0Oif* O+0U0 1« +  02* 2,J +03*3f+ 04* 4tf +  03* S ij 
0otj = 0o  + u 0 j   + e oy 
0Ui = 0i +uij
u v
“2
~N(0,  Q j  :   Qu  = Gu 0
J L
_O u10  1 _
e Oij ~N(0?   Qe)  :   Qe =
2
o„o  °_
-2*log(lite) = 24643.690
The parameters  u0j  and  uxj  are the random (between-individual) effects which allow each individual 
to  have  their  own  intercept  and  slope  respectively  and  indicate  the  deviation  of each  individual’s
195intercept and slope from the mean intercept and slope.  These “level 2” random effects parameters are 
assumed to be bivariate normal with mean 0 and variance defined by the variance-covariance matrix 
which has entries given by the variance of  u0 j  (var( u0 j,)= (J20), the variance of  «1;  (var( «1; )=  )
and the covariance between  u0 j  and  u{ j  (cov( u0j, u{j )= < J ul0).  The  within-individual  (“level  1”) 
variation  e0 ij  at age 36 years is also allowed to vary with age (eUj)  and is assumed to be bivariate 
normally distributed, with mean 0 and variance defined by the variance-covariance matrix which has 
entries  given  by  the  variance  of  e0ij  (var( e0 lj )= <Je 2 0),  the  variance  of  eU j  (var( eU j )=  )  and  the
covariance between  eQ lj  and  euj  (cov( e0ij, eUj).  The variance  (J2 el  was  set to 0,  so that the level  1 
variance increased linearly with age.
Estimates  for  the  basic  models  including  pulse  pressure,  systolic  and  diastolic  blood  pressure, 
respectively, are given below.
196Pulse pressure
y„~  N(J®#  q)
yi} = 0o? o + 0u? iy + 0.066(0.005)x ^ + -2.126(0.418>X3;. + 0.784(0.116)?^ + -0.046(0.006)x^ 
fa. =44.245(0.294) + u ^ + eQ ij 
/?t.  =-0.625(0.082) + « v
w0 j ~N(0,  Q j  :  Qu = 36.593(3.883)
“v. -0.711(0.284)  0.146(0.033)
e O y ~N(0,  Qe)  :  Qe = 86.036(3.756)
1.191(0.233)  0
-2*log(like) = 68687.630
Systolic blo o d pr essu r e 
~N(ZB, Q)
Jy -  00? o + / v  IV  + 0.067(0.005)x 2,? + -5.427(0.548)x3; + 0.474(0.136)x4y + -0.036(0.008^ 
^  = 122.718(0.386)+ !^ + ^
^  =-0.109(0.096)+ « v
.  V.
N(0,  QJ  :  Qu = 97.849(6.301)
-0.160(0.430)  0.468(0.050)
O y
lyj
N(0,  Q.)  : 117.529(5.287) 
1.267(0.330)  0
-2*log(like) = 73504.520
197Diastolic blood pressure
ytJ ~ N(ZB, Q)
ytj = 0oi? o  + fin? iy + -3.616(0.418)x2 j + -O.mtO^Ix^ 
/?oy =78-454(0.295) + w0 j. + e0 iJ  
^=0.524(0.023)+ « v
54.459(4.179)
-0.477(0.265)  0.089(0.027)
e O ff ~N(0,  Qe)  :  Qe = 97.384(3.622)
f  1'J. -0.496(0.197)  0
-2*log(like) = 68251.630
u
oj
“ ui
N(0,  Q j  :  Q„ =
198Appendix 3 Project Viva response rates at the 3 year follow-up
ORIGINAL COHORT (LIVE BIRTHS) 2128
NOT INPERSON ELIGIBLE (NO PREGNANCY FFQ) AND NOT IN IMMUNE 
SUBSTUDY
-177
ELIGIBLE FOR 3 YEAR INPERSON VISIT 1951
DISENROLLED BEFORE 3 YEAR FOLLOW-UP -97
"REFUSED" TODDLER ENROLLMENT BEFORE 3 YEAR FOLLOW-UP -275
"UNENROLLED" AT 3 YEAR FOLLOW-UP -37
REFUSED TODDLER ENROLLMENT AT 3 YEAR FOLLOW-UP -26
MISSING VISIT FORMS -  NO 3 YEAR VISIT -29
NO 3 YEAR DATA ("NOT YET") -118
CONTACTED AND GAVE INFORMATION 1369
POSTAL/ PHONE CONTACT ONLY 106
HOME VISIT 1263
MISSING BLOOD PRESSURE DATA -92
MISSING ATHROPOMETRY -21
PREMATURE BIRTHS -17
FINAL COHORT FOR ANALYSIS 1133
RESPONSE RATES
OF THE WHOLE COHORT 53%
OF THOSE ELIGIBLE FOR THE 3 YEAR FOLLOW-UP 58%
OF THOSE ATTENDING THE 3 YEAR FOLLOW-UP 83%
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